Localization and Functional Analysis of the Calcium Permeable Melastatin-like Channel TRPM3 by Chen, Xiaodi & Plant, Tim (Prof. Dr.)
Aus dem Institut fu¨r Pharmakologie und Toxikologie
Gescha¨ftsfu¨hrender Direktor: Prof. Dr. Frank Czubayko
des Fachbereichs Medizin der Philipps–Universitu¨t Marburg
Localization and Functional Analysis of the
Calcium Permeable Melastatin–like Channel
TRPM3
Inaugural–Dissertation zur Erlangung
des Doktorgrades der Humanbiologie
dem Fachbereich Medizin der Philipps–Universita¨t Marburg
vorgelegt von
CHEN, XIAODI
aus Shanghai, China
Marburg/Lahn 2009
Angenommen vom Fachbereich Medizin der Philipps–Universita¨t Marburg
am: 10.12.2009
Gedruckt mit Genehmigung des Fachbereichs.
Dekan: Prof. Dr. Matthias Rothmund
Referent: Prof. Dr. Tim Plant
Korreferent: Prof. Dr. Dr. Ju¨rgen Daut
To my wife and daughter
Acknowledgement
I would like to acknowledge all those very helpful people who have assisted me in my work.
First and foremost, I would like to sincerely thank my mentor, Dr. Thomas Hofmann,
for his guidance, understanding, insightful criticisms, patience, and most importantly, his
friendship during my doctoral thesis at Philipps–University Marburg. He encouraged me
to develop independent thinking and research skills, and helped me in the final stage of
writing the thesis.
I wish to express my sincere gratitude to Prof. Dr. Tim Plant for his kindness, support
and suggestions throughout all stages of the thesis. I would also like to thank Dr. Vladimir
Chubanov for his assistance and guidance in various molecular biologic approaches.
My thanks go to all of the members of the Dr. Thomas Hofmann research group, especially,
Fatma Aktuna, Anna Dietz, for helping me in the experiments and giving some needed
humor and entertainment in a somewhat stressful laboratory environment. Thanks to Prof.
Dr. Alexander Dietrich, Prof. Dr. Achim Aigner, and Prof. Dr. Frank Czubayko, whose
advice, guidance and wisdom aided the writing of this thesis. My thanks also go to Daniel
Schulze, Meike Fahlbusch, Tim Mayer, Sabrina Ho¨bel, Ahmed Ibrahim, Winfried Lorenz,
Susanne Ziegler, with whom I worked efficiently and solved many of the same problems.
I am deeply grateful to the Department of Pharmacology and Toxicology at Philipps–
University Marburg, especially to those members who gave me their valuable input and
advice.
Philipps University
Marburg
December 11, 2009
Table of Contents
Acknowledgement iv
List of Figures xi
List of Tables xiii
List of Abbreviations xiv
1 Introduction 1
1.1 Ca2+ signaling and phospholipase C–mediated signaling pathways . . . . . 1
1.2 TRP channels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.2.1 The molecular structure of mammalian TRP channels . . . . . . . . 3
1.2.1.1 Transmembrane domains, N– and C–termini of TRP channels 3
1.2.1.2 Multimerization of mammalian TRP channel subunits . . . 5
1.2.2 Tissue expression and biological functions of mammalian TRP channels 5
1.2.3 TRPM channels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.3 TRPM3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
1.3.1 Structural features of TRPM3 . . . . . . . . . . . . . . . . . . . . . 9
1.3.1.1 Genomic regions and transcript variants . . . . . . . . . . . 9
1.3.1.2 Protein structure . . . . . . . . . . . . . . . . . . . . . . . . 10
1.3.2 Tissue distribution of TRPM3 . . . . . . . . . . . . . . . . . . . . . 10
1.3.3 Channel properties of TRPM3 . . . . . . . . . . . . . . . . . . . . . 11
1.3.4 Inhibition, blockage and activation of TRPM3 . . . . . . . . . . . . 12
1.3.5 Biological role and relevance of TRPM3 . . . . . . . . . . . . . . . . 13
1.4 Objectives of this thesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
iv
TABLE OF CONTENTS
2 Materials and Methods 14
2.1 Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.1.1 Animals, bacteria, cell lines and yeast cells . . . . . . . . . . . . . . 14
2.1.2 Antibodies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.1.3 Cell culture materials . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.1.4 Chemicals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.1.5 Consumables and laboratory equipment . . . . . . . . . . . . . . . . 17
2.1.6 Enzymes and peptides . . . . . . . . . . . . . . . . . . . . . . . . . . 18
2.1.7 Molecular biology reagent systems . . . . . . . . . . . . . . . . . . . 18
2.1.8 Nucleic acids and plasmids . . . . . . . . . . . . . . . . . . . . . . . 19
2.1.9 Bioinformatic tools and online databases . . . . . . . . . . . . . . . . 19
2.1.10 Oligonucleotides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.2.1 DNA analysis and preparation . . . . . . . . . . . . . . . . . . . . . 21
2.2.1.1 General DNA methods . . . . . . . . . . . . . . . . . . . . 21
2.2.1.2 Polymerase chain reaction (PCR) . . . . . . . . . . . . . . 21
2.2.1.3 Preparation of chemocompetent DH5α E.coli cells . . . . . 22
2.2.1.4 DNA transfection . . . . . . . . . . . . . . . . . . . . . . . 23
2.2.1.5 Rapid amplification of cDNA ends (RACE) . . . . . . . . . 23
2.2.1.6 Site–directed mutagenesis . . . . . . . . . . . . . . . . . . . 25
2.2.1.7 TOPO®–cloning . . . . . . . . . . . . . . . . . . . . . . . . 25
2.2.2 RNA analysis and preparation . . . . . . . . . . . . . . . . . . . . . 26
2.2.2.1 Isolation of total RNA from eukaryotic cells and tissues . . 26
2.2.2.2 Selection of Poly(A)+ RNA from total RNA . . . . . . . . 26
2.2.2.3 Electrophoresis of RNA with agarose–formaldehyde gels . . 27
2.2.2.4 Northern blotting . . . . . . . . . . . . . . . . . . . . . . . 27
2.2.2.5 Random–primed radioactive DNA labeling . . . . . . . . . 28
2.2.2.6 Northern hybridization . . . . . . . . . . . . . . . . . . . . 29
2.2.3 Protein biochemical analysis . . . . . . . . . . . . . . . . . . . . . . 29
2.2.3.1 Membrane protein extraction from mouse tissues . . . . . . 30
2.2.3.2 SDS–PAGE . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.2.3.3 Western blot . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.2.3.4 Co–immunoprecipitation . . . . . . . . . . . . . . . . . . . 31
v
TABLE OF CONTENTS
2.2.3.5 Fluorescence resonance energy transfer (FRET) . . . . . . 32
2.2.4 Yeast genetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.2.4.1 Yeast two hybrid screening . . . . . . . . . . . . . . . . . . 33
2.2.4.2 Transformation of DNA into competent yeast cells . . . . . 37
2.2.4.3 Preparation of yeast total DNA using glass beads . . . . . 37
2.2.4.4 Yeast protein extraction . . . . . . . . . . . . . . . . . . . . 38
2.2.4.5 Yeast colony–PCR . . . . . . . . . . . . . . . . . . . . . . . 39
2.2.4.6 Colony–lift filter assay . . . . . . . . . . . . . . . . . . . . . 39
2.2.5 Cell culture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.2.5.1 General cell culture techniques . . . . . . . . . . . . . . . . 39
2.2.5.2 Primary cell culture: melanocyte isolation from the mouse
dermis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.2.5.3 Generation of stable mammalian cell lines using the GeneSwitch™
system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
2.2.6 Methods for histology and immunohistochemistry . . . . . . . . . . . 42
2.2.6.1 General histological techniques . . . . . . . . . . . . . . . . 42
2.2.6.2 β-galactosidase (lacZ) assay . . . . . . . . . . . . . . . . . 42
2.2.6.3 Immunofluorescent labeling of adherent cells . . . . . . . . 44
2.2.6.4 Confocal and fluorescence microscopy . . . . . . . . . . . . 44
2.2.6.5 Antigen design and antibody production . . . . . . . . . . 44
2.2.7 Measurement of the intracellular free Ca2+ concentration . . . . . . 45
2.2.7.1 Fura-2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
2.2.7.2 Aequorin . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
2.2.8 LacZ transgenic TRPM3 mouse, mouse genotyping and phenotyping 48
2.2.8.1 LacZ transgenic TRPM3 mouse . . . . . . . . . . . . . . . 48
2.2.8.2 Genotyping of lacZ transgenic TRPM3 mice . . . . . . . . 48
2.2.8.3 Phenotypic analysis of TRPM3−/− mice . . . . . . . . . . . 50
3 Results 52
3.1 Molecular cloning and functional analysis of mTRPM3 . . . . . . . . . . . . 52
3.1.1 Molecular cloning of mM31719 and mM31337 . . . . . . . . . . . . . . 52
3.1.2 Analysis of mM31719 and mM31337 protein expression . . . . . . . . 53
3.1.3 Functional analysis of mM31719 . . . . . . . . . . . . . . . . . . . . . 56
vi
TABLE OF CONTENTS
3.1.3.1 Quantification of intracellular Ca2+ concentration increase
in HEK-293 cells expressing mM31719 and mM31337 . . . . 57
3.1.3.2 Effects of divalent cations on Ca2+ entry in HEK-293 cells
expressing mM31719 . . . . . . . . . . . . . . . . . . . . . . 59
3.2 Identification of functional domains in mM31719 . . . . . . . . . . . . . . . . 61
3.2.1 Structure of the pore and C–terminus of mM31719 . . . . . . . . . . 61
3.2.1.1 Site–directed mutagenesis of amino acid residues relevant to
Ca2+ entry in the mM31719 pore . . . . . . . . . . . . . . . 61
3.2.1.2 Characterization of the mM31719 C–terminus . . . . . . . . 64
3.2.2 Analysis of mM31719 homomer formation . . . . . . . . . . . . . . . 69
3.2.3 Identification of putative interaction partners of mM31719 . . . . . . 74
3.2.3.1 Identification of putative interaction partners of mM31719
using the yeast two hybrid system . . . . . . . . . . . . . . 74
3.2.3.2 Analysis of protein kinase inhibitor–gamma as an interaction
partner for mM31719 . . . . . . . . . . . . . . . . . . . . . . 77
3.3 Tissue distribution of mouse TRPM3 . . . . . . . . . . . . . . . . . . . . . . 79
3.3.1 Northern blot analysis of mouse TRPM3 tissue distribution . . . . . 79
3.3.2 Western blot analysis of mouse TRPM3 expression . . . . . . . . . . 80
3.3.2.1 Characterization of mouse TRPM3 antibodies . . . . . . . 80
3.3.2.2 Analysis of the TRPM3 protein expression in the adult mouse
eye . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
3.3.3 Histochemical and immunohistochemical analysis of TRPM3 expres-
sion using a lacZ transgenic mouse model . . . . . . . . . . . . . . . 83
3.3.3.1 LacZ gene expression in lacZ transgenic TRPM3−/− adult
mice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
3.3.3.2 Tissue distribution of TRPM3 during mouse development . 90
3.4 Phenotypic analysis of a TRPM3−/− mouse model . . . . . . . . . . . . . . 96
3.4.1 Genotyping and genetic background correction . . . . . . . . . . . . 96
3.4.2 The viability of TRPM3−/− mice . . . . . . . . . . . . . . . . . . . . 98
3.4.3 Morphological observations on TRPM3−/− mice . . . . . . . . . . . 99
3.4.4 Behavioral analyses of the visual ability of TRPM3−/− mice . . . . . 99
4 Discussion 101
4.1 Molecular cloning and functional analysis of mM31719 and mM31337 . . . . . 101
vii
TABLE OF CONTENTS
4.1.1 Cloning and characterization of mM31719 and mM31337 . . . . . . . . 101
4.1.2 Mutagenesis analysis of the pore . . . . . . . . . . . . . . . . . . . . 104
4.2 Molecular structure and functional relevance of the C–terminus . . . . . . . 106
4.2.1 C–terminus of mM31719 and palmitoylation . . . . . . . . . . . . . . 106
4.2.2 C–terminus of mM31719 and homomultimerization . . . . . . . . . . 108
4.2.3 C–terminus of mM31719 and its putative interaction partners . . . . 109
4.3 Expression pattern of mouse TRPM3 . . . . . . . . . . . . . . . . . . . . . . 110
4.3.1 Expression analysis of TRPM3 in mouse tissues using Northern blot,
antibodies and lacZ staining . . . . . . . . . . . . . . . . . . . . . . 110
4.3.2 Mouse TRPM3 and subcellular localization . . . . . . . . . . . . . . 111
4.3.3 Mouse TRPM3 expression and its biological roles . . . . . . . . . . . 112
4.4 Phenotype of the TRPM3 knockout mice . . . . . . . . . . . . . . . . . . . 113
5 Conclusions 115
References 139
Curriculum Vitae 141
Declaration 143
viii
List of Figures
1.1 Ca2+ signaling and phospholipase C–mediated signaling pathways . . . . . 2
1.2 Phylogenetic tree of mammalian TRP channels . . . . . . . . . . . . . . . . 3
1.3 Molecular structure of TRP channels . . . . . . . . . . . . . . . . . . . . . . 4
1.4 Phylogenetic relationship and domain comparison of the TRPM subfamily . 7
1.5 Putative pore structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.1 General principle of FRET . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.2 Principle of yeast two hybrid library screening . . . . . . . . . . . . . . . . . 34
2.3 Flow chart of yeast two hybrid screening and verification of putative protein
interactions in yeast cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
2.4 Mechanism of the GeneSwitch™ system . . . . . . . . . . . . . . . . . . . . 41
2.5 Mechanism of the β-galactosidase (lacZ) assay . . . . . . . . . . . . . . . . 43
2.6 Introduction of fura-2 into the cytoplasm and excitation spectrum of fura-2
under different Ca2+-concentrations . . . . . . . . . . . . . . . . . . . . . . 46
2.7 Ca2+–induced bioluminescence of aequorin . . . . . . . . . . . . . . . . . . . 47
2.8 Gene trap strategy for generating TRPM3 mutations and primer selection
for genotyping . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
2.9 Visual Cliff Apparatus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.1 Sequence of TRPM3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
3.2 Localization of mM31719 and mM31337 in HEK-293 cells and/or MDCK cells 55
3.3 Quantification of intracellular Ca2+ concentration increases caused by extra-
cellular Ca2+ and PS applications in HEK-293 cells expressing mM31719 and
mM31337 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.4 Analysis of the effects of extracellular Ni2+ on Ca2+ entry in mM31719 . . . 59
ix
LIST OF FIGURES
3.5 Effects of divalent ions on Ca2+ entry through mM31719 . . . . . . . . . . . 60
3.6 Ca2+ entry through mM31719 with P1060R and G1066V pore mutations . . 62
3.7 Ca2+ entry through mM31719 with the D1074A pore mutation . . . . . . . . 64
3.8 Protein expression of the mM31719 C–terminus in HEK-293 cells and the
putative role of PH–domain in the plasma membrane attachment of the
mM31719 C–terminus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
3.9 Effects of cysteine residues on the plasma membrane attachment of M3TC . 67
3.10 Effects of palmitoylation on the function and subcellular localization of mM31719 68
3.11 Analysis of mM31719 homomultimerization using the FRET technique . . . 71
3.12 Analysis of mM31719 homomultimerization using co-immunoprecipitation . . 72
3.13 Analysis of the mM31719 and mM31337 subunit interactions using the yeast
two hybrid system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
3.14 Subunit interaction analysis between mTRPM3 and PKIG . . . . . . . . . . 77
3.15 Effects of db-cAMP on Ca2+ entry through mTRPM3 . . . . . . . . . . . . 78
3.16 Northern blot analysis of mouse TRPM3 expression . . . . . . . . . . . . . 80
3.17 Immunofluorescence with mouse TRPM3 antibodies . . . . . . . . . . . . . 81
3.18 Analysis of TRPM3 protein expression in the adult mouse eye . . . . . . . . 82
3.19 LacZ gene expression of mouse TRPM3 in the CNS . . . . . . . . . . . . . 84
3.20 LacZ gene expression of mouse TRPM3 in the retina . . . . . . . . . . . . . 85
3.21 LacZ gene expression of mouse TRPM3 in the gastrointestinal tract . . . . 86
3.22 LacZ gene expression of mouse TRPM3 in the liver and pancreas . . . . . . 87
3.23 LacZ gene expression of mouse TRPM3 in the reproductive system . . . . . 88
3.24 LacZ gene expression of mouse TRPM3 in the skin, heart, kidney, conducting
airways and spleen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
3.25 LacZ staining of whole TRPM3−/− mouse embryos . . . . . . . . . . . . . . 90
3.26 TRPM3–lacZ expression in frozen cranial sections at stage 13 . . . . . . . . 91
3.27 TRPM3–lacZ expression in frozen cranial and cervical sections at stage 13 . 92
3.28 TRPM3–lacZ expression in frozen thoracic sections at stage 13 . . . . . . . 93
3.29 TRPM3–lacZ expression in frozen caudal sections at stage 13 . . . . . . . . 94
3.30 Generation of homozygous Agouti and non-albino TRPM3−/− mouse . . . 97
3.31 Generation of homozygous Agouti and non-albino TRPM3−/− mice using
genotyping and DNA sequencing . . . . . . . . . . . . . . . . . . . . . . . . 98
3.32 Phenotype of TRPM3−/− mice and visual testing . . . . . . . . . . . . . . . 100
x
LIST OF FIGURES
4.1 TRPM3 protein isoforms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
4.2 Pore model of mM31719 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
xi
List of Tables
2.1 Animals, bacteria, cell lines and yeast cells . . . . . . . . . . . . . . . . . . . 14
2.2 Antibodies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.3 Cell culture materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.4 Chemicals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.5 Consumables and laboratory equipment . . . . . . . . . . . . . . . . . . . . 17
2.6 Enzymes and peptides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
2.7 Molecular biology reagent systems . . . . . . . . . . . . . . . . . . . . . . . 18
2.8 Nucleic acids and plasmids . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.9 Bioinformatic tools and online databases . . . . . . . . . . . . . . . . . . . . 19
2.10 Oligonucleotides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.11 Standard PCR components . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.12 Standard PCR conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.13 Buffer and medium for chemocompetent DH5α E.coli cells preparation . . . 22
2.14 Transfection conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.15 PCR components for first and nested reaction . . . . . . . . . . . . . . . . . 24
2.16 PCR conditions for first and nested reaction . . . . . . . . . . . . . . . . . . 25
2.17 Thermal cycling parameters for site-directed mutagenesis . . . . . . . . . . 26
2.18 Total RNA isolation from HEK293 cells and mouse tissues . . . . . . . . . . 27
2.19 Touchdown PCR conditions for mouse genotyping . . . . . . . . . . . . . . 50
3.1 Putative interaction partners of mM31719 identified by high stringency selection 75
3.2 Putative interaction partners of mM31719 identified by medium stringency
selection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
3.3 LacZ gene expression in the lacZ transgenic TRPM3−/− mouse . . . . . . . 95
xii
LIST OF TABLES
4.1 Domain composition of mM31719 . . . . . . . . . . . . . . . . . . . . . . . . 108
xiii
List of Abbreviations
3-AT . . . . . . . . . . . . . . . . . . . . 3-amino-1,2,4-triazole
AER . . . . . . . . . . . . . . . . . . . . apical ectodermal ridge
ANKTM1 . . . . . . . . . . . . . . . ankyrin-like with transmembrane domains 1
APS . . . . . . . . . . . . . . . . . . . . ammonium persulfate
BSA . . . . . . . . . . . . . . . . . . . . bovine serum albumin
CP . . . . . . . . . . . . . . . . . . . . . . choroid plexus
CSF . . . . . . . . . . . . . . . . . . . . . cerebrospinal fluid
DAG . . . . . . . . . . . . . . . . . . . . diacyglycerol
DAPI . . . . . . . . . . . . . . . . . . . 4’, 6-diamidino-2-phenylindole
DEPC . . . . . . . . . . . . . . . . . . diethyl pyrocarbonate
DMF . . . . . . . . . . . . . . . . . . . . N,N-dimethylformamide
DMSO . . . . . . . . . . . . . . . . . . dimethyl sulfoxide
DTT . . . . . . . . . . . . . . . . . . . . dithiothreitol
EDTA . . . . . . . . . . . . . . . . . . ethylene-diamine-tetraacetic acid
EGTA . . . . . . . . . . . . . . . . . . ethylene-glycol-tetraacetic acid
FCS . . . . . . . . . . . . . . . . . . . . . fetal calf serum
Fura-2AM . . . . . . . . . . . . . . . fura-2-acetoxymethyl ester
GFP . . . . . . . . . . . . . . . . . . . . green fluorescent protein
HA . . . . . . . . . . . . . . . . . . . . . hemagglutinin
HEPES . . . . . . . . . . . . . . . . . 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HRP . . . . . . . . . . . . . . . . . . . . horseradish peroxidase
IPTG . . . . . . . . . . . . . . . . . . . isopropyl-β-D-thiogalacto-pyranoside
LiAc . . . . . . . . . . . . . . . . . . . . lithium acetate
MDCK . . . . . . . . . . . . . . . . . . Madin-Darby canine kidney
mM3-S . . . . . . . . . . . . . . . . . . mouse TRPM3 short splice variant
LIST OF ABBREVIATIONS
mM3-T . . . . . . . . . . . . . . . . . mouse TRPM3-T splice variant
MOPS . . . . . . . . . . . . . . . . . . 3-(N-morpholino)propanesulfonic acid
NCC . . . . . . . . . . . . . . . . . . . . neural crest cells
NOMP-C . . . . . . . . . . . . . . . no mechanoreceptor potential-C
NP-40 . . . . . . . . . . . . . . . . . . . nonylphenyl polyethylene glycol
NUDT9 . . . . . . . . . . . . . . . . . human nucleoside diphosphate-linked moiety X-type motif 9
PAGE . . . . . . . . . . . . . . . . . . . polyacrylamide gel electrophoresis
PEG . . . . . . . . . . . . . . . . . . . . polyethylene glycol
PET . . . . . . . . . . . . . . . . . . . . polyester
PFA . . . . . . . . . . . . . . . . . . . . paraformaldehyde
PIC . . . . . . . . . . . . . . . . . . . . . pancreatic islet cells
PIP2 . . . . . . . . . . . . . . . . . . . . phosphatidylinositol(4,5)-biphosphate
PIPES . . . . . . . . . . . . . . . . . . piperazine-N,N´-bis(2-ethanesulfonic acid)
PKIG . . . . . . . . . . . . . . . . . . . protein kinase inhibitor gamma
PLCγ . . . . . . . . . . . . . . . . . . . phospholipase Cγ
PMSF . . . . . . . . . . . . . . . . . . . phenylmethylsulphonyl fluoride
PS . . . . . . . . . . . . . . . . . . . . . . pregnenolone sulfate
pS . . . . . . . . . . . . . . . . . . . . . . picosiemens
RIPA . . . . . . . . . . . . . . . . . . . radio-immuno-precipitation assay
RLM-RACE . . . . . . . . . . . . RNA ligase-mediated rapid amplification of 5'and 3'cDNA ends
SAP . . . . . . . . . . . . . . . . . . . . shrimp alkaline phosphatase
SDS . . . . . . . . . . . . . . . . . . . . . sodium dodecyl sulfate
SSC . . . . . . . . . . . . . . . . . . . . . sodium chloride/sodium citrate
TAE . . . . . . . . . . . . . . . . . . . . tris acetate EDTA
TCA . . . . . . . . . . . . . . . . . . . . trichloroacetic acid
TEMED . . . . . . . . . . . . . . . . N,N,N´N´-tetramethyl-ethylendiamine
Tris base . . . . . . . . . . . . . . . . 2-amino-2-hydroxymethyl-propane-1,3-diol
UAS . . . . . . . . . . . . . . . . . . . . upstream activating sequence
X-gal . . . . . . . . . . . . . . . . . . . . 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside
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1Introduction
1.1 Ca2+ signaling and phospholipase C–mediated signaling
pathways
Calcium (Ca2+) is a universal second messenger that is responsible for fundamental bio-
logical processes such as excitation–contraction coupling of muscle cells, signaling in the
nervous system and embryonic development [16, 207, 237]. The spatial Ca2+ distribution
between cellular compartments (cytosol: ∼10−7 M, intracellular Ca2+ stores: 10−4–10−3
M) and extracellular fluid (∼10−3 M) plays a decisive role in Ca2+ signaling, and is strictly
controlled by several mechanisms including Ca2+ permeable channels, Ca2+ pumps and
Ca2+–Na+ exchangers [208]. The large Ca2+ concentration (
[
Ca2+
]
) gradient between in-
tracellular and extracellular compartments permits a rapid intracellular Ca2+ concentration
(
[
Ca2+
]
i) change and therefore gives Ca2+ a signal character. Opening of Ca2+ permeable
channels caused by ligand binding, mechanical stretch, membrane depolarization [108], or
by depletion of intracellular Ca2+ stores [32] results in an increase of intracellular Ca2+
coming either from the lumen of endoplasmic reticulum/sarcoplasmic reticulum (ER/SR)
or from the cell exterior across the plasma membrane. The increased cytosolic free Ca2+
triggers Ca2+–dependent signal cascades that are mediated either directly by Ca2+–binding
molecules such as calmodulin and troponin C that e.g., initiate muscle cell contraction,
or indirectly by Ca2+/calmodulin–dependent protein kinases (CaM–kinases) that result in
serine or threonine phosphorylation of target proteins.
Many non–excitable cells can be stimulated by neurotransmitters, hormones or growth
factors that cause
[
Ca2+
]
i increases through phospholipase C (PLC)–mediated signaling
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pathway. The activated PLC cleaves phosphatidylinositol 4,5-bisphosphate (PIP2), a mem-
brane–bound inositol phospholipid, into two second messengers: diacylglycerol (DAG) and
inositol 1,4,5-trisphosphate (IP3). Whereas DAG remains within the plasma membrane and
activates PKC or some non–voltage–dependent Ca2+ channels (e.g., TRPC3/6/7 cation
channels [14, 77]), IP3 diffuses into the cytosol and binds to the IP3 receptor resulting in
Ca2+ release from the lumen of ER (Figure: 1.1). It is well known that the PLC–mediated
signaling pathway is involved in the physiological functions of various membrane receptors
and ion channels such as transient receptor potential (TRP) channels.
Figure 1.1: Ca2+ signaling and phospholipase C–mediated signaling pathways
PLC(β or γ) can be activated by active G–proteins or receptor tyrosine kinases and in turn
hydrolyzes PIP2 into DAG and IP3. Apart from PLC–mediated signaling pathways (s. text for
detail), a Ca2+ influx from cell exterior into cytosol can also be induced by store–operated chan-
nels (SOCs) which are activated by the depletion of intracellular Ca2+ stores (e.g., thapsigargin
treatment) [5, 85, 144, 164]. Abbreviations: GPCR, G protein–coupled receptor; PLCβ,
phospholipase Cβ; PLCγ, phospholipase Cγ; PIP2, phosphatidylinositol 4,5-biphosphate; IP3,
inositol 1,4,5-triphosphate; IP3-R, inositol triphosphate receptor; DAG, diacylglycerol; PKC,
protein kinase C; TK-R, tyrosine kinase receptor; TRP channel, transient receptor potential
channel; SOC, store-operated channel.
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1.2 TRP channels
Figure 1.2: Phylogenetic tree of mam-
malian TRP channels The dendrogram showing
the evolutionary relationship among mammalian
TRP channels was produced by using ClustalW2
for multiple sequence alignments and Dendroscope
2 for a graphical representation [83]. The evo-
lutionary distance is expressed as the number of
amino acid substitutions per residue.
Transient receptor potential (TRP) chan-
nels were first described in Drosophila,
where they play a critical role in PLC–
mediated visual transduction [38, 126, 131].
In Drosophila, the trp mutant has a tran-
sient voltage response to light and ex-
hibits a visual defect caused by a signifi-
cant decrease in light–induced Ca2+ influx
into photoreceptors [67, 124, 125]. TRP
channels are highly conserved throughout
evolution [123] and have been classified
into seven subfamilies. With the excep-
tion of TRPN (NOMP-C) which is only
found in zebrafish [200] and invertebrates
[233], TRPC (Classical or Canonical),
TRPA (ANKTM1), TRPV (Vanilloid),
TRPM (Melastatin), TRPP (Polycystin)
and TRPML (Mucolipin) channels are
widely expressed in both vertebrates and in-
vertebrates [132] (Figure: 1.2).
1.2.1 The molecular structure of mammalian TRP channels
TRP channels constitute a complex group of cation channels and demonstrate their biolog-
ical diversity not only in ion selectivities and physiological functions, but also in activation
and regulation mechanisms [66]. However, TRP channels have several structural similarities
such as six putative transmembrane domains with a pore region between the fifth and sixth
transmembrane (TM5 and TM6) domains, and cytoplasmic N– and C–termini.
1.2.1.1 Transmembrane domains, N– and C–termini of TRP channels
The precise molecular structure of the six transmembrane (6TM) domains of TRP channels
is unknown, but the TM5 and TM6 domains are thought to be analogous to the 2TM
3
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Figure 1.3: Molecular structure of TRP channels
A: Tetrameric assembly of TRP channels. 4×TM5–loop–TM6 units form a cation permeable
channel. B: Cations diffusing into the cytosol are mainly controlled by selectivity filter and lower
gate. The photo was adapted from Clapham, 2003 [32]. C: Structural topology of mammalian
TRP channels. Ankyrin repeats are found in TRPC, TRPV (3–4 in number) and TRPA1 (14 in
number). The TRP domain in TRPC is more conserved than it in TRPV and TRPM channels.
Homer, an adaptor protein, regulates protein interaction between TRPC1 and IP3R1, thus
affecting Ca2+ influx [251]. CIRB is conserved in all seven TRPC channels and may be crucial
to the channel activity [159, 210, 239]. Walker A and B domains binding with ATP regulate
the biological function of TRPV1 [90]. PDZ–binding sites in TRPC4 and TRPC5; and PH
(pleckstrin homology) domain in TRPC3 [221] and TRPM4 [145] are not shown.
of voltage–dependent KcsA channels [42, 249]. The 6TM domains assemble to form a
tetramer [95] in which the TM5 domain faces the lipid membrane and the TM6 domain lines
the pore region [33]. Four “TM5–pore–TM6” units construct a special cation–permeable
channel that contains a selectivity filter (upper gate) and a lower gate (Figure: 1.3). The
selectivity filter, which is located near the outer face of the membrane and formed by
amino acids of the four selectivity loop units, selects cations to diffuse into cytosol. The
lower gate formed by cytoplasmic ends of TM6 domains regulates the cation influx through
the channel [32]. The detailed structure of the TM1–4 domains remains unclear; even so,
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the deficiency of positively charged arginines in TM4 domain probably explains the weak
voltage dependence of TRP channels [26]. Compared to other TRP channels, the TRPP and
TRPML superfamilies have a large extracellular loop between TM1–2 domains and share a
low sequence similarity in the transmembrane domains. They are classified as Group 2 TRP
channels, while the TRPC, TRPV, TRPM, TRPA and TRPN channels belong to Group 1
TRP channels [132, 226].
Protein motifs in the cytoplasmic N– and C–termini are the basic structural features of
the TRP channels. TRPC and some TRPV channels contain multiple ankyrin repeats in
the N terminus which probably play an essential role in specific protein–protein interactions
[192]. In the TRPC, TRPM and TRPN channels, a highly conserved amino acid region –
the TRP domain – is located C–terminally of the TM6 helix [132]. The TRP domain
contains a TRP box (WKFQR) which is followed by proline–rich sequences in some TRP
channels. Roha´cs and colleagues found that the TRP domain may function as a interaction
site for PI(4,5)P2 to regulate TRPM8 channel activity [178]. Some other important motifs
are shown in Figure 1.3.
1.2.1.2 Multimerization of mammalian TRP channel subunits
Except for voltage dependent Ca2+ and Na+ channels, all hexahelical cation channels require
a functional pore structure assembled by four subunits [187]. Due to analogy with the
more distantly related KcsA channels [42] and cyclic-nucleotide–gated channels [94], TRP
channels are presumed to be expressed as oligomeric complexes composed of two or more
highly phylogenetically related TRP subunits [132, 187]. However, the mechanisms and
biological functions of the channel multimerization are still poorly understood. Several TRP
channels have been confirmed to form homomeric and/or heteromeric channel complexes
such as TRPC3/6/7 [56] and TRPM6/7 [31]. The N–terminus [8, 49] and C–terminus [54]
of TRPs may be responsible for the channel subunit–subunit interactions.
1.2.2 Tissue expression and biological functions of mammalian TRP chan-
nels
The TRP channels constitute one of the largest ion channel families known [162]. The gene
expression of the TRP channels can be found in various tissues and organs where they fulfill
their specific physiological functions [177]. For example, TRPC5 is widely expressed in the
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brain and plays a role in the neurite outgrowth and axonal pathfinding [57]. TRPV5–
6 channels are enriched in intestinal tract and kidney where they are involved in Ca2+
reabsorption [49]. Due to the localization in both kino– and stereocilia, TRPP channels
are thought to be able to detect signal changes in the extracellular environment such as
osmolarity in fluid flow and mechanical stress [132]. TRPML3 is found in hair cells and has
effects on hearing [41].
Almost all TRP channels are non–selective cation channels (with the exception of the
Ca2+ impermeable TRPM4 and TRPM5 channels [104, 110], and the highly Ca2+ permeable
TRPV5 and TRPV6 channels [161]), and the activation mechanisms of them are largely
unknown. However, the TRP channels are thought to be mainly activated or modulated by
PLC–signal transduction pathways [32, 133]. The biological functions of the TRP channels
are considered to be closely related to their specific tissue expressions [34, 132]. For example,
“loss–” or “gain–of–function” of TRP channels can induce the pathophysiological changes in
tissues [153]. Besides the PLC–mediated signaling pathways, the cAMP/PKA–dependent
signaling is also involved in the regulation of TRP channel activities. For example, PKA
plays a role in the phosphorylation and sensitization of TRPV1 [172] and in the channel
activity up–regulation of TRPM7 [209].
1.2.3 TRPM channels
The TRPM subfamily is named after its founding member, melastatin (TRPM1). In verte-
brates, the TRPM subfamily consists of eight members which have been classified into four
groups: TRPM1/3, TRPM2/8, TRPM4/5 and TRPM6/7 based on the sequence similarity
(Figure: 1.2).
In comparison with TRPC and TRPV channels, the N–termini of TRPM channels
are longer (∼750 residues) and do not contain ankyrin repeats but have a large “TRPM
homology region” whose functions are still elusive [132]. The six transmembrane domains
(6TM) of TRPM channels constitute a cation permeable channel in a functional multimeric
form [31, 109, 171, 187]. The 6TM and pore structures among the members of TRPM
subfamily are highly conserved. The C–termini of TRPM channels can be divided into
two regions [113]: a conserved region containing TRP and Coiled–Coil (C–C) domains,
and a variable region whose molecular structure are little known (Figure: 1.4). The TRP
domain is C–terminally close to the TM6 and probably serves as a binding site for PI(4,5)P2
in the TRPM8 channel [178]. The C–C domain may be associated with channel subunit
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Figure 1.4: Phylogenetic relationship and domain comparison of the TRPM sub-
family
The dendrogram was generated using ClustalW2 for multiple sequence alignments and Den-
droscope 2 for a graphical representation [83]. The evolutionary distance was expressed as the
number of amino acid substitutions per residue (A). See text for the detail description of the
important structural domains of TRPM subfamily.
multimerization and probably has regulatory function on the channel activities [47, 48,
88, 118, 218]. The TRPM2, TRPM6 and TRPM7 channels were referred as “chanzymes”
because of the C–terminal fusion with enzymatic domains. The NUDIX box domain of
TRPM2 channel is highly homologous to NUDT9 which is a NUDIX enzyme with ADP–
ribose hydrolase activity [169, 185, 193]. The NUDIX domain probably plays an important
role in TRPM channel evolution. During evolution, a loss of NUDIX domain–coding exons
causes TRPM3–like channels (TRPM1, TRPM3, TRPM6, TRPM7) in bilateral animals
[117]. The Ser/Thr protein kinase domains of TRPM6 and TRPM7 [139, 181] belong
to the atypical α–kinase family [182] which includes elongation factor–2 kinase [183] and
myosin heavy chain kinase A [53]. While the functions of the TRPM6 kinase domain remain
unknown, the kinase activity of TRPM7 was thought to modulate channel sensitivity for
Mg2+ inhibition [190] and intracellular cAMP regulation [209]. TRPM6 and TRPM7 form
a multimeric complex which is required for TRPM6 plasma membrane localization [29,
31]. TRPM8 and TRPM2 belong to the same subgroup, but TRPM8 does not contain an
enzymatic domain. Phelps et al. found that the N– and C–termini were critical for TRPM8
physiological function, and the six transmembrane domains were sufficient for TPRM8
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tetramerization [171]. TRPM4 possesses a C–terminal pleckstrin homology (PH) domain,
a putative PIP2 binding domain, which modulates the Ca2+ sensitivity of the channel
[66, 110, 145]. Besides the typical TRPM channel structures: four homology domains in
the N–termini, six transmembrane domains, TRP domains followed by C–C domains in the
C–termini, no enzymatic or other functional domains have been described in the TRPM1
and TRPM3 channels until now.
The members of the TRPM subfamily have individual characteristics in their expression
patterns, ion selectivities and gating mechanisms, which are directly involved in the channel
biological functions such as controlling cation entry and cell growth. TRPM1 was isolated
from mouse melanoma cell lines and supposed to be a constitutively open Ca2+ entry channel
[247]. TRPM2 is a voltage–independent non–selective cation channel. TRPM2 is permeable
not only to monovalent cations such as Na+, K+ and Cs+, but also to divalent cations
such as Ca2+ [72, 169]. TRPM2 expression can be detected in many cell types, especially
in brain and immune cells [140, 185], and its channel activity is regulated by a variety of
factors including warm temperature (>35℃), oxidative stress and TNFα [65, 121, 214, 240].
TRPM3 is the last identified member of the TRPM subfamily and is structurally most
related to TRPM1 (Section: 1.3) [106, 156]. TRPM4 is expressed as three isoforms in man
(TRPM4a, TRPM4b and TRPM4c [137, 148]) and found in various tissues and cell types
including excitable and non–excitable cells. TRPM4b is reported to be a monovalent cation
selective channel that is impermeable to Ca2+. However, TRPM4b can be directly activated
by increased
[
Ca2+
]
i [104] and is regulated by PIP2, PKC phosphorylation and the presence
of calmodulin [145, 148, 151, 152]. TRPM5, like TRPM4, is a Ca2+– activated non–selective
cation channel (CAN) impermeable to divalent cations, but non–selective for monovalent
cations [76]. TRPM5 is broadly distributed in different tissues, especially in the taste
receptor cells where it is essential for the signal transduction of sweet, umami, and bitter
tastes [168, 174, 254]. By desensitizing and re-sensitizing the TRPM5 channel respectively,
intracellular Ca2+ and PIP2 regulate the taste transduction in the taste receptor cells [110].
TRPM6 is highly expressed in the kidney and intestine, and plays an important role in renal
and intestinal Mg2+ homeostasis and reabsorption [230]. TRPM6 is mainly permeable to
divalent cations (Mg2+>Ca2+) [109]. TRPM7 is a divalent specific cation channel permeable
not only to Mg2+ and Ca2+ but also to many trace metal ions, with a permeability sequence
of Zn2+ ≈ Ni2+  Ba2+ > Co2+ > Mg2+ ≥Mn2+ ≥ Sr2+ ≥ Cd2+ ≥ Ca2+ [130]. The tissue
expression of TRPM7 is ubiquitous and the channel activity of TRPM7 can be stimulated by
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intracellular alkalinization, by protons and by fluid flow [89, 98, 139, 154]. TRPM8 is found
in the prostate and dorsal root and trigeminal ganglia where it executes functions in the
thermosensation and nociception [99, 167, 217]. TRPM8 is also one of the “thermoTRPs”
because it can be activated by cool temperature (<26℃) [115] and cooling agents such as
icilin and menthol [142, 167, 227].
1.3 TRPM3
TRPM3 is most phylogenetically related to TRPM1 which is the founding member of the
TRPM subfamily. In comparison to other TRPM channels (e.g., TRPM4, TRPM6 and
TRPM7), TRPM1 and TRPM3 lack functional elements such as an enzyme domain in their
C–termini. Because TRPM1 and TRPM3 are highly conserved throughout evolution, they
are considered as archetypal channels in the TRPM subfamily [117]. Whereas the expression
of TRPM1 is restricted to melanocytes and pigmented melanoma cell lines [43, 44, 81]
and can be transcriptionally regulated by microphthalmia–associated transcription factor
(MITF) [120], the tissue distribution and regulation mechanisms of TRPM3 remain elusive.
1.3.1 Structural features of TRPM3
1.3.1.1 Genomic regions and transcript variants
The TRPM3 gene is highly conserved across mammalian species. The mouse TRPM3
(mTRPM3) gene is more than 850 kb and contains 28 exons located on the chromosome
19qB [157], while the human TRPM3 (hTRPM3) gene is more than 910 kb and consists of
24 exons mapped to the chromosome 9q21.11–q21.12 [106].
Due to alternative splicing, the TRPM3 gene encodes many different transcript variants.
Oberwinkler et al. (2005) cloned five different TRPM3 cDNAs (mTRPM3α1-5) from mouse
brain, whose protein coding sequences range from 1699 to 1721 amino acid residues [157].
The second exon (exon 2) of mTRPM3α1–5 cDNAs is not transcriptionally expressed.
However, exon 2 is the first encoded exon of a human splice variant, hTRPM31325. This
hTRPM31325 transcript variant isolated by Grimm et al. (2003) from human kidney has
a shorter C–terminus and contains only 1325 amino acid residues [58, 156, 157]. About
350 amino acid residues and part of the untranslated region at its C–terminus are removed
by splicing within exon 28, that also introduces a frameshift resulting in seven alternative
amino acid residues at the C–terminal end [58, 156]. According to the start codon present in
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exon 4 predicted by using sequence alignment, Lee et al. (2003) cloned six human TRPM3
cDNAs (hTRPM3a–f) from a human kidney cDNA library [106]. Because the exon 1 and
exon 2 were overlooked, the N–termini of hTRPM3a–f variants are 155 amino acid residues
shorter than the N–termini of mTRPM3α1–5 variants [156]. As a result of alternative
splicing, the TRPM3 transcript variants differ also by the presence or absence of four short
amino acid fragments (10–25 in length) encoded by exons 8, 15, 17 and 24. The divergent
pictures of TRPM3 function in the literature may reflect the diversity of cDNAs used in
these studies.
1.3.1.2 Protein structure
Almost all TRPM3 isoforms share the typical TRP channel structural features: six trans-
membrane domains (6TM) with a pore region between TM5 and TM6, and cytoplasmatic
N– and C–termini.
In the N–terminus, a large TRPM homology region is present. The start sequence of this
homology region, (W/F)IX3-(F/L/I)CK(R/K)EC(V/I/S)X12−24CXCG [58], only exists in
the mTRPM3-a/b/c/d/e/f, hTRPM3-k and hTRPM31325 isoforms. In contrast to the N–
terminus, the structural characteristics of TRPM3 C–terminus remains elusive. Except for
the TRP domain and Coiled–Coil domain (C–C domain), no other functional elements have
been found so far. Whereas the sequences of 6TM are identical among the TRPM3 isoforms,
the sequences of pore region vary in thirteen amino acid residues, RKQVYDSHTPKSA,
that are only present in mTRPM3-a and hTRPM3c isoforms (Figure: 4.1). The presence
or absence of this short amino acid stretch probably has an effect on the ion selectivity
[157] (Section: 1.3.3). Moreover, a hydrophobic pore helix conserved in all TRPM channels
and a putative ion selectivity loop domain are detected within the TRPM3 pore region
[149, 161, 215, 244], although, how they influence the ion permeation and selectivity is
poorly understood.
1.3.2 Tissue distribution of TRPM3
Using different molecular techniques including RT–PCR, in situ hybridization, immunocy-
tochemistry, Northern and Western blots, TRPM3 expression was detected in some human
and/or mouse tissues such as human kidney and mouse brain [58, 106, 157]. Nevertheless,
its expression could not be proved in a given tissue and cell type due to the sensitivity of the
methods and the amplification of parts of the transcripts [156]. The expression pattern of
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Figure 1.5: Putative pore structure
Pore regions of some TRPM3 isoforms compared to the corresponding sequences of other TRPM
channels. ClustalW2 and Jalview 2.4 were used for multiple sequence alignments and a graphical
representation, respectively. BLOSUM62 score matrix was used to calculate pairs of aligned
residues based on alignments with identity of at least 62%. Within the TRPM3 subfamily, the
hTRPM3c (not shown) and mTRPM3–a isoforms possess an additional 12 amino acids in the
pore region. The localizations of the conserved hydrophobic pore helix and putative selectivity
loop are shown. The two red–boxed proline residues in the TRPM6 and TRPM7 and one
aspartate residue in the TRPM4 are highly conserved and were mutated to generate dominant
negative mutants [30, 117, 149]. Pro1060, Gly1066 and Asp1074 boxed in yellow are identical
in all TRPM subfamily. Their functional relevance were tested by site–directed mutagenesis
(P→R, G→V, D→A, respectively).
TRPM3 is still not conclusively resolved, e.g., TRPM3 was mostly found in human kidney,
but not in mouse kidney [58, 106, 157].
1.3.3 Channel properties of TRPM3
Although several TRPM3 splice variants have been reported, functional data for them are
only limited to four isoforms, mTRPM3-a [157], mTRPM3-c [157], hTRPM3a [106] and
hTRPM31325 [58, 59, 246]. The biophysical properties, like selectivity and conductance,
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are highly dependent upon the TRPM3 splice variant and the experimental conditions
[58, 59, 157].
The mTRPM3-c and hTRPM31325 channels had a significantly higher divalent to mono-
valent permeability ratio than the mTRPM3-a channel. Contrarily, mTRPM3-a showed a
lower permeability to divalent cations based on the experimental results that no significant
inward currents through the channel were observed [157]. TRPM3 has also been reported
to have constitutive activity when expressed in a heterologous system [58, 106, 157]. The
cells expressing TRPM3 have a higher
[
Ca2+
]
i than the control cells, even in the absence
of any stimuli [58, 106, 157]. In electrophysiological experiments, Grimm et al. (2003) and
Oberwinkler et al. (2005) observed decrease and increase in
[
Ca2+
]
i occurred on removal
and readmission of extracellular
[
Ca2+
]
, respectively.
1.3.4 Inhibition, blockage and activation of TRPM3
TM3E3, a polyclonal antibody, raised against the third extracellular (E3) loop of TRPM3
was reported to partially inhibit Ca2+ entry in cells expressing human TRPM3 in a peptide–
specific manner [141]. Oberwinkler and co–workers (2005) reported that the constitutive
activities of heterologously expressed mTRPM3-a and mTRPM3-c channels were similarly
inhibited by millimolar
[
Mg2+
]
i. It was suggested that the selectivity filters of both isoforms
did not have effects on the intracellular Mg2+–induced channel inhibition [157].
2-aminoethoxydiphenyl borate (2-APB, 100 µM) has been reported to block the channel
activity of TRPM3 expressed in HEK-293 cells from the extracellular face of the membrane
[246]. Some ions such as Gd3+ (100 µM) and La3+ (100 µM) can block Ca2+ entry through
TRPM3 channels [58, 106]. The mechanisms by which these ions inhibit Ca2+ entry are not
fully understood. However, all these substances are not specific for TRPM3 channels and
can block a number of other TRP channels and other Ca2+–permeable channels [164, 175].
Lee et al. (2003) treated hTRPM3-a–transfected cells with thapsigargin and carbachol
to empty Ca2+ stores. Then, they added Ca2+ at different concentrations to HEK-293
cells and found that the
[
Ca2+
]
i increase in hTRPM3-a–transfected cells was larger than
in control cells [106]. However, Grimm et al. (2005) performed similar experiments using
hTRPM31325 variant, and did not find any increase in Mn2+– or Ca2+–entry after thapsi-
gargin treatment [58, 59]. Hence, it is still controversial whether store depletion is able to
activate TRPM3 channel activity. TRPM3 has also been suggested to be a cation channel
activated by extracellular hypotonicity [68]. Compared to control cells,
[
Ca2+
]
i in HEK 293
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cells expressing hTRPM31325 was increased when the extracellular osmolarity was decreased
to 200 mosmol/L [58]. Some pharmacological substances such as nifedipine (a dihydropy-
ridine Ca2+ channel blocker) and pregnenolone sulphate (PS) have been show to enhance
TRPM3 channel activity [231]. However, their physiological importance of TRPM3 channel
function need to be investigated further.
1.3.5 Biological role and relevance of TRPM3
It has been suggested that TRPM3 might be involved in renal Ca2+ homeostasis and os-
moregulation, because it is permeable to divalent cations, sensitive to extracellular hypo-
osmolarity changes and present in human renal tubules [58, 106]. Recently, Wagner et al.
(2008) found that TRPM3 was present in pancreatic β cells. Insulin secretion was enhanced
when TRPM3 was activated by 50 µM pregnenolone sulfate [231]. This indicates that
TRPM3 might have an endocrine function and play a role in insulin release from pancreatic
islets. TRPM3 is also a candidate gene for some diseases, e.g., haemophagocytic lympho-
histiocytosis, infantile nephronophthisis, amyotrophic lateral sclerosis with frontotemporal
dementia, and early-onset pulverent cataract [106, 146]. However, convincing evidence for
a functional relevance in these diseases is missing so far.
1.4 Objectives of this thesis
Throughout evolution, TRPM3 is one of the most highly conserved members of the TRPM
subfamily. The phenotypes of mutation in the TRPM3 gene are unknown and the available
data concerning its expression patterns and functions are still controversial. Therefore, the
goals of this work are to:
1. clone a new cDNA of mouse TRPM3 and study its biological function in vitro;
2. raise antibodies against mouse TRPM3 in order to determine its expression profiles;
3. obtain a mouse with a TRPM3 knockout allele, and investigate its phenotype.
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2Materials and Methods
2.1 Materials
2.1.1 Animals, bacteria, cell lines and yeast cells
Table 2.1: Animals, bacteria, cell lines and yeast cells
Name Provider
Competent yeast cells AH109 and Y187 Clontech
E.coli DH5α Invitrogen
GeneSwitch™–293 cell line Invitrogen
GeneSwitch™–MDCK cell line Invitrogen
LacZ transgenic TRPM3 knockout mice Lexicon Genetics
2.1.2 Antibodies
Table 2.2: Antibodies
Antibodies Dilution Animal Manufaturer
Anti–GFP antibody polyclonal 1:1000 (IF) rabbit Clontech
Anti–HA antibody polyclonal 1:1000 (IF) rabbit Sigma-Aldrich
Anti–TRPM3 antibodies polyclonal 1:2000 (IF) rabbit Eurogentec
Anti–rabbit-IgG Alexa Fluor 488 1:2000 (IF) goat Eugene
Anti–rabbit-IgG peroxidase 1:2000 (IF) goat Sigma-Aldrich
Anti–rabbit-MAP2 polyclonal 1:200 (IF) rabbit Abcam
2.1. Materials
2.1.3 Cell culture materials
Table 2.3: Cell culture materials
Name Manufaturer
Bovine pituitary extract Invitrogen
Cell culture dishes, flasks and scrapers SARSTEDT AG & Co
Dulbecco’s modified eagle medium (DMEM), high Glu-
cose (4,5 g/l)
PAA Laboratories
DMSO Carl Roth
Fetal calf serum Gibco-BRL
Glutamine Invitrogen
Goat serum PAA Laboratories
Ham’s F-10 medium Invitrogen
Minimal essential medium eagle (MEM) PAA Laboratories
Newborn calf serum Invitrogen
Opti-MEM® I reduced serum medium Invitrogen
Transwell® PET membrane insert (0.4 µM) Corning Life Sciences
Penicillin/Streptomycin (100x) PAA Laboratories
Penicillin/Streptomycin/fungizone (100x) VWR International GmbH
Trypsin/EDTA (10x) PAA Laboratories
2.1.4 Chemicals
Table 2.4: Chemicals
Name Manufaturer
3-AT Sigma-Aldrich
12-O-tetradecanoylphorbol-13-acetate Sigma-Aldrich[
α−32P]-dCTP GE Healthcare
Adenine hemisulfate Sigma-Aldrich
Bacto™-agar Becton Dickinson
2-Bromopalmitate Sigma-Aldrich
Coelenterazine Biaffin
Coomassie-Brilliant Blue G-250 Merck
DAPI Sigma-Aldrich
Deoxycholate Sigma-Aldrich
D-erythro-Sphingosine Calbiochem
Dibutyryl adenosine cyclic 3’,5’-monophosphate Sigma-Aldrich
dNTP Mix (10mM) Fermentas
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EDTA, EGTA Carl Roth
Fluorescence mounting medium DaKo
Forskolin Sigma-Aldrich
FuGENE® HD transfection reagent Roche Diagnostics
Fura-2AM Fluka
Geneticin (G418 sulphate) PAA Laboratories
Glutaraldehyde Sigma-Aldrich
Glycogen Fermentas
HEPES Carl Roth
Hygromycin B PAA Laboratories
Isobutylmethylxanthine Sigma-Aldrich
Isoflurane Baxter
L-Histidine HCl monohydrate Sigma-Aldrich
L-Leucine Sigma-Aldrich
L-Tryptophan Sigma-Aldrich
Lipofectamine™ 2000 Invitrogen
Lithium acetate Sigma-Aldrich
2-Mercaptoethanol Sigma-Aldrich
Mifepristone Invitrogen
NP-40 Calbiochem
PEG 3350 Sigma-Aldrich
Phenol:Chloroform:Isoamyl Alcohol 25:24:1 Carl Roth
PIPES Sigma-Aldrich
PMSF Sigma-Aldrich
Potassium acetate Carl Roth
Potassium ferrocyanide Sigma-Aldrich
Potassium ferricyanide Sigma-Aldrich
Pregnenolone sulfate Sigma-Aldrich
Protease inhibitor cocktail tablets Roche Diagnostics
Protein A-Sepharose® from Staphylococcus aureus Sigma-Aldrich
Roti phenol Carl Roth
RotiPhorese® Gel 40 Carl Roth
SD/-Ade/-His/-Leu/-Trp supplement Clontech
SD/-Leu/-Trp supplement Clontech
Silver nitrate (AgNO3) Merck
Streptomycin PAA Laboratories
TEMED Sigma-Aldrich
Trichloroacetic acid (TCA) Sigma-Aldrich
Triton X-100 Calbiochem
TRIzol® reagent Sigma-Aldrich
Tryptone Carl Roth
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Tween 20 Sigma-Aldrich
Urea Carl Roth
Yeast extract Carl Roth
Yeast nitrogen base without amino acids Sigma-Aldrich
X-α-gal Carl Roth
X-gal Sigma-Aldrich
Zeocin™ Invitrogen
2.1.5 Consumables and laboratory equipment
Table 2.5: Consumables and laboratory equipment
Names Manufaturer
Axiovert 200M inverted microscope Carl Zeiss
Beckman LS 6000IC liquid scintillation counter Beckman Coulter
BioMax MS and X-OMAT™ films Kodak
Biomax TranScreen LE Kodak
BioPhotometer 6131 Eppendorf AG
Bio-Spin® 6 columns Bio-Rad
Centrifuge Bio-, Megafuge Heraeus Instruments
Cryocut 1850 cryomicrotome Leica MICROSYSTEMS
Exposition chamber hypercassette™ Amersham Bioscience
FLUOstar OPTIMA BMG LABTECH
Glass beads Sigma-Aldrich
Hybond™-N membrane Amersham Bioscience
Hybridization oven Robbins Scientific
Laser scanning microscope (LSM 510 META) Carl Zeiss
MiniVE system blot module Amersham Bioscience
MiniVE vertical electrophoresis system Amersham Bioscience
Nitrocellulose membrane Schleicher&Schuell BioScience
Olympus IX70 inverted microscope Olympus America, Inc.
PCR machine T3 thermal cycler Biometra
Superfrost® plus microscope slides Thermo SCIENTIFIC
TILLvisION highest speed imaging system TILL Photonics GmbH
Video documentation system (INFINITY Model) PEQLAB Biotechnology
VWR grade 410 paper filters VWR International
Whatman paper Whatman International
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2.1.6 Enzymes and peptides
Table 2.6: Enzymes and peptides
Name Manufaturer
GeneRuler™ DNA Ladder Plus (100 bp, 1k bp) Fermentas
PageRuler™ Prestained Protein Ladder Fermentas
Proteinase K, recombinant Roche Diagnostics
Restriction enzymes (10-20 U/µl) Fermentas
Ribonuclease A Sigma-Aldrich
ssRNA ladder New England Biolabs
SuperScript™ III reverse transcriptase Invitrogen
Taq-Polymerase (500 U/µl) Fermentas
T4 DNA ligase (200-1000 U/µl) Fermentas
2.1.7 Molecular biology reagent systems
Table 2.7: Molecular biology reagent systems
Name Manufaturer
Expand High FidelityPLUS PCR System Roche Diagnostics
Expand Long Template PCR System Roche Diagnostics
GeneJET™ Plasmid Miniprep Kit Fermentas
GeneRacer™ Kit Invitrogen
HexaLabel™ DNA Labeling Kit Fermentas
NUCLEOBOND Midi-prep Kit Macherey-Nagel
Oligotex Direct mRNA Mini Kit QIAGEN
pcDNA3.1/V5-His© TOPO® TA Expression Kit Invitrogen
peqGOLD Gel Extraction Kit PEQLAB Biotechnology
peqGOLD Plasmid Miniprep Kit II PEQLAB Biotechnology
Pretransformed Human Kidney Matchmaker™ cDNA Library Clontech
QuikChange® XL Site-Directed Mutagenesis Kit Stratagene
SuperSignal West Pico Chemiluminescent Substrate Pierce Biotechnology
SuperSignal West Femto Maximum Sensitivity Substrate Pierce Biotechnology
Topo TA Cloning® Kit for Sequencing Invitrogen
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2.1.8 Nucleic acids and plasmids
Table 2.8: Nucleic acids and plasmids
Name Provider
DNA sodium salt from herring testes Type XIV Sigma-Aldrich
pACT2 AD vector Clontech
pEGFP-C1 and pEGFP-N1 vectors Clontech
pGAD424 AD vector Clontech
pGADT7-T control vector Clontech
pGBKT7 DNA-BD vector Clontech
pGBKT7-53 control vector Clontech
pGene/V5-His A, B, C vector Invitrogen
pSwitch vector Invitrogen
2.1.9 Bioinformatic tools and online databases
Table 2.9: Bioinformatic tools and online databases
Tools and Databases URL or Manufaturer
Axio vision 3.1 Carl Zeiss Vision GmbH
Blast http://www.ncbi.nlm.nih.gov/blast/Blast.cgi
ClustalW2 EMBL-European Bioinformatics Institute
Dendroscope 2 Center for Bioinformatics Tu¨bingen (ZBIT)
DNA Sequencing MWG Biotech AG
ENSEMBL http://www.ensembl.org/index.html
ExPASy Proteomics Server http://www.expasy.org/
Mouse Gene Expression Database (GXD) http://www.informatics.jax.org/mgihome
Human Protein Reference Database http://www.hprd.org/
ImageJ National Institutes of Health
Jalview 2.4 The Barton Group, University of Dundee
JAX Mice Database http://jaxmice.jax.org/
LaserGene DNASTAR, Inc.
Mammalian Protein Localization Database http://locate.imb.uq.edu.au/
Mouse Genome Informatics (MGI) http://www.informatics.jax.org
National Center for Biotechnology Information (NCBI) http://www.ncbi.nlm.nih.gov/
SOSUI Sever Mitaku Group, Nagoya University
TILLvisION 3.0 TILL Photonics GmbH
Worldwide Protein Data Bank http://www.wwpdb.org/
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2.1.10 Oligonucleotides
Table 2.10: Oligonucleotides
Applications Primers (5'→3')
5'-RACE
GeneRacer™ 5' primer: CGACTGGAGCACGAGGACACTGA
GeneRacer™ 5' nested primer: GGACACTGACATGGACTGAAGGAGTA
GSP primer 1: AGTTTCACCTCTGCTCCGTATTTC
GSP primer 2: ATCAAAAGATACTCGGACATACATAG
GSP primer 3: CTATGAGGCGTCCACAGCAACAC
M
u
ta
g
e
n
e
si
s
Rey
Forward: GGTCAGGGATGTCAAAAAGGGAAACCTGCCCCC
Reverse: GGGGGCAGGTTTCCCTTTTTGACATCCCTGACC
T1088I
Forward: CGAGAGGATGGCAAGATAATCCAGCTGCCCCC
Reverse: GGGGGCAGCTGGATTATCTTGCCATCCTCTCG
P1060R
Forward: GCCAAGAATATCTTCTACATGCGTTATTGGATGATTTATGGGG
Reverse: CCCCATAAATCATCCAATAACGCATGTAGAAGATATTCTTGGC
G1066V
Forward: GCCTTATTGGATGATTTATGTGGAAGTGTTTGCTGACC
Reverse: GGTCAGCAAACACTTCCACATAAATCATCCAATAAGGC
D1074A
Forward: GCTGACCAGATAGCCCCTCCCTGTGGAC
Reverse: GTCCACAGGGAGGGGCTATCTGGTCAGC
C1301S
Forward: AGGACCTCCTCAGACAGCACAGATGCAGCC
Reverse: GGCTGCATCTGTGCTGTCTGAGGAGGTCCT
C1210S
Forward: GTACACGATTTTGAAGAGCAGAGCATAGAGGAATATTTCCGA
Reverse: TCGGAAATATTCCTCTATGCTCTGCTCTTCAAAATCGTGTAC
CC1174SS
Forward: ATCTTCCAGCATGTGTCCTCCCGGTGGAGGAAGCAT
Reverse: ATGCTTCCTCCACCGGGAGGACACATGCTGGAAGTA
M
o
u
se
G
e
n
o
ty
p
in
g TRPM3– Forward: CTGTGGCTGCCAAGCACCGTGAC
WT Reverse: CCTCAAGACTCCCAATCCAAG
TRPM3– Forward: CCTCAAGACTCCCAATCCAAG
Neo Reverse: GCAGCGCATCGCCTTCTATC
Non–Agouti Forward: GGAGAGGCGTGGGTGGCTGAATGG
(a) Reverse: TTACAAGAAGAAGTGGGGAATGAAGA
Tyrosinase Forward: GCTGTTTTGTATTGCCTTCTGTGGAGTTTC
(C) Reverse: AAGGATGCTGGGCTGAGTAAGTTAGGATTTTC
M3TC Cloning
Forward: ACCGCCATGACCATGATCTTCCAGC
Reverse: TTACGCGTAATCAGGAACATCATATGG
Forward: ACCGCCATGACCATGATCTTCCAGC
Reverse: GAATTCCTTGTACAGCTCGTCCATGCC
Y
2
H
C
o
n
st
ru
c
ts
N–Termi
Forward: CAATTGCCAGGGCCGTGGGGGACC
Reverse: GTCGACCTACTCATAGATTTTTCGGCCCACG
C–Termi
Forward: GAATTCTCGATATCCAACCAAGTATGG
Reverse: GTCGACTTAGTTGTGCTTGCTTTCAAAGC
C–Termi(S)
Forward: GAATTCTCGATATCCAACCAAGTATGG
Reverse: GTCGACTTATACTGAATAAAAAGGATGTTCTGCAGGGTC
20
2.2. Methods
2.2 Methods
2.2.1 DNA analysis and preparation
2.2.1.1 General DNA methods
The standard molecular biological methods for DNA analysis such as agarose gel elec-
trophoresis, DNA digestion and ligation, DNA isolation from agarose gel, DNA purifica-
tion by phenol extraction and ethanol/isopropanol precipitation, DNA transformation into
competent E.coli, and mini-, midi- and maxi-preparations of plasmid DNA were carried out
according to Sambrook et.al [2000] [184] and Ausubel et.al [2001] [10], and are not described
here in detail. All experiments and centrifugations were performed at room temperature
unless otherwise stated.
2.2.1.2 Polymerase chain reaction (PCR)
The polymerase chain reaction (PCR) was used to amplify specific DNA sequences. The
components and conditions of standard PCR are shown in the following tables. Some
variations on the standard PCR, such as PCR in mutagenesis, touchdown PCR, nested
PCR and colony PCR, are described in the corresponding sections.
Table 2.11: Standard PCR components
Components Amount
DNA (template) ∼ 0.5 µg
10x reaction buffer 2.5 µl
(Mg2+ final concentration: 1.5–2.5 mM)
dNTP (10 mM) 0.5 µl
Forward primer (50 µM) 0.25 µl
Reverse primer (50 µM) 0.25 µl
Polymerase 0.25 µl
ddH2O Add to 25 µl
Samples were handled on ice, and enzymes were always added last. The annealing tem-
perature was selected according to different primer pairs. The PCR products were directly
analyzed by means of agarose gel electrophoresis and visualized by ethidium bromide.
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Table 2.12: Standard PCR conditions
Steps Temp. Time Note
1 94℃ 3 min
2 94℃ 1 min
3 58℃ 1 min
4 68℃ 1 min/kb amplified DNA Go to 2, 30 cycles
5 68℃ 5 min
6 4℃ hold
2.2.1.3 Preparation of chemocompetent DH5α E.coli cells
Chemocompetent DH5α cells were prepared according to a Mn2+–based method that yield
1x 108 to 3x 108 transformed colonies/mg of plasmid DNA [84]. Transformation buffer and
SOB bacterial medium were as fresh as possible when used (Table: 2.13).
Table 2.13: Buffer and medium for chemocompetent DH5α E.coli cells preparation
Buffer/Medium Composition
Transformation buffer: PIPES 10 mM
CaCl2 15 mM
KCl 250 mM
MnCl2 55 mM
ddH2O ad 500 ml
Adjusted to pH 6.7. Add MnCl2 only after the titra-
tion and sterilize the buffer by filtration (0.45 µm).
SOB medium: KCl 2.5 mM
NaCl 8.55 mM
MgCl2 10 mM
Tryptone 20 g/L
Yeast extract 5 g/L
Adjusted to pH 7.0 with HCl. Autoclave the medium.
A strain of E.coli was streaked on an antibiotic–free LB plate and incubated at 37℃
overnight. A single colony (3-5 mm in diameter) was cut out of the agar and transferred
into 400 ml of SOB medium in a flask. The culture was incubated at 18℃ with shaking until
an OD600 of 0.4–0.6 was reached. The flask was cooled on ice for 10 min, and the pellet was
collected by centrifugation at 2500g at 4℃ for 10 min. The cells were gently resuspended
in >100 ml of ice–cold transformation buffer and harvested again as above. The pellet was
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resuspended in 20 ml of ice–cold transformation buffer, and 7% DMSO was added slowly
with gentle shaking. After additional 10 min incubation on ice, the bacterial suspension was
aliquoted into 0.5 ml Eppendorf tubes (110 µl each). The aliquots were immediately shock–
frozen in a bath of liquid nitrogen and stored at -80℃. To test transformation efficiency
(with 10 pg DNA), a non–transformation aliquot as negative control and a commercial
competent cell (like “OneShots” from Invitrogen) as positive control were tested.
2.2.1.4 DNA transfection
At the time of transfection, the cells were 70-90% confluent in the proper growth medium.
The DNA transfection progress is described in Table 2.14:
Table 2.14: Transfection conditions
Cell lines Reagents Transfection solution per
well in a 6-well plate
Transfection protocol
HEK-293
(Attached;
Human
Epithelial)
FuGENE-HD ∼2 µg DNA + 4 µl FuGENE-
HD in 100 µl Opti-MEM® I
reduced serum medium
Incubate the transfection solution at
room temperature for 15 min; vortex
briefly and add to the well containing
cells.
MDCK
(Attached;
Dog Epithe-
lial)
Lipofectamine™
2000
Solution A: 4 µg DNA +
50 µl Opti-MEM® I reduced
serum medium; Solution B:
10 µl lipofectamine™ 2000 +
50 µl Opti-MEM® I reduced
serum medium
Incubate solution A and B at room
temperature for 5 min, and mix the so-
lutions gently; incubate the complex at
room temperature for another 20 min,
then add the complex to the well con-
taining cells.
2.2.1.5 Rapid amplification of cDNA ends (RACE)
RACE is a PCR–based cloning technique particularly applied to obtain full length cDNA
ends and to identify unknown terminal sequences. RACE amplifies the transcripts of in-
terest through reverse transcription and anchored PCR using gene–specific primers (GSP)
and adapter primers that anneal with defined internal sites of exon and target unknown
sequences at either the 5' or 3' end of the mRNA, respectively. In this thesis, GeneRacer™
kit (Invitrogen) 5'-RACE was used to clone cDNA variants of mTRPM3.
Treatment of 5' end of Poly(A)+ mRNA for 5'–RACE To dephosphorylate non-
mRNA or truncated mRNA, 1 µg of mouse kidney Poly(A)+ mRNA (Section: 2.2.2.2) was
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treated with 1 µl of calf intestinal phosphatase (CIP, 10 U/µl) in a 10 µl reaction in DEPC
H2O containing 1 µl of CIP buffer and 1 µl of RNaseOut™ (40 U/µl). After 1 hr incubation
at 50℃, the dephosphorylated mRNA and the intact full length mRNA were extracted with
phenol:chloroform and precipitated with 100% ethanol (Section: 2.18). To ligate with the
GeneRacer™ RNA Oligo (5'-CGACUGGAGCACGAGGACACUGACAUGGACUGAAGGAGUAGA-
AA), the 5' phosphate of the full-length mRNA was exposed through treating the precipi-
tated mRNA (7 µl) with 1 µl of tobacco acid pyrophosphatase (TAP, 0.5 U/µl) in a 10 µl
decapping reaction containing 1 µl of 10× TAP buffer and 1 µl of RNaseOut™ (40 U/µl).
The mixture was incubated at 37℃ for 1 hr, and the decapped full-length mRNA was
phenol:chloroform extracted and ethanol precipitated.
First strand cDNA synthesis The first strand cDNA was synthesized by SuperScript™
III reverse transcriptase (Invitrogen). The mixture containing 10 µl of ligated RNA, 0.5 µl
of GeneRacer™ 5' primer, 0.5 µl of GSP primer 1 (Table: 2.10), 1 µl of dNTP and 1 µl of
ddH2O was incubated at 65℃ for 5 min and then chilled on ice for 1 min. After adding 4
µl of 5x first strand buffer, 1 µl of 0.1 M DTT, 1 µl of RNaseOut™ (40 U/µl) and 1 µl of
SuperScript™ III reverse transcriptase (200 U/µl), the reaction mix was incubated at 50℃
for 60 min and at 55℃ for 5 min. The reaction was deactivated at 70℃ for 15 min, and the
reaction mix chilled on ice followed by incubation with 1 µl of RNase H (2 U) at 37℃ for
30 min.
Table 2.15: PCR components for first and nested reaction
First reaction Nested reaction Amount
DNA (first strand cDNA) DNA (from first reaction, 1:50 dilution) 1 µl
10x reaction buffer 10× reaction buffer 2.5 µl
dNTP (10 mM) dNTP (10 mM) 1.25 µl
10 µM GSP primer 1 (or GSP primer 2) 10 µM GSP primer 2 (or GSP primer 3) 1 µl
GeneRacer™ 5' primer GeneRacer™ 5' nested primer 1 µl
Expand long template polymerase Expand long template polymerase 0.5 µl
ddH2O ddH2O Add to 25 µl
Amplification of 5' end of mTRPM3 cDNA The 5' cDNA end of mTRPM3 was
amplified by touchdown PCR and nested PCR using GeneRacer™ 5' primer /nested primer
and GSP primers 1/2/3 (Table: 2.10) derived from the core mRNA sequence of mTRPM3
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(GenBank™ accession number: NM−001035240). The amplified PCR product was cloned
into the pCR®4-TOPO® vector for sequence analysis.
Table 2.16: PCR conditions for first and nested reaction
Steps
First reaction Nested reaction
Temp. Time Note Temp. Time Note
1 94℃ 2 min 94℃ 2 min
2 94℃ 1 min 94℃ 1 min
3 65℃ 1 min 60℃ 1 min
4 68℃ 1 min/kb Go to 2, 10 cycles 68℃ 1 min/kb Go to 2, 10 cycles
5 94℃ 1 min 94℃ 1 min
6 65℃ 1 min 60℃ 1 min
7 68℃ 1 min/kb Go to 5, 30 cycles,
dt(s):10 sec
68℃ 1 min/kb Go to 5, 20 cycles,
dt(s):10 sec
8 68℃ 10 min 68℃ 10 min
9 4℃ hold 4℃ hold
2.2.1.6 Site–directed mutagenesis
Point mutations, frameshift mutations, deletion/insertion of amino acid(s) were performed
by using QuikChange® XL Site–Directed Mutagenesis Kit. Once the specific primers were
synthesized, 1 µl of template DNA (10 ng) was amplified by 0.3 µl of Pfu Turbo polymerase
(2.5 U/µl) in a final volume of 12.5 µl reaction solution containing 1.25 µl of 10× reaction
buffer, 0.5 µl of each primer (0.5 mM), 0.25 µl of dNTP (10 mM), 0.75 µl of QuikSolution
and 8.25 µl of ddH2O. The thermal cycling parameters were described in Table 2.17. Finally,
the amplification product was thoroughly mixed with 1 µl of Dpn I restriction enzyme (10
U/µl) which digests the dam-methylated parental template DNA. After incubation at 37℃
for 1–2 hr, the reaction complex was transformed into the chemocompetent DH5α cells as
described in Section 2.2.1.3.
2.2.1.7 TOPO®–cloning
TOPO® cloning was performed using a linearized pcDNA3.1/V5-His-TOPO® vector (In-
vitrogen) which is engineered with 3' thymidine (T) overhangs and covalently bound to
Topoisomerase I. Before the TOPO® cloning, the blunt–ended PCR fragments (10 µl)
which were amplified by some proofreading ploymerases like pfu polymerase were first in-
cubated with 0.5 µl of dNTP and 0.5 µl of Taq polymerase (72℃, 30 min) in order to add
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a 3'-single–stranded poly(A)–tail. The sticky–ended PCR fragments (2 µl) were directly
ligated with 0.5 µl of pcDNA3.1/V5-His-TOPO® vector combined with 0.5 µl of salt solu-
tion. After incubation for 15 min at room temperature, the TOPO cloning products were
transformed into the chemocompetent DH5α cells, and the correct orientation of the PCR
fragments was analyzed using the endonuclease restriction method.
Table 2.17: Thermal cycling parameters for site-directed mutagenesis
Steps Temp. Time Note
1 95℃ 1 min
2 95℃ 50 sec
3 58℃ 50 sec
4 68℃ 1 min/kb amplified DNA Go to 2, 18 cycles
5 68℃ 7 min
6 4℃ hold
2.2.2 RNA analysis and preparation
RNA handling was carried out under RNase–free conditions. Sterile disposable plasticware
was used throughout the laboratory procedures. Non-disposable plasticware and glass-
ware were thoroughly rinsed with 0.1 M NaOH for 1 hr followed by DEPC–treated ddH2O
(0.1%, v/v). Lab bench and electrophoresis tanks were cleaned with 10% SDS to maintain
an RNase–free environment. The buffers and solutions for RNA analysis were prepared
according to Sambrook et.al [2000] [184] and Ausubel et.al [2001] [10].
2.2.2.1 Isolation of total RNA from eukaryotic cells and tissues
The total RNA isolation from eukaryotic cells grown in monolayer and from animal tissue
samples are indicated in Table 2.18.
2.2.2.2 Selection of Poly(A)+ RNA from total RNA
The Poly(A)+ RNA which is enriched for mRNA was purified from total RNA by using
Oligotex Direct mRNA Mini Kit (Qiagen). The Poly(A)+ RNA was bound to ‘Oligotex’
resin through the Poly(A)+ tails which were exposed by denaturing the total RNA. The
remainder of total RNA was washed away and the Poly(A)+ RNA was eluted with warm
salt–free elution buffer.
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Table 2.18: Total RNA isolation from HEK293 cells and mouse tissues
Procedures
Materials
HEK293 cells Mouse tissues
Tissue lysis Wash cells once with ice–cold PBS (2
ml per 100 mm dish). Lyse cells in
TRIzol® reagent (1 ml per 100 mm
dish). Transfer the cell lysates into a
fresh 1.5 ml Eppendorf tube.
Place the isolated tissues directly into liq-
uid nitrogen. Pulverize the frozen tissues
(∼ 1 g) with a pestle in a mortar contain-
ing liquid nitrogen. Transfer the powder
to a l5 ml Falcon tube containing 10 ml
of TRIzol® reagent.
Homogenization Homogenize the samples with a polytron homogenizer for 15-30 seconds.
RNA extraction Incubate the samples at room temperature for 5 min. Add 0.1 ml of 2 M sodium
acetate (pH 4.0), 1 ml of equilibrated phenol, and 0.2 ml of chloroform-isoamyl
alcohol per ml of TRIzol® reagent used. Vortex the mixture vigorously for 15
sec and incubate it for an additional 15 min. Centrifuge the mixture at 13,000
rpm for 30 min at 4℃ and then transfer the upper aqueous phase to a fresh
Eppendorf-tube.
RNA precipitation Add 0.5 ml of isopropanol to the RNA extract, mix it well, and incubate it at -80℃
for 1 hr. Centrifugate the solution at 13,000 rpm at 4℃, wash the pellet with 75%
ethanol. Air-dry the RNA pellet at room temperature (10–15 min). Dissolve the
pellet with 100 µl of DEPC-treated ddH2O and store the RNA solution at -80℃ .
2.2.2.3 Electrophoresis of RNA with agarose–formaldehyde gels
Under denaturing conditions, RNA is fully denatured and can be separated according to
its size (log10 of molecular weight). RNA gel loading mix was incubated at 65℃ for 15 min
prior to being loaded onto an agarose–formaldehyde gel. RNA samples and RNA marker
were co-electrophoresed at 4 V/cm for 1–2 hr until the bromophenol blue dye reached
approximately 3/4 the gel length. To calculate the sizes of RNA samples after Northern-
Hybridization (Section: 2.2.2.6), the gel slice containing the RNA marker was cut out and
visualized by ethidium bromide staining (0.5 µg/ml in 0.1 M ammonium acetate, 45 min).
The RNA samples were transferred from the gel onto a nitrocellulose membrane as described
in Section 2.2.2.4.
2.2.2.4 Northern blotting
Following electrophoresis, the denatured gel containing RNA of interest was successively
soaked briefly in DEPC–treated water, in 0.05 N NaOH for 20 min, briefly in DEPC–
treated water, and in 20× SSC for 45 min. The capillary blotting apparatus for Northern
analysis was assembled according to Sambrook et al. (2000). After RNA transfer (6–18 hr),
the nitrocellulose membrane was removed to a tray containing 6× SSC for 5 min incubation
27
2.2. Methods
with slight shaking. The membrane was air–dried on a paper towel for at least 30 min. The
dried membrane was placed between two pieces of Whatman paper and baked at 80℃ for
2 hr in a vacuum oven. The efficiency of RNA transfer was analyzed by staining the gel
with ethidium bromide (0.5 µg/ml in 0.1 M ammonium acetate) for 45 min and visualized
by UV illumination.
2.2.2.5 Random–primed radioactive DNA labeling
Template DNA preparation for radioactive labeling 5 µg of plasmid was digested
by restriction enzymes (BcuI, MluI, XbalI, XmaJI) which only cut the recipient vector
(pcDNA3.1) so that the insert fragment (mTRPM3) could be separated from the recipient
vector by agarose gel electrophoresis and then purified with a gel extraction kit. Subse-
quently, the purified TRPM3 insert was digested by BauI, BglII, PstI restriction enzymes
so that the template DNA was between 400–800 bp in size . While 5 µl of the digested
DNA fragments were loaded into agarose gel to check the quality of the restriction process,
the rest was directly radiolabeled for Northern hybridization (Section: 2.2.2.5).
DNA labeling by random oligonucleotide extension DNA template (mTRPM3)
was labeled with
[
α−32P]-dCTP by using the HexaLabel™ DNA Labeling Kit according
to the manufacturer's instruction. The complementary radiolabeled DNA sequences were
synthesized by Klenow fragment in the presence of random hexanucleotide primers and
radiolabeled dNTP. Briefly, 10 ng of DNA template, 10 µl of 5× reaction buffer and ddH2O
were added to a final volume of 40 µl in a microcentrifuge tube. To denature the DNA
template, the mixture was boiled for 10 min and then cooled quickly on ice. In the same
tube 3 µl of Mix C, 5 µl of
[
α−32P]-dCTP (50 µCi) and 1 µl of Klenow Fragment (exo−,
5 U) were added. The tube was shaken briefly and centrifuged for 3–5 sec followed by 30
min incubation at 37℃. After adding 4 µl of dNTP, the sample was incubated at 37℃ for
a further 5 min. The reaction was stopped by adding 1 µl of EDTA (0.5 M, pH 8.0).
Purification of radioactively labelled DNA Prior to Northern hybridization (Sec-
tion: 2.2.2.6), the unincorporated dNTPs were removed by Bio-Spin® columns following
the manufacturer's instruction. 250 µl of the reaction mixture was obtained after the pu-
rification.
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Determination of the degree of radioactive labeling 2 µl of the purified reaction
mixture was spotted onto two pieces of Whatman paper and air-dried. One piece of What-
man paper was then successively washed three times for 5 min in 100 ml of sodium phosphate
(0.5 M, pH 6.8), once in ddH2O for 1 min and once in 70% ethanol for 2 min, then air-
dried. The incorporated radioactivity (washed Whatman paper) and the total radioactivity
(unwashed Whatman paper) were measured with a liquid scintillation counter (Beckmann).
The specific activity of the radiolabeled probe was calculated to be 2.4 x 109 cpm/µg based
on the following formula (simplified):
incorporated radioactivity (cpm)× total reaction volume
input DNA (ng)× 0.001 (µg/ng) = specific activity (cpm/µg) (2.1)
2.2.2.6 Northern hybridization
The nitrocellulose membrane was incubated at 68℃ for 2 hr in a hybridization tube contain-
ing 20 ml of prehybridization solution. Radiolabeled DNA template (mTRPM3) was boiled
for 5 min and chilled quickly on ice. The denatured radiolabeled probe was directly added
to the prehybridization solution and hybridized with RNA transferred to the membrane
overnight (12–16 hr) at 42℃. After hybridization, the membrane was removed from the hy-
bridization tube and rinsed with 2× SSC for 30 min at room temperature. Subsequently, the
membrane was washed with three prewarmed wash buffers (55℃) in succession: 2× SSC,
0.5× SSC with 0.1% SDS, and 0.1× SSC with 0.1% SDS. Each washing step was carried
out for 20 min with gentle shaking. The membrane was air-dried and then exposed to X-ray
film (BioMax MS) at -80℃ with an intensifying screen (Biomax TranScreen LE) for 3–4
weeks. After exposure, the film was developed in the dark–room until the cassette came to
room temperature thus avoiding black dots or stripes on the autoradiogram resulting from
static discharge.
2.2.3 Protein biochemical analysis
The buffers and solutions for protein analysis such as SDS-PAGE and Western blot were
prepared according to Sambrook et.al [2000] [184] and Ausubel et.al [2001] [10].
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2.2.3.1 Membrane protein extraction from mouse tissues
Tissues (eyes) isolated from TRPM3−/− and TRPM3+/+ mice were washed in ice–cold
PBS and frozen in liquid nitrogen. The tissues were ground in a mortar. The powdered
tissues were transfered into 10 ml of lysis buffer (5 mM Tris-HCl (pH 7.4), 2 mM EDTA
and protease inhibitor cocktail (1 tablet)) and homogenized by using a polytron 5 times
(20 sec bursts/20 sec cooling/200–300 Watt). After centrifugation for 15 min at 500g at
4℃, the supernatant of the samples was kept and the pellet was homogenized again with
an additional 1 ml of lysis buffer (5× 20 sec bursts/20 sec cooling/200–300 Watt). The
samples were centrifuged again for 15 min at 500g at 4℃. Both supernatants were pooled
and centrifuged at 45.000g at 4℃ for 15 min. The pellets were washed twice with lysis
buffer, and resuspended in resuspension buffer (75 mM Tris-HCl (pH 7.4), 12.5 mM MgCl2
and 5 mM EDTA). The samples were stored at -80℃ or directly used for western blot
analysis.
2.2.3.2 SDS–PAGE
SDS-polyacrylamide gel electrophoresis (SDS–PAGE) was used to separate proteins accord-
ing to their molecular weights. After assembling the electrophoresis apparatus and casting
polyacrylamide gels, the proteins to be analyzed were mixed with 1× Laemmli buffer and
subsequently boiled for 5 min. The mixture was directly placed on ice and then centrifuged
briefly. 20 µl of the denatured proteins and 5 µl protein–ladder were loaded into the wells
formed in the polyacrylamide gel submerged in 1× SDS–running buffer. A constant current
of 10–15 mA per gel was applied for 2–4 hr causing the negatively–charged proteins to
migrate towards the positive electrode. Finally, proteins were visualized by either Western
blot, Coomassie blue or silver staining.
2.2.3.3 Western blot
Following SDS-PAGE, the polyacrylamide gel containing the separated proteins was care-
fully removed from the electrophoresis apparatus with a gel knife. The gel/blot sandwich
was assembled in a MiniVE System Blot Module following the manufacturer's instruction.
The separated proteins were transferred onto a nitrocellulose membrane (0.45 µm pore size)
by electroelution performed with a constant current of 30mA in 1× SDS transfer buffer
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supplemented with 20% methanol overnight. After transfer, the membrane was gently sep-
arated from the polyacrylamide gel and immediately washed with 1× TBST for 5 min in
a Petri dish. To prevent nonspecific binding of antibodies, the membrane was blocked in
blocking buffer (1% BSA in 1× TBST, w/v) for 1 hr and afterwards rinsed with 1× TBST
three times for 5 min. To detect proteins, the membrane was incubated with the primary
antibody at 4℃ for 2 hr. Unbound antibodies were removed by washing three times. The
membrane was then incubated for 1 hr with the secondary antibody. Finally, the membrane
was washed for 5 min three times with 1× TBST to remove unbound secondary antibody.
The proteins were visualized using a chemiluminescence substrate (Pierce) prepared accord-
ing to manufacturer's instructions. X-ray film was exposed in the dark–room and several
different duration of exposure were tried.
2.2.3.4 Co–immunoprecipitation
The following procedure was used for co–immunoprecipitation (Co-IP) using adherent cells.
The plasmids containing the DNA sequences of the proteins of interest were co-transfected
into the cells in a 6 cm culture dish (Table: 2.14). Following 24–48 hr incubation, the culture
dish was placed on ice and the growth medium was removed by aspiration. After washing
cells with ice–cold PBS and lysing them with ice–cold lysis buffer (10 ml of RIPA buffer
(NaCl (150 mM), Nonidet P-40 (1% (v/v)), SDS (0.1% (v/v)), sodium deoxycholate (0.5%
(v/v)) and Tris-HCl (pH 8.0, 50 mM)) and one tablet of protease inhibitor cocktail), the
cell suspension was gently transferred into a pre–cooled microfuge tube and centrifuged at
9,000g for 15 min at 4℃. The supernatant was carefully transferred into a fresh pre–cooled
microfuge tube and centrifuged at 50,000g for 2 hr at 4℃. 50 µl of supernatant (lysate) was
kept as a control sample at 4℃. 2 µg of the appropriate antibody were added to 400 µl of
lysate. The supernatant–antibody mixture was rocked at 4℃ overnight. 10 mg of protein
A-Sepharose powder was incubated with 50–100 µl of lysis buffer in a microfuge tube and
washed for ∼30 min to allow it to swell. The protein A-Sepharose slurry was centrifuged at
2,000 rpm for 1–2 min and rinsed with 1 ml RIPA buffer three times as above. 10 µl of the
protein A-Sepharose beads were added to the reaction mixture. Following 2 hr incubation
of the immunoprecipitate–bead mixture at 4℃ under rotary agitation, the mixture was
centrifuged at 3,000 rpm for 2 min and subsequently washed with 1 ml RIPA buffer three
times. The immunoprecipitate–bead pellet and lysate were mixed with 2× Laemmli buffer,
then boiled for 5–10 min and cooled on ice. The samples (ca. 25 µl) were directly loaded
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onto the SDS–PAGE gradient gel for further analysis.
2.2.3.5 Fluorescence resonance energy transfer (FRET)
Figure 2.1: General principle of FRET
A: Two membrane proteins tagged with CFP (donor) and YFP (acceptor) were excited at 456
nm wavelength. Due to the spectral overlap between CFP emission and YFP absorption, the
FRET occurs when both proteins are extremely adjacent to each other (≤100 A˚). The FRET
efficiency can be measured with acceptor photobleaching method by comparing donor emission
intensity before and after bleaching the acceptor. B: r/R0 indicates FRET efficiency (E) to be
a function of the actual distance between the fluorophores (r) in units of R0. R0 is the Fo¨rster
distance at which 50% energy from donor was transferred to acceptor. C: The shaded area
shows the spectral overlap between CFP emission and YFP absorption. Figure B and C were
adapted from Protein–Protein Interactions: A Molecular Cloning Manual 2nd Ed., © 2005 by Cold
Spring Harbor Laboratory Press.
FRET is widely used to detect protein–protein interactions [40, 96], to image cellular
processes [242] and to analyze protein localization [248]. FRET occurs between a donor
fluorophore and an acceptor fluorophore. When both are in close proximity (typically ≤100
A˚) [35, 243] and the spectra of donor emission and acceptor absorption overlap [180, 220],
the energy is non–radiatively transferred from the excited donor fluorophore to the acceptor
fluorophore. The cyan fluorescent protein (CFP) – yellow fluorescent protein (YFP) pair is
a frequently used FRET fluorophore pair in which CFP can be excited at a wavelength 420–
460 nm and YFP has a peak excitation wavelength at 514 nm [63]. To measure static FRET,
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acceptor photobleaching is an effective method whereby the donor emission is increased after
photobleaching of the acceptor through quenching. Under these conditions, the FRET
efficiency (E ) is proportional to the intensity of increased donor emission:
E = 1−
(
Ii
Ia
)
(2.2)
where Ii and Ia represent the donor emission intensity in the presence and absence of FRET,
respectively [63].
C-terminally CFP– and YFP–fused TRPM3 cDNAs were transiently co-transfected into
HEK-293 cells at a molar ratio of 1:3 (CFP:YFP) [78]. The intensities of several regions of
interests (ROIs) were measured and quantified by using the TILLvisION imaging system
(TILL Photonics). The detailed protocols for fluorescence videoimaging and acceptor pho-
tobleaching are available in Amiri et al. [6] and Hofmann et al. [78]. The FRET efficiency
was obtained by linear regression analysis whereby the CFP fluorescence intensities mea-
sured at various time points before and after photobleaching were plotted against fractional
YFP fluorescence intensities. Data were presented as the means ± SEM from a minimum
of three independent experiments, and Student's t-test was used for statistical analysis.
2.2.4 Yeast genetics
The buffers and solutions for all yeast experiments were prepared according to the manual
of the Matchmaker™ GAL4 Two–Hybrid System 3 & Libraries (Clontech).
2.2.4.1 Yeast two hybrid screening
The yeast two hybrid (Y2H) system is a standard approach to detect protein–protein in-
teractions and protein–DNA interactions [27, 51, 82, 250]. This assay is based on the fact
that the eukaryotic transcriptional activator (such as GAL4) consists of two individual do-
mains, the DNA binding domain (DNA–BD) and the transcriptional activation domain
(AD) [21, 80]. The DNA–BD recognizes the binding site in the UAS region, and the AD
coordinates the transcriptional machinery and enables RNA polymerase II to transcribe
a specific reporter gene downstream of the promoter sequence. The protein fused to the
DNA–BD (“bait”) and the protein fused to the AD (“prey”) are either co–expressed in yeast
cells to determine whether the two proteins interact, or separately expressed in two different
haploid yeast strains of opposite mating type for yeast mating [15]. The prey can be either a
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single known protein or a library of known or unknown proteins from a particular organism
or tissue. After mating or co-transformation, the proteins interact. The interaction between
“bait” and “prey” allows AD to come in the proximity of DNA–BD constituting an active
transcription activator so that the reporter gene is activated (Figure: 2.2).
Figure 2.2: Principle of yeast two hybrid library screening
The transcriptional activator GAL4 is divided into two parts: DNA binding domain (DNA–BD)
and activation domain (AD). The bait, C–terminus of mM31719 (M3CT), was fused to GAL-BD
in the pGBKT7 vector, while the preys, human kidney cDNA library, were constructed in the
pACT2 vector. When a given prey has a high affinity with the bait, AD comes into proximity
of DNA–BD constituting an active transcription activator that enables RNA polymerase II to
transcribe reporter genes of the yeast strain AH109.
To study the multimerization of mM31719 and to identify its putative interacting part-
ners, the Matchmaker™ GAL4 Two–Hybrid System (Clontech) was used. In response to
two–hybrid interactions, yeast strain AH109 stably expresses four reporter genes (HIS3,
ADE2, MEL1 and lacZ) under the control of distinct Gal4–responsive UASs and TATA
boxes, whereby the false positives are virtually eliminated. The HIS3 and ADE2 reporter
genes provide a strong nutritional selection, whereas the MEL1 and lacZ reporter genes
which encode α-galactosidase and β-galactosidase, respectively, are used for the X-gal as-
say.
For the analysis of mM31719 homomultimerization, the cDNAs of baits and preys were
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amplified by using primers specific for the N–terminus of mM31719 cDNA and C–termini
of mM31719 and mM31337 cDNAs (Table: 2.10). The amplified PCR products were sub-
cloned into both pGBKT7 and pGAD424 vectors. Before the two hybrid assay, control
experiments like auto-activation and toxicity test of bait/prey were performed according to
the manufacturer's instructions. Transformation of baits/preys cDNA constructs into yeast
cells and interaction confirmation of two known proteins using high–, or medium–stringency
selection are described in Section 2.2.4.2 and in Figure 2.3, respectively.
For the identification of new proteins that interact with mM31719, the Matchmaker™
pretransformed cDNA library of human kidney was used. The key screening procedures are
shown in Figure 2.3. The C–terminus of mM31719 (bait) was cloned into pGBKT7. Before
screening the library, the autonomous activation and toxicity of bait were tested, and the
library was titered by using the protocols from Clontech. The library titer (colony forming
units per milliliter (cfu/ml)) was calculated according to following formula:
cfu/ml =
number of colonies on a SD/-Leu plate
plating volume (ml)× dilution factor (2.3)
Two–hybrid library screening was performed using the yeast mating method (Sec-
tion: 2.2.4.1) according to the manufacturer's instructions. The mating efficiency which
should be more than 1% was determined as decribed below:
Mating efficiency =
Viability of diploid
Viability of prey library
=
No. of cfu/ml on a SD/-Leu/-Trp plate
No. of cfu/ml on a SD/-Leu plate
(2.4)
200 µl of mated culture was plated on SD/-Ade/-His/-Leu/-Trp/X-α-Gal (QDO/X-α-
Gal) agar plates (150 mm in diameter) and incubated at 37℃ for 3–8 days. The plasmids
pGBKT7-53 and pGADT7-T encoding DNA-BD/murine p53 fusion protein and AD/SV40
large T antigen fusion protein, respectively, were used as positive controls. Compared to the
positive control, blue colonies (≥2 mm) were picked and restreaked on QDO/X-α-Gal agar
plates (100 mm in diameter) in order to confirm the correct phenotype based on the fact
that the initial library co-transformants contain more than one AD/prey plasmid. After 2–4
days of incubation at 37℃, single blue colonies (≥2 mm) grown on QDO/X-α-Gal plates
were picked for colony PCR which eliminates duplicates containing the same AD/prey and
reduces false positives of which the AD/prey plasmid does not exist (Section: 2.2.4.5). The
35
2.2. Methods
Figure 2.3: Flowchart of yeast two hybrid screen and verification of putative pro-
tein interactions in yeast cells
The procedures for yeast two hybrid screening are shown (gray). The protein interaction be-
tween bait and candidate prey was retested in yeast by co-transformation (yellow). Selection
with medium stringency was also used for screening interacting proteins because weak and
transient protein interaction may be missed by high stringency selection. The positive con-
trol (pG-BKT7-53/pGADT7-T) and negative controls (pGBKT7-bait/pGAD424-empty and
pGBKT7-empty/pACT2-prey) were always done in the experiments (not shown).
PCR products were separated using agarose gel electrophoresis and isolated by using a gel
extraction kit. After DNA sequencing, the AD/prey plasmid of interest was rescued from
yeast through two steps: first step, total nucleic acids in yeast (bait plasmid, prey plasmid
and yeast genomic DNA) were directly prepared from yeast (Section: 2.2.4.3); second step,
the prepared total yeast nucleic acids were transformed into E.coli and the AD/prey plasmid
of interest was isolated by ampicillin selection followed by standard plasmid preparation
procedure.
In some cases, the AD/prey can activate reporter genes in the absence of BD/bait.
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To reduce these false positives and verify genuine positive interactions between BD/bait
and AD/prey, the isolated AD/prey plasmid candidate was separately co-transformed with
BD/bait and BD/empty plasmids into AH109 yeast cells. The co-tranformants were either
directly plated on a QDO/X-α-Gal agar plate for high stringency selection, or first plated on
a SD/-His/-Leu/-Trp/X-α-Gal (TDO/X-α-Gal) agar plate, then replicated on a QDO/X-α-
Gal agar plate for medium stringency selection (Figure: 2.3). The high stringency selection
reduces the number of false positives, but weak and transient interactions will be missed.
Once the genuine positive interactions that require both BD/bait and AD/prey to activate
reporter genes were identified, the prey cDNAs of interest were fused with HA– and YFP–
tags and subcloned into the mammalian expression vector pcDNA3.1/V5-His for Co-IP
and/or FRET assays.
2.2.4.2 Transformation of DNA into competent yeast cells
A single colony (1–3 week-old, 2–3 mm) was picked from a YPDA plate and inoculated in
1 ml of YPDA medium. The cell clumps were dispersed by vortexing and transferred to
a flask containing 50 ml of YPDA medium for cultivating overnight at 30℃ with shaking.
The overnight cell culture (OD600≥1.5) was centrifuged at 1000g for 5 min to collect the
cell pellet. The cell pellet was successively washed with 10 ml of ddH2O and 5 ml of freshly
prepared 1× TE/LiAc solution. The cell pellet was recollected as above. After resuspending
the cell pellet in 1 ml of 1× TE/LiAc solution, 100 µl of the competent cells were mixed
with 1 µg of plasmid DNA, 50 µg of denatured herring testes DNA (95℃, 20 min) and 500
µl of freshly prepared PEG/LiAC solution in a clean 1.5 ml Eppendorf tube. The complexes
were vigorously vortexed and incubated at 30℃ for 30 min with shaking. After the addition
of 50 µl of DMSO, the gently mixed complexes were heat–shocked at 42℃ for 15 min. The
cells were pelleted at 3000 rpm for 30 sec and resuspended in 100 µl of 1× TE buffer. 10–30
µl of cell suspension was plated on the appropriate SD selection plate.
2.2.4.3 Preparation of yeast total DNA using glass beads
15 ml of cell culture in SD selective medium were incubated at 30℃ overnight with shaking
until an OD600 of 1.5 was reached. The cell pellet was collected by centrifugation at 1000g
for 5 min and suspended in 1 ml of ddH2O. The cell suspension was transferred to a fresh
Eppendorf tube and spun down again as above. The cell pellet was resuspended in 150
µl of breaking buffer, and then mixed with 150 µl of phenol-chloroform-isoamylalcohol and
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150 µl of glass beads. The mixture was vigorously vortexed for 8×30 sec with 30 sec on
ice between the pulses, and subsequently centrifuged for 15 min at 13000 rpm at 4℃. DNA
precipitation was achieved by adding 1/10 volume of 3 M NaAc (pH 5.2) and 2.5 volume
of 100% ethanol. The sample was incubated at -80℃ for 30 min followed by centrifugation
as above. After rinsing the precipitate with 400 µl of 75% ethanol, the pellet was air-dried
and resuspended in 100 µl of 1x TE buffer.
2.2.4.4 Yeast protein extraction
Yeast culture preparation Yeast cultures for protein extraction were prepared accord-
ing to the Yeast Protocols Handbook (Clontech). Before storing the cells at -70℃, the cell
pellet was washed with ice–cold 20% TCA (see below), recovered by centrifugation at 1000g
for 5 min at 4℃, and immediately frozen in liquid nitrogen.
Yeast whole cell protein extraction using the TCA method Trichloroacetic acid
(TCA) is used for precipitating proteins because the dissociated chloride ions of TCA com-
pete with water for hydrogen bonds of protein and the dissociated acetate ions strongly
change the pH value in solution [202]. For Western blot analysis, the protocol for yeast
whole cell protein extraction was adapted from the Keogh Lab [97], and all steps were per-
formed at 4℃ unless otherwise noted. Briefly, the cell pellet was thawed on ice (10–20
min) and suspended in 250 µl of ice–cold 20% TCA. The suspension was incubated with
250 µl of glass beads on ice for 5 min, and then vortexed at maximum speed for 4×1 min
with 1 min on ice between. The Eppendorf tube containing the suspension and the glass
beads was pierced at the bottom with a 21G needle (B. Braun Melsungen), and immediately
placed into another fresh, prechilled Eppendorf tube. The first cell extract was collected by
centrifugation at 6000 rpm for 2 min. The glass beads were washed with 300 µl of ice–cold
5% TCA, and centrifuged as above. The resulting cell extract containing the first spin
was mixed with 700 µl of 5% ice–cold TCA by pipetting, and centrifuged at 14000 rpm for
10 min. The pellet was washed with 750 µl of 100% ethanol (-20℃), and resuspended in
40 µl of Tris-HCl (pH 8.0) and 80 µl of 2× SDS–PAGE loading buffer (60 mM Tris-HCl,
pH 6.8, 2% SDS, 10% glycerol, 0.2% bromophenol blue, 100 mM DTT). After 5 min of
boiling, the insoluble material was removed by centrifugation at 14000 rpm for 5 min at
room temperature, and 15 µl of the supernatant was directly loaded on an SDS–PAGE gel
(Section: 2.2.3.2) to further analysis.
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2.2.4.5 Yeast colony–PCR
A fresh yeast colony (2–3 mm) was touched with a sterile pipet tip (10 µl), and directly
transferred to a PCR mix containing 1.25 µl of 10× reaction buffer (15 mM Mg2+), 0.25 µl
of dNTP (10 mM), 0.5 µl of forward primer (50 µM), 0.5 µl of reverse primer (50 µM), 0.15
µl of Expand High Fidelity Enzyme and 10 µl of ddH2O. The cell clumps were dispersed
by gently pipetting up and down. With the help of the primers (5' → 3': CTATTCGATGAT-
GAAGATACCCCACCAAACCC, GTGAACTTGCGGGGTTTTTCAGTATCTACGAT), the insert was
amplified by PCR under the conditions described in Table 2.12 and analyzed using agarose
gel electrophoresis.
2.2.4.6 Colony–lift filter assay
The β-galactosidase colony–lift filter assay was used to detect an interaction between two
known proteins in the GAL4 two-hybrid system. The assay was carried out according to
the Yeast Protocols Handbook (Clontech).
2.2.5 Cell culture
2.2.5.1 General cell culture techniques
All cell culture experiments were performed under a laminar flow hood under sterile condi-
tions. Cells were incubated in a humidified 37℃, 5% CO2 incubator unless otherwise stated.
Antibiotics penicillin/streptomycin solution and FCS were added to the media at a final
concentration of 100 U/ml, 100 µg/ml and 10%, respectively. Media, trypsin/EDTA, and
PBS were pre-warmed to 37℃ before use. The cell freezing, thawing and passaging were
carried out according to the manufacture's instruction or Sambrook et.al [2000] [184].
2.2.5.2 Primary cell culture: melanocyte isolation from the mouse dermis
Melanocytes were isolated from dorsal skin of 1 day old mice (B6(Cg)-Tyrc−2J/J mice). The
dissected skin was rinsed immediately with 70% ethanol twice and with PBS twice in quick
succession. The skin was individually incubated in 3 ml of 0.25% trypsin in MEM at 4℃
overnight. The epidermis was carefully removed and the dermis cut into small pieces and
transfered into 3 ml of melanocyte growth medium (MGM) consisting of Ham’s F-10 medium
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supplemented with 10% fetal bovine serum, 10% newborn calf serum, 0.1 mM isobutyl-
methylxanthine, 10 µg/ml bovine pituitary extract, 48 nM 12-O-tetradecanoylphorbol-13-
acetate, 1% Penicillin/Streptomycin/fungizone and 1 mM glutamine. The tissues were
incubated in a humidified 37℃, 5% CO2 incubator. After 2 days, tissue debris was removed
by suction and the cells treated with MGM supplemented with 100 µg/ml geneticin (G418
sulphate) until no fibroblasts and keratinocytes persisted. Once pure melanocyte colonies
appeared, the medium was changed to the melanocyte maintenance medium (MMM) con-
taining Ham’s F-10 medium supplemented with 20% fetal bovine serum, 0.1 mM dibu-
tyryl adenosine cyclic 3’,5’-monophosphate, 10 µg/ml bovine pituitary extract, 48 nM 12-
O-tetradecanoylphorbol-13-acetate, 1% Penicillin/Streptomycin/fungizone and 1 mM glu-
tamine. The isolated melanocytes were cultured using MMM during the experiments.
2.2.5.3 Generation of stable mammalian cell lines using the GeneSwitch™ sys-
tem
The stable MDCK cell line in which HA–tagged mTRPM31719 (mM31719) expression can be
induced by mifepristone [234] were established using the GeneSwitch™ System (Invitrogen).
The GeneSwitch™ System consists of a combination of an inducible expression plasmid
(pGene/V5–His) and a regulatory plasmid (pSwitch). The pGene/V5–His plasmid carry-
ing a zeocin resistance expresses the gene of interest, whereas the pSwitch plasmid with
hygromycin resistance expresses a regulatory fusion protein (/GAL4-DBD/hPR-LBD/p65-
AD) under the control of the GAL4 UAS promoter. In the absence of mifepristone, a
synthetic 19-norsteroid, the pSwitch regulatory protein is minimally expressed and predom-
inantly localized in the cell nucleus in an inactive form [13]. Upon addition, mifepristone
binds to the truncated hPR-LBD (human progesterone receptor ligand binding domain)
with high affinity (Kd: ∼3×10−9 M) [223]. Mifepristone binding causes a conformational
change in the hPR-LBD so that the expressed pSwitch regulatory protein dimerizes to an
active form. This ligand–bound homodimer interacts with GAL4 binding sites in the GAL4
UAS of pGene/V5–His, initiating expression of the gene of interest. Moreover, the expres-
sion is further amplified by an auto-regulatory feedback loop whereby the active regulatory
protein up-regulates its own gene expression via binding to GAL4 binding sites in the GAL4
UAS of pSwitch plasmid (Figure: 2.4).
The HA–tagged mM31719 cDNA was subcloned into the pGene/V5–His A expression
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Figure 2.4: Mechanism of the GeneSwitch™ system
In the GeneSwitch™ System, the mifepriston–bound dimerized pSwitch regulatory fusion protein
(GAL4-DBD/hPR-LBD/p65-AD) binds to GAL4 site within GAL4 UAS promoter resulting in
expression of both the gene of interest and its own gene (positive feedback). Abbreviations: E1b,
adenovirus major late E1b gene; TK, thymidine kinase from herpes simplex virus; DBD, DNA
binding domain; hPR, human progesterone receptor; LBD, ligand binding domain; p65, human
p65 subunit of NF-κB; AD, activation domain. This figure is modified from “GeneSwitch™
System: A Mifepristone–Regulated Expression System for Mammalian Cells” (Invitrogen).
vector and transfected into the GeneSwitch™–MDCK cell lines engineered with pSwitch reg-
ulatory plasmid (Section: 2.14). After 24–48 hrs of transfection, the medium was changed
to D-MEM medium supplemented with 50 µg/ml of hygromycin and 400 µg/ml of Zeocin™.
The medium was exchanged three times a week, and the dual selection was maintained for
2 weeks. Thereafter, the cells were trypsinized and resuspended in a 15 ml falcon tube. One
or two serial dilutions were made and the concentration of the cell dilution was determined
with a cytometer. A sufficient amount of a 10–15 cells/ml cell dilution was prepared in
hygromycin– and Zeocin™ –supplemented D-MEM medium. 100 µl of this cell solution was
distributed to each well of a 96-well plate. The cells were grown in the wells for 2 weeks and
the selection medium was exchanged 3 times a week. Once monoclonal colonies were visible
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(about 1/4 of the well diameter), they were trypsinized and transferred to a 6-well plate
filled with selection medium. The selected cell clones were tested for mifepristone–induced
mM31719 expression (1×10−8 M) in Western blots (Section: 2.2.3.3) or immunofluorescent
labeling (Section: 2.2.6.3) using a polyclonal anti–HA antibody. The GeneSwitch™–MDCK
cells stably expressing HA–tagged mM31719 (M3pGene cells) were polarized on a semiper-
meable Polyester Transwell membrane filter (Corning Life Sciences) with 0.4 µm pore size.
The expression of mM31719 induced by mifepristone was tested by immunofluorescent la-
beling using a polyclonal anti–HA antibody, and fluorescent images were captured using a
confocal microscope (Section: 2.2.6.4).
2.2.6 Methods for histology and immunohistochemistry
2.2.6.1 General histological techniques
General histological techniques such as paraformaldehyde fixation, embedding and section-
ing of frozen mouse tissues and embryos were performed according to Ausubel et.al [10].
For paraformaldehyde fixation, the dissected tissues and embryos were fixed with freshly
prepared 4% paraformaldehyde (PFA) in labeled vials at 4℃. The fixation time varied de-
pending on the age and size of the samples (15 min to 4 hr). For embedding and sectioning,
the dissected tissues and embryos were quickly frozen in dry ice, embedded on cryostat
chucks and sectioned (10 µm in thickness) by a cryomicrotome. The frozen sections were
collected on microscope slides and stored at -80℃.
2.2.6.2 β-galactosidase (lacZ) assay
The β-galactosidase encoded by the lacZ gene hydrolyzes β-galactosides into mono-saccha-
rides. The X-gal is a chromogenic substance consisting of a galactoside and an indole ring.
In the presence of β-galactosidase, X-gal is cleaved into galactose and 5-bromo-4-chloro-3-
hydroxyindole, which is oxidized to an insoluble blue product, 5,5'-dibromo-4,4'-dichloro-
indigo (Figure: 2.5). The X-gal staining method has particularly been used to distinguish
functional lacZ gene in the β-geo cassette. The protocol for the X-gal staining buffer was
adapted from the homepage of the The Wellcome Trust Sanger Institute. In order to prevent
precipitation of X-Gal, staining buffer was pre-warmed to 37℃ before adding X-Gal and
filtered through a 0.45 micron syringe filter.
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Figure 2.5: Mechanism of the β-galactosidase (lacZ) assay
As a substrate of β-galactosidase, colorless X-gal is hydrolyzed to 5-bromo-4-chloro-3-hydro-
xyindole which is quickly oxidized to an insoluble blue 5,5'-dibromo-4,4'-dichloro-indigo.
Adapted and modified from Joung et al. [91].
X-gal staining of frozen cryostat sections The frozen cryostat sections were air–dried
for 15 min and directly fixed for 15 min in fixation buffer containing 0.2% glutaraldehyde.
The fixed sections were washed in wash buffer (3×5 min) and then stained in staining
buffer containg X-gal (1 mg/ml). The slides were transferred to a humidified chamber and
incubated overnight at 37℃. After rinsing the slides in wash buffer (2×5 min), the sections
were counter–stained with 50 ng/ml DAPI in wash buffer for 30 min and mounted with
fluorescence mounting medium (DaKo) for visualizing under an Axiovert 200M inverted
microscope (Zeiss).
X-gal staining of whole mouse embryos Whole mouse embryos (up to 14 days post
coitum (dpc)) were carefully dissected away from their extraembryonic membranes and
transferred to a 24-well tissue culture dish filled with PBS solution. The embryos were
fixed in fixation buffer for 15–30 min, washed three times for 5–15 min in wash buffer, and
incubated in staining buffer at 37℃ in the dark until the color was maximally developed.
After staining, the embryos were dehydrated successively with 70%, 90%, 95%, and 100%
ethanol prepared in xylene, and visualized using a microscope, or cryosectioned for further
analysis.
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2.2.6.3 Immunofluorescent labeling of adherent cells
The cells to be analyzed were grown to confluence on glass cover slips in 6-well culture
dishes. The cells were washed for 5 min in PBS followed by fixation for 10 min in 0.15 M
sodium phosphate buffer containing 4% PFA. After the sodium phosphate buffer washes
(3×10 min), the cells were permeabilized by incubation with 0.15 mM sodium phosphate
buffer supplemented with Triton X-100 (0.1%, v/v) and goat serum (1%, v/v) for 1 hr.
Subsequently, the cells were incubated with the primary antibodies (1 µg/ml) for 1 hr,
washed three times (10 min/wash) and incubated with the Alexa 488 secondary antibody
(1 µg/ml) for 1 hr. The primary and secondary antibodies were prepared in 0.15 mM sodium
phosphate buffer containing Triton X-100 (0.1%, v/v) and goat serum (1%, v/v). Finally,
the glass cover slips were mounted with mounting medium and inverted on the microscope
slides for observation using either an inverted or a confocal microscope.
2.2.6.4 Confocal and fluorescence microscopy
Application of confocal microscopy For confocal microscopy, living cells were visu-
alized with a laser scanning microscope (LSM 510 META, Carl Zeiss) by using a Plan-
Apochromat 63×1.4 NA objective. The images of cells expressing HA–, CFP– and YFP–
tagged TRPM3 channels were obtained using an argon laser with an excitation wavelength
of 488-nm. Emission filters BP 460–500 and LP 505 were used for CFP and YFP, respec-
tively. The pinhole size was adjusted to 0.8 Airy units in order to get the best signal:noise
ratio (optical slices ≤0.8 µm). To study the localization of the HA–tagged TRPM3 channel
in the polarized MDCK cell line, images were collected using the Z–Sectioning module. The
optimal Z –interval depended on the objective used, and the pinhole setting was determined
(0.3–0.7 µm) using Optical Slice Option.
Application of fluorescence microscopy Images of cryostat sections were captured
with an Axiovert 200M inverted microscope (Carl Zeiss). DAPI fluorescence was excited
by a mercury–arc lamp at 330–385 nm with a 420 nm emission filter.
2.2.6.5 Antigen design and antibody production
Before the antibodies were raised, specific peptide sequences of mM31719 were selected by
means of analysis algorithms incorporated in the commercial software package DNAStar™
[165, 166]. The appropriate sequences (M3-7; M3-8) were accepted when they passed the
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following selection criteria: 1) the antigenic epitopes of the peptide sequences must be
hydrophilic, surface orientated and flexible [219]; 2) the sequences should contain highly
hydrophilic and antigenic regions, which were calculated by Kyte–Doolittle and Jameson–
Wolf methods, respectively; 3) the sequences were chosen in the C–terminus of mM31719,
because the C–terminus is more variable than the N–terminus which is homologous in the
TRPM channel subfamily; 4) the length of the selected peptide sequences ranged between
10–20 residues. The anti–peptide rabbit antibodies (M3-7 and M3-8) were generated and
affinity–purified by Eurogentec. The purified antibodies were characterized by immunohis-
tochemical staining as well as by Western blot (Section: 3.3.2.1).
2.2.7 Measurement of the intracellular free Ca2+ concentration
2.2.7.1 Fura-2
Fura-2 is a UV-excitable fluorescent calcium indicator. Upon binding of Ca2+, the fluores-
cent excitation maximum of fura-2 shifts from 380 nm (Ca2+–free) to 340 nm (Ca2+–saturated),
while the fluorescent emission maximum remains basically unchanged at 500 nm. Normally,
hydrophilic fura-2 is introduced into the cells by means of its lipophilic derivative – fura-
2-acetoxymethyl ester (fura-2AM). Once inside the cell, the acetoxymethyl ester group of
fura-2-AM is cleaved by esterases releasing fura-2 to bind with Ca2+ (Figure: 2.6).
HEK 293 cells transfected with the cDNAs to be analyzed were grown on a glass coverslip
in a 35 mm cell culture dish. The cells were washed once with HBS/Ca2+ buffer (10 mM
HEPES, 1 mM MgCl2, 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 5 mM glucose, 0.1%
BSA, pH 7.4) and loaded with fura-2AM (5 µM) prepared in 1 ml of HBS/Ca2+ buffer at
room temperature in the dark. After 30 min incubation, the cells were rinsed with 1 ml
of HBS/Ca2+ buffer. The glass coverslip was removed from the culture dish, mounted in
a perfusion chamber, and covered with HBS/Ca2+ buffer. Ca2+ imaging was performed
using an Olympus IX70 inverted microscope and controlled by a computer running the
TILLvisION 3.0 software. The cells were alternatingly excited at wavelengths of 340 nm
(Ca2+–saturated) and 380 nm (Ca2+–free) [60], ROIs (region of interest) and backgrounds
were marked at each wavelength. After 60 sec, the agonists at different concentrations were
carefully pipetted onto the cells. The experiment was stopped after about 600 sec. The
340/380 nm fluorescence quotient is a measure of the absolute
[
Ca2+
]
i regardless of fura-
2 loading efficiency, illumination intensity, and optical path length [11]. The background
values were subtracted and the
[
Ca2+
]
i was calculated using following equation [60, 238]:
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Figure 2.6: Introduction of fura-2 into the cytoplasm and excitation spectrum of
fura-2 under different Ca2+–concentrations:
A: Fura-2AM, a lipophilic derivative of fura-2, permeates into the cell and is de-esterified by
cellular esterases to fura-2 free acid. The cells loaded with fura-2 are alternatively excited at 340
and 380 nm wavelength, and the fluorescence emission (500 nm) can be quantitatively analyzed
for
[
Ca2+
]
i. B: The excitation spectrum of fura-2 in the presence of different concentrations
of Ca2+. The fluorescence intensities were measured at 510 nm emission wavelength using
excitation wavelengths between 250 nm and 450 nm. [After Richard P. I Jaugland, and Karen
D. Larison, Handbook of Fluorescent Probes and Research Chemicals (5th Edition 1992-1994).]
[
Ca2+
]
i
= Kd × R−Rmin
Rmax −R ×
F380min
F380max
(2.5)
where Kd is the dissociation constant of fura-2 (264 nM at 22℃), R is fura-2 340/380 nm
ratio, Rmax and Rmin are the 340/380 nm ratios in the presence of a saturating
[
Ca2+
]
or
in the absence of Ca2+ respectively, F380min is the fluorescence of Ca2+-free fura-2 sample,
and F380max is the fluorescence of Ca2+-saturated fura-2 sample.
2.2.7.2 Aequorin
Aequorin, a Ca2+–binding photoprotein, was originally isolated from the jellyfish A. victoria
[195, 197] and is composed of the apoprotein apoaequorin and the prosthetic group coelen-
terazine [194]. In the presence of molecular oxygen, aequorin reconstitutes spontaneously
from apoaequorin and coelenterazine [196]. Binding of three Ca2+ to aequorin triggers an
intramolecular oxidation by which coelenterazine is oxidized to coelenteramide [158]. When
the excited coelenteramide returns to its ground state, blue light (λmax = 469 nm) is emit-
ted. Because aequorin and other bioluminescent molecules have a low quantum light yield
of a few photons per molecule, the bioluminescent signals are difficult to measure [12]. On
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the other hand, photoproteins like aequorin can be easily transfected as a cDNA into cul-
tured cells. The stability of aequorin can be increased by a GFP–aequorin fusion [12, 128].
GFP absorbs the blue light emitted from aequorin and gives off green fluorescence with a
maximum wavelength of 509 nm (Figure: 2.7). Ward and Cormier studied photoproteins in
Renilla and concluded that such radiationless energy transfer increased the quantum light
yield and gain measured in the bioluminescent processes [235, 236]. Baubet and colleagues
constructed numerous GFP–apoaequorin fusion proteins with linker sequences of different
sizes (5 aa to 55 aa) between GFP and apoaequorin, and found that the Ca2+–triggered
bioluminescence and quantum yield of all these fusion proteins were better than aequorin
alone. GFP probably stabilizes apoaequorin in the recombinant chimaera, and therefore
the light–emitting activity is increased [12]. Based on these mechanisms, aequorin has
been extensively used as a Ca2+ indicator to measure changes in
[
Ca2+
]
i. Using regular
coelenterazine, 0.1–1 µM was the useful sensitivity range [119].
Figure 2.7: Ca2+–induced bioluminescence of aequorin, which is composed of apoaequorin
and coelenterazine.
Two microgram of the cDNAs to be analyzed were co-transfected with 0.2 µg of pG5A
into HEK 293 cells using FuGENE-HD (Table: 2.14). pG5A is the pEGFP-C1 vector
containing a fusion construct of GFP–apoaequorin with 5 added linker sequences [12]. 24
hrs after transfection, the cells were trypsinized and collected by centrifugation at 2000
rpm for 2 min. The cells were washed once with HBS/Ca2+ buffer and then incubated with
coelenterazine (5 µM) for 15 min in the dark. After washing twice with HBS/Ca2+ buffer,
50–100 µl of cells were transferred to a luminometer microplate. Aequorin light emission
was recorded every second using a FLUOstar OPTIMA (BMG LABTECH) when Ca2+ (10
mM) and pregnenolone sulfate (50 µM) were applied into extracellular compartments of the
cells. Finally, an equal volume of HBS/Ca2+ buffer supplemented with 0.5% Triton X-100
was injected to the sample to quench all aequorin [127]. Because the speed of aequorin
consumption is dependent on the Ca2+ concentration [208],
[
Ca2+
]
i can be calculated by a
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rate constant (κ) using following equation [24]:
pCa2+ = 0.332588× (− log κ) + 5.5593 (2.6)
κ =
luminescence at a given point (photon counts/s)
total luminescence counts
(2.7)
where pCa2+ is the negative decadic logarithm of the
[
Ca2+
]
.
2.2.8 LacZ transgenic TRPM3 mouse, mouse genotyping and phenotyp-
ing
2.2.8.1 LacZ transgenic TRPM3 mouse
Due to the support by the National Institutes of Health (NIH), we could purchase TRPM3
mice which are heterozygous for the TRPM3 knockout allele and have 129S5EvBrd and
B6(Cg)-Tyrc−2J/J genetic background generated by Lexicon Pharmaceuticals using a gene
trap approach in 129S5EvBrd–derived embryonic stem (ES) cells. Compared to gene target-
ing which targets a specific gene sequence by homologous recombination, the gene trapping
randomly inserts a gene cassette into an intron of the targeted gene with gene trap vectors.
To generate a TRPM3 mutation, the gene trap vector (pKOS-55) that is composed of a
promoterless gene trap cassette (β-geo) flanked by an upstream splice acceptor sequence
(SA) and a downstream polyadenylation sequence (PA) (Figure: 2.8) was integrated into
the intron between exons 1–2 resulting in incorrect splicing and disruption of the protein ex-
pression. Only β-geo and exon(s) upstream of the insertion site are transcribed in the form
of a fusion protein. β-geo is a fusion of neomycin phosphotransferase and β-galactosidase
genes, the former is used as a neomycin resistance gene and the latter is applied for in vivo
expression studies such as immunohistochemistry or lacZ staining assay (Section: 2.2.6.2).
2.2.8.2 Genotyping of lacZ transgenic TRPM3 mice
The mouse genotypes were determined by PCR analysis using genomic DNA isolated from
tail tissue. The primer pairs for identifying the wild–type, heterozygous and homozygous
TRPM3 mutant mice are shown in the Table 2.10 and Figure 2.8. To confirm the gene
trap insertion, a primer in Neo (PNeo) was combined with a primer (P6) in the intron
upstream of the 5' end of exon 2. A primer in the intron at position 17 (P3) was used in
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Figure 2.8: Gene trap strategy for generating TRPM3 mutation and primer selec-
tion for genotyping
The mTRPM3 gene is located on chromosome 19qB. The pKOS-55 gene trap vector contains
a β-geo cassette and is integrated into the intron at position 17 between exon 1 and exon 2 of
mTRPM3. Only β-geo and its upstream exon were transcribed in the form of a fusion protein.
The lacZ gene in the β-geo cassette can be used for immunohistochemical staining. The primer
pairs P3/P6 and PNeo/P6 were used for detecting wild–type allele and gene trap insertion,
respectively. Abbreviations: SA, splice acceptor sequence; PA, polyadenylation sequence.
combination with P6 to detect the wild-type allele. The primers for the selection of the
homozygous Agouti and non-albino (A/A; C/C) mice were chosen based on the sequence
of the viral insert resulting in a non-agouti allele (GenBank: NC 000068) and tyrosinase
sequence (GeneBank: NM 011661), respectively (Section: 2.2.8.2).
Genomic DNA isolation from mouse tissues The genomic DNA isolation from mouse
tissues, such as mouse tail and ear, was performed by using the protease K method [79].
Under anesthesia, 6–10 mm of mouse tail (from mice of approx. three weeks of age) or
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100 mg of mouse tissues were removed and transferred to a 1.5 ml microcentrifuge tube.
The sample was mixed with 300 µl of Tail Buffer (25 mM EDTA, pH 8.0, 75 mM NaCl),
30 µl of 10% SDS and protease K (1 µg/µl), and incubated at 55℃ overnight. Following
additional incubation with 1.2 µl of RNAse A (5 mg/mL) at 37℃ for 1 hr, proteins and
other contaminants were precipitated by adding 100 µl of saturated sodium chloride. The
precipitates were removed by centrifugation (13000 rpm, 30 min), and the DNA recovered by
precipitation with 800 µl of 100% ethanol. The DNA pellet was washed with 75% ethanol,
air–dried and resuspended in 100 µl of ddH2O.
Mouse genotyping using touchdown PCR The mouse genotype was determined by
using touchdown PCR. In 25 µl of PCR reaction mix, 1 µl of mouse tail DNA was mixed
with 0.5 µl of dNTP, 4 µl of 10x buffer (
[
Mg2+
]
Fin : 1.5 mM), 0.5 µl of each forward and
reverse primers (50 µM) and 0.2 µl of polymerase. The touchdown PCR conditions, the
primers and the polymerases used for genotyping are listed in Tables 2.10 and 2.19.
Table 2.19: Touchdown PCR conditions for mouse genotyping
Steps Temp. Time Note
1 94℃ 2 min
2 94℃ 30 sec
3 65℃ 30 sec -1℃/cycle
4 72℃ 1 min/kb amplified DNA Go to 2, 10 cycles
5 94℃ 30 sec
6 55℃ 30 sec
7 72℃ 1 min/kb amplified DNA Go to 5, 35 cycles
8 4℃ hold
2.2.8.3 Phenotypic analysis of TRPM3−/− mice
General observations To detect overt and serious dysfunctions, the TRPM3 wild–type
and knock–out mice were routinely observed, especially in the following areas: color of the
body hair, thickness of the whiskers, grooming behavior, body size, posture and gait (in the
open field).
Visual placing test Mouse vision was tested by using the visual placing test [39, 75, 173].
When the tail of the mouse was held at height of ca. 15 cm above a table surface, its limbs
were held close to the body. Then, the mouse was gradually lowered towards the table
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surface. The wild–type mouse sees the approaching table surface and extends its forepaws
for landing, whereas the blind mouse does not extends its forepaws until its whiskers or
nose touch the table.
Figure 2.9: Visual cliff apparatus
Visual cliff test The gross visual ability, in-
cluding visual acuity and depth perception, of
TRPM3 wild–type and knock–out mice was
studied in a visual cliff test [2, 52, 62]. The
procedures were performed according to Craw-
ley et al. [39, 71, 101]. Briefly, the mouse to
be tested was placed on a black block (38 cm
length×3.8 cm width×2 cm height) at the cen-
ter of an open–top box (70 cm length×40 cm
width×65 cm height) (Figure: 2.9). This box is
composed of a horizontal plane (“safe” side), a
vertical drop (0.5 meter) and a second horizon-
tal plane at a lower level (“unsafe” side). The
inside surfaces of the box were covered by a
black and white checkerboard pattern of 2 cm
squares to accentuate the vertical drop–off. A
sheet of clear Plexiglas was placed across the top horizontal plane extending across the
cliff. Each mouse was tested for 10 consecutive trials. The trial was measured as positive
when the mouse moved off the center block with all 4 paws placed one side of the block.
Between trials, the Plexiglas, box walls and block were cleaned using diluted ethanol on a
fresh paper towel. The percentage of the time taken for the mouse to walk over the “safe”
side as opposed to over the “unsafe” side was recorded (percent correct (%)).
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3.1 Molecular cloning and functional analysis of mTRPM3
In order to assess TRPM3 function, we need a valid TRPM3 cDNA which is expressable in
HEK-293 cells and should preferably correspond to the major splice variant in most tissues.
Therefore, we cloned new mouse TRPM3 cDNAs and tested their protein expression level
in heterologous systems. Subsequently, the functions of splice variants were analyzed by
using aequorin– and/or fura-2–based intracellular Ca2+ assays.
3.1.1 Molecular cloning of mM31719 and mM31337
Because the 3’–end cDNA sequences of TRPM members are identical, the 5'–RACE system
was used to generate 5’–end partial mouse TRPM3 (mTRPM3) cDNA clones. 1 µg of mouse
kidney Poly(A)+ mRNA was sequentially pre-treated with dephosphorylation, decapping
and GeneRacer™ RNA–Oligo ligation procedures (Section: 2.2.1.5). The 5' cDNA end of
mTRPM3 was amplified by PCRs between the RACE anchor primer and the GSP–RT
primer directly against the known core sequence of mTRPM3. The resulting products were
subcloned and sequenced, and showed a valid transcription start and first coding exon of
mTRPM3. Subsequently, we performed a PCR against the whole sequence of mTRPM3
from the starting exon previously found by 5'–RACE to the final exon, covering the whole
coding sequence. The 3' reverse primers for mTRPM3 cDNA amplification were used with
the known 3' UTR of TRPM3 under the GenBank™ accession numbers AJ544534 [157]
and AJ505026 [59]. Both cDNA clones (mM31719 and mM31337) were TOPO–cloned into
pcDNA3.1 vector for sequencing and further analyses (Section: 2.2.1.7).
3.1. Molecular cloning and functional analysis of mTRPM3
Figure 3.1: Sequence of TRPM3
Protein sequences encoded by cDNAs of mM31719, mM31337 and hTRPM3-k are shown. Puta-
tive transmembrane domains, TRP and Coiled–Coil domains are marked in red.
3.1.2 Analysis of mM31719 and mM31337 protein expression
Protein expression of mM31719 and mM31337 in HEK-293 cells To test whether
the cDNAs of mM31719 and mM31337 are expressed as proteins, so that they can be used to
further investigate the physiological functions of TRPM3, both cDNAs were transfected into
HEK-293 cells and their protein expression was checked by immunocytochemical staining
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and Western blot.
Because no specific mTRPM3 antibodies were available when I began this work (the
purchased commercially available antibodies proved to be useless after testing), the cDNA
constructions of C–terminally hemagglutinin (HA)– and yellow fluorescent protein (YFP)–
tagged mM31719 and mM31337 were generated. The stop codons of mM31719 and mM31337
cDNAs were replaced by SalI restriction sites using PCR. The HA and YFP cDNAs were
added to the C–termini of both mM31719 and mM31337 cDNAs by means of in–frame fu-
sion. The physiological properties of mM31719 and mM31337 such as channel activities and
subcellular localization were not influenced by the HA and YFP tags according to the in-
tracellular Ca2+ assay with aequorin and immunocytochemical staining, respectively (data
not shown).
The protein expression of HA– and YFP–tagged mM31719 and mM31337 was confirmed
in Western blots by using anti–HA and anti–GFP antibodies (Figure: 3.2 and 3.12). The
observed molecular weights (mM31719: ca. 180 kDa, mM31337: ca. 140 kDa) match with
the data calculated by bioinformatic tools (e.g., DNAstar). This result implies that both
cDNAs are expressed as proteins in the heterologous system, and no truncated and post–
translationally modified forms of both expressed proteins exist under these conditions.
Furthermore, we tested in which subcellular compartments of HEK-293 cells the cDNAs
of mM31719 and mM31337 were expressed. Using immunocytochemical staining (Alexa-488
was used as a secondary antibody) and confocal microscopy, mM31719 and mM31337 were
predominantly to be localized in intracellular compartments (Figure: 3.2). Occasionally, the
immunofluorescence signals of mM31719 and mM31337 were observed at the plasma mem-
brane of HEK-293 cells. In summary, either splice variant of mTRPM3 was expressable in
HEK-293 cells, and appears to be able to reach the plasma membrane. However, we wanted
to test whether mTRPM3 is expressed at the plasma membrane under more physiological
conditions, like in differentiated epithelia.
Protein expression of mM31719 and mM31337 in MDCK cells The predominantly
intracellular localization of mM31719 and mM31337 in HEK-293 cells could either indicate
that TRPM3 functions as an intracellular channel, or reflect a channel overexpression ar-
tifact. In order to address this question, we studied the protein expression and subcellular
localization of both newly cloned mTRPM3 cDNAs in Madin–Darby canine kidney (MDCK)
cells. MDCK cells derived from the dog kidney collecting duct are an established cell model
for studying epithelial differentiation [25, 64]. When grown on semipermeable filters in
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Figure 3.2: Cellular localization of mM31719 in transiently transfected HEK-293
cells and differentiated MDCK cells
A: Western blot shows the dose–dependent mifepristone–induced mM31719–HA expression in
the M3pGene cells. The immuno–reactive bands with the predicted molecular weight (>170 kDa)
were detected by an anti–HA antibody and first observed when the cell lines were treated with
the lowest tested mifepristone concentration of 1 nM. Compared with HEK-293 cells transiently
transfected with pcDNA3.1 and mM31719 (1 µg, respectively), the mM31719–HA expression
induced by mifepristone (≥10 nM) showed strong immunoreactive signals. B: The localization
of HA– and YFP–tagged mM31719 (a, b) and mM31337 (c, d) was primarily found in the
intracellular compartments of HEK-293 cells (arrows). The expression of TRPM3 was also
occasionally found in the plasma membrane region (d, inset, arrowhead). C: The MDCK cells
stably expressing HA–tagged mM31719 were grown and polarized on a semi–permeable filter.
C: Basolateral localization of mM31719 in the polarized MDCK cells was shown by horizontal
(xy plane) and vertical (xz and yz planes) confocal scans (0.7 µm). Cells were immuno–stained
with an anti–HA antibody, and observed with a confocal microscope with a detector pinhole
diameter of 0.8 Airy units. Each bar represents 10 µm.
cell culture, these cells differentiate to form polarized monolayers and retain most of the
properties of in vivo epithelia [37, 103].
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Because transiently transfected MDCK cells showed a predominantly intracellular local-
ization (data not shown), a stable MDCK cell line inducibly expressing HA–tagged mM31719
(M3pGene cell line) was generated in order to characterize the steady–state distribution of
mM31719. The HA–tagged mM31719 cDNA was subcloned into the pGene/V5–His A ex-
pression vector and transfected into the GeneSwitch™–MDCK cell lines engineered with the
pSwitch regulatory plasmid. The cells were grown under double–antibiotic selection (hy-
gromycin (50 µg/mL) and Zeocin™ (400 µg/mL)) for ≥2 weeks. Once monoclonal colonies
were visible, they were tested for mifepristone–induced mM31719 expression by Western blots
and immunofluorescent labeling (Section: 2.2.5.3). The expression of mM31719 was induced
by mifepristone with the induction concentration adjusted to 10 nM according to the West-
ern blot analysis (Figure:3.2A). It was found that the protein expression of mM31719–HA
in the undifferentiated M3pGene cells remained in the intracellular compartment (data not
shown). However, when the M3pGene cells were grown on a Transwell® PET membrane for
≥2 weeks, and differentiated to a polarized monolayer, the protein expression of mM31719–
HA was observed at the basolateral side of the differentiated MDCK cells (Figure: 3.2C).
These data indicate that mM31719 is expressable in the MDCK cells and primarily localized
at the basolateral plasma membrane of epithelial cells.
3.1.3 Functional analysis of mM31719
To study Ca2+ entry through mM31719 and mM31337, we used HEK-293 cells instead of
MDCK cells as a cell model, because MDCK differentiation is extensively time consuming
and the transient transfection efficiency of HEK-293 cells is much higher. Since a different
TRPM3 splice variant with the same pore splicing configuration has been reported to be
Ca2+–permeable when expressed in a heterologous system [58, 106, 157], calcium indicators
aequorin and fura–2 were applied to measure changes in
[
Ca2+
]
i upon extracellular appli-
cation of different chemicals in HEK-293 cells. Compared to patch clamp, these aequorin–
and fura–2–based
[
Ca2+
]
i measurements provide simple and sensitive analytical approaches
to characterize physiological functions of ion channels that are Ca2+ permeable at an ap-
preciable rate [163].
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3.1.3.1 Quantification of intracellular Ca2+ concentration increase in HEK-293
cells expressing mM31719 and mM31337
To measure Ca2+ entry through mM31719 and mM31337, the aequorin–based method was
preferred, because 1) aequorin measurement in a cuvette can be safely calibrated; 2) this
method has high signal-to-noise ratio; 3) aequorin is nearly insensitive to the buffer con-
ditions such as pH value and changes in
[
Mg2+
]
[22]; 4) single cell measurement is not
important under these experimental conditions. The
[
Ca2+
]
in HBS buffer solution was
adjusted to 2 mM (data not shown) before the experiments.
It is disputed whether TRPM3 is either a SOC [58, 106], osmolality–regulated [68, 70],
or a lipid–activated channel [59]. Firstly, we examined the responses of HEK-293 cells
expressing mM31719 and mM31337 to an application of thapsigargin (1 µM) which depletes
intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+–ATPase
[211]. However, no responses were observed during the experiments. We also used 200 Osm
and D–erythro–sphingosine (20 µM) to respectively test whether mM31719 and mM31337 are
activated by hypo–osmolality and lipid. Like the result from the thapsigargin experiment,
neither of the new mTRPM3 splice variants was activated by 200 Osm and D–erythro–
sphingosine (data not shown). It has also been reported that TRPM3 can be activated by
pregnenolone sulfate (PS) [231]. Therefore, we applied PS (50 µM) to the cells expressing
mM31719 and mM31337. Both groups of cells showed a strong
[
Ca2+
]
i increase. Because
TRPM3 is thought to be constitutively active, we increased the Ca2+ driving force across the
plasma membrane by Ca2+ steps (extracellular
[
Ca2+
]
was increased from 2 mM to 12 mM)
in order to amplify the constitutive channel activity. The Ca2+ influx was highly increased
in the cells expressing mM31719 and mM31337 compared to the control cells (Figure: 3.3C-E).
The Ca2+ steps–induced Ca2+ influx through mM31719 was also observed in the fura–2
measurement. We observed the changes of the 340/380 nm fluorescence ratio in response to
Ca2+ steps. Whereas no major changes occurred in pcDNA3.1–transfected cells, addition
of Ca2+ resulted in large increase in
[
Ca2+
]
i in mM31719–transfected cells (Figure: 3.3A, B).
Thus, in summary, our findings show that 1) mM31719 and mM31337 are not store–
operated channels and cannot be activated by hypo–osmolality and D–erythro–sphingosine;
2) mM31719 and mM31337 can be activated by extracellular application of PS (50 µM),
however, it is still questionable whether PS is a physiological activator of TRPM3 because
the physiological concentration of PS is in the nanomolar range; 3) mM31719 and mM31337
are constitutively active and functional Ca2+ permeable channels. Based on the results
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Figure 3.3: Quantification of
[
Ca2+
]
i increases caused by extracellular Ca2+ and PS
applications in HEK-293 cells expressing mM31719 and mM31337
A-B: Ca2+ influx through mM31719 was detected in fura-2–loaded HEK-293 cells expressing
mM31719 in response to changes in
[
Ca2+
]
in the buffer solution. Data are mean ± SEM of n=5
independent transfection experiments containing data from a total number of 25 (pcDNA3.1)
and 80 cells (mM31719). C-E: Intracellular Ca2+ measurement with aequorin showed that
cells expressing either mM31719 or mM31337 respond to changes in the extracellular Ca2+ or
PS. Moreover, the induced responses in cells expressing mM31337 is stronger than that in cells
expressing mM31719. For statistical analysis, unpaired Student’s t-test (n=5, 6) was used to
calculate the P -value. Numbers above the bars indicate the total number of experiments per-
formed. ??? = P<0.001. Abbreviation: PS, pregnenolone sulfate.
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described above, Ca2+ steps and PS application combined with aequorin bioluminescence
were used as standard approaches to score modulation of the TRPM3 activity.
3.1.3.2 Effects of divalent cations on Ca2+ entry in HEK-293 cells expressing
mM31719
The Ca2+ permeability of TRPM3 raises the possibilities that TRPM3 might be influenced
or inhibited by other divalent cations.
Ni2+ was first chosen to investigate cation selectivity for mM31719, because: 1) some
TRPM channels such as TRPM6 [230] and TRPM7 [130] have been reported to conduct
Ni2+ (20 mM and 1 mM
[
Ni2+
]
, respectively); 2) Ni2+ has been shown to selectively block
t-type calcium channels [105] and SOCE pathway [114].
After 18 hr transfection with 2 µg of mM31719 or pcDNA3.1 (as negative control), the
transfected HEK-293 cells were prepared in a series of HBS/Ca2+ solutions containing 0
µM, 1 µM, 3 µM, 10 µM, 30 µM, 100 µM, 300 µM, 1 mM, 3 mM, 10 mM and 30 mM NiCl2
for 10–15 min. Upon the application of PS (50 µM) and Ca2+ (10 mM), the changes of[
Ca2+
]
i were recorded by an aequorin–based intracellular Ca2+ measurement.
Figure 3.4: Analysis of the effects of extracellular Ni2+ on Ca2+ entry in mM31719
A-B: Dose response curves were plotted from maximal
[
Ca2+
]
i. Extracellular Ni2+ decreased
Ca2+– and PS–induced
[
Ca2+
]
i increase in a concentration–dependent manner, with an IC50
of 575±224.7 µM (P<0.05) and 531.1±88.9 µM (P<0.001), respectively. Both IC50 values are
in a similar range. Data represent the average responses from five independent transfection
experiments (Mean±SEM, n=5). For statistics, unpaired Student’s t-test was performed. The
total number of experiments was shown as numbers above the bars. Abbreviation: PS,
pregnenolone sulfate.
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Figure 3.4 shows that the channel activities of mM31719 were not affected when the
extracellular Ni2+ concentration was lower than 100 µM. However, the Ca2+ influx through
mM31719 was extensively reduced when the extracellular Ni2+ concentration reached 1 mM.
Dose–response analysis indicates that Ni2+ reduced Ca2+– and PS–induced Ca2+ influx
through mM31719 in a concentration–dependent manner, with an IC50 of 575±224.7 µM
(P<0.05) and 531.1±88.9 µM (P<0.001), respectively. Both IC50 values are in a similar
range.
Figure 3.5: Effects of divalent ions on Ca2+ entry through mM31719
Aequorin–based intracellular Ca2+ measurement indicated that PS– and Ca2+–induced
[
Ca2+
]
i
increases in the cells expressing mM31719 were inhibited by extracellular application of 1 mM
Cd2+, Co2+, Cu2+, Ni2+, Sr2+, Zn2+ and Mn2+. Mg2+ (1 mM) did not have any inhibitory
effects on the Ca2+ entry through mM31719. Bar graphs represent mean±SEM, n=4. Num-
bers above the bars indicate the total number of experiments. ? = 0.01<P<0.05, ?? =
0.001<P<0.01, ??? = P<0.001. Abbreviation: PS, pregnenolone sulfate.
To test whether other divalent ions have effects on the Ca2+ permeability of mM31719,
several trace divalent ions such as cadmium (Cd2+), cobalt (Co2+), copper (Cu2+), stron-
tium (Sr2+), magnesium (Mg2+), zinc (Zn2+) and manganese (Mn2+), were examined. This
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is because these trace divalent ions are known to permeate TRPM7 which is phylogenet-
ically related to TRPM3 (Figure: 1.4). These divalent ions might also be meaningful for
the TRPM7’s function and phenotype [130]. Based on the results from Ni2+ experiment
above, the cells expressing mM31719 and pcDNA3.1 were placed in the HBS/Ca2+ solution
containing such divalent ions (1 mM). Ca2+ influxes were induced by PS (50 µM) and Ca2+
(10 mM) applications. The
[
Ca2+
]
i change was measured with aequorin. The results show
that 1 mM of all divalent ions tested with the notable exception of Mg2+ reduced Ca2+
influx through mM31719 (Figure: 3.5).
In summary, the experimental data indicate that many divalent cations probably have
inhibitory effects on the mM31719 Ca2+ entry at millimolar concentration; and that Mg2+,
at the physiological concentration, does not inhibit mM31719 Ca2+ entry.
3.2 Identification of functional domains in mM31719
Based on the studies with TRPM4, TRPM6 and TRPM7, we can predict which residues
in the pore might be involved in Ca2+ permeation, channel inhibition by other divalent
ions, and possibly channel gating. We therefore introduced the analogous mutations into
the pore of mM31719. Additionally, because the N–terminus of TRPM3 is highly conserved
among the members of TRPM subfamily (Figure: 1.4), we focused on the C–terminus of
mM31719 to analyze features of its molecular structure and to elucidate its biological roles
in the channel properties and functions.
3.2.1 Structure of the pore and C–terminus of mM31719
3.2.1.1 Site–directed mutagenesis of amino acid residues relevant to Ca2+ entry
in the mM31719 pore
Comparisons of the cDNA sequences of the TRPM subfamily establish that the pore region
of all such proteins shares some common structures, namely, pore helix and selectivity loop
[149, 244] (Figure: 4.1). Here, the effects of the pore region on the biophysical properties of
the mM31719 channel were investigated by using various molecular biological methods (e.g.,
site–directed mutagenesis) and pharmacological approaches.
Analysis of mutations in Pro1060 and Gly1066 in the mM31719 pore region Pro1060
in the pore helix and Gly1066 in the linker between pore helix and selectivity loop are highly
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consistent and conserved in the TRPM subfamily (Figure: 1.5). Studies in other TRPM
showed that the mutations of Pro1060 and Gly1066 in the TRPM6 and TRPM7 channels
generate dominant–negative mutants [30, 117, 149]. In mM31719, Pro1060 was mutated to
Arg1060 (P1060R mutation, mM3-RYW mutant) because both amino acids contain 3 carbon
atoms in the side–chain group. Arginine (Arg) has a positively charged guanidino group,
whereas proline (Pro) has a nonpolar side chain. Gly1066 was mutated to Val1066 (G1066V
mutation, mM3-VEV mutant) because valine (Val) is not only an analog of glycine (Gly)
but also has less conformational flexibility due to its isopropyl side chain.
Figure 3.6: Ca2+ entry through mM31719 with P1060R and G1066V pore muta-
tions
Ca2+ entry in mM31719 with P1060R and G1066V pore mutations were analyzed by using
aequorin–based intracellular Ca2+ measurements. HEK-293 cells were co-transfected with dif-
ferent cDNA combinations. The cells expressing mM3-RYW or mM3-VEV did not show Ca2+
influx in response to application of extracellular Ca2+ (10 mM) and PS (50 µM). Bar graphs
represent the average of transfection experiments (n=4); error bars represent ± SEM. Num-
bers next to the bars indicate the total number of experiments performed. ??? = P<0.001.
Abbreviation: PS, pregnenolone sulfate.
To test whether Pro1060 and Gly1066 are essential for the channel activities of mM31719,
and whether mM3-RYW and mM3-VEV are dominant–negative mutants, different cDNA
combinations (2 µg) of pcDNA3.1/pcDNA3.1, mM31719/pcDNA3.1, mM3-RYW/pcDNA3.1,
mM3–VEV/pcDNA3.1, mM31719/mM3–RYW, mM31719/mM3–VEV, mM31719/mM31719,
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were co-transfected into HEK-293 cells (cDNA ratio, 1:1). In comparison with the cells ex-
pressing mM31719 wild–type, no Ca2+ influx was detected in the cells expressing mM3-RYW
or mM3-VEV mutants (Figure: 3.6). This result indicates that the P1060R and G1066V
mutations probably cause loss of Ca2+ conduction through the channel. However, the
mM3-RYW and mM3-VEV mutants did not show any inhibitory effects on the function of
mM31719 wild–type, because all cells expressing mM31719/mM31719, mM3-RYW/mM31719
and mM3-VEV/mM31719 exhibited similar responses to the extracellular Ca2+ and PS
applications. Theoretically, we would have expected a less than 50% response of mM3-
RYW/mM31719 and mM3-VEV/mM31719 compared to mM31719/mM31719 if one of these
mutants had a dominant–negative effect. Thus, the mM3-RYW and mM3-VEV mutants
are not dominant–negative mutants for mM31719, although they disrupt mM31719 function.
Analysis of mutations in Asp1074 in the mM31719 selectivity loop The Asp1074
amino acid residue is highly conserved and identical in the TRPM subfamily (Figure: 1.5).
The neutralization of this Asp amino acid residue in TRPM4 yielded a non–functional
channel with a dominant–negative mutation [150]. To analyze its effects on the channel ac-
tivity and ion selectivity of mM31719, Asp1074 of mM31719 was mutated to Ala1074 (D1074A
mutation, mM3-AP mutant) by site–directed mutagenesis. 2 µg of cDNA combinations
of pcDNA3.1/pcDNA3.1, mM3-AP/pcDNA3.1, mM31719/pcDNA3.1, mM31719/mM3-AP,
and mM31719/mM31719, were co-transfected into HEK-293 cells (cDNA ratio, 1:1). Upon
the application of extracellular Ca2+ (10 mM) and PS (50 µM), a
[
Ca2+
]
i increase was ob-
served in the cells expressing mM3-AP/pcDNA3.1, although the measured Ca2+ influx was
less than in the cells expressing mM31719/pcDNA3.1. Since the expression level between
them can be expected to be the same, our results indicate a partial reduction in Ca2+ entry.
This is either due to a reduced channel activity, or, more likely, due to a decrease in Ca2+
permeability. Like the mM3-RYW and mM3-VEV mutants, the mM3-AP mutant did not
inhibit the channel function of mM31719 by 50% under this experimental condition, and
thus it could not function as a dominant–negative mutant (Figure: 3.7).
In summary, we identified three amino acid residues, Pro1060, Gly1066 and Asp1074 which
may play a role in the Ca2+ entry through mM31719, and thus may be critical for the function
of mM31719.
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Figure 3.7: Ca2+ entry through mM31719 with D1074A pore mutation
The Ca2+ entry in mM31719 with D1074A pore mutation were analyzed using aequorin–based
intracellular Ca2+ measurements. The cells expressing the mM3-AP mutant showed increased
Ca2+ influx upon the extracellular Ca2+ (10 mM) and PS (50 µM) applications. However, the[
Ca2+
]
i increase in the mM3-AP transfected cells was less than it was in the mM31719 trans-
fected cells. When mM3-AP and mM31719 were co-expressed, the mM3-AP mutant did not
inhibit the channel activity of mM31719. Therefore, mM3-AP is a functional channel without
dominant–negative properties. For statistics, unpaired Student’s t-test and independent trans-
fection experiments (Mean ± SEM, n=4) were performed. Numbers next to the bars indicate
the total number of performed experiments. ??? = P<0.001. Abbreviation: PS, pregnenolone
sulfate.
3.2.1.2 Characterization of the mM31719 C–terminus
Little is known about the structure and function of the C–terminus of TRPM3. Firstly, the
molecular structure of C–terminus is variable among the TRPM channels, but conserved in
the TRPM3–like channels. Besides a TRP domain and a coiled–coil (C–C) domain which
are close to the 6 transmembrane segments (6TM), the C–terminal protein sequence lacks
predicted domains such as enzymatic domains. Secondly, PS– and Ca2+–induced Ca2+
entry through the short splice variant mM31337 was significantly larger than that through
the long splice variant mM31719. This indicates that the protein structure of the C-terminus
probably plays an important role in the specific regulation of the TRPM3 channel. Hence,
to investigate the biological roles of the mTRPM3 C–terminus, we studied its molecular
structure and function using subcellular localization studies and Ca2+ entry measurements
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with C–terminal mM31719 mutants.
Subcellular localization of the soluble mM31719 C–terminus protein The cDNA
sequence of the mM31719 C–terminus (M3TC, amino acid residues 1166–1719) was amplified
by PCR using specific primers with a Kozak consensus sequence (Section: 2.10). The ampli-
fied cDNA fragment was cloned into the pcDNA3.1/V5-His-TOPO® vector, and afterwards
C–terminally fused with YFP–, and HA–tags by using in–frame fusion. To test whether
the cloned C–terminal sequence of mM31719 is expressable in HEK cells and to study its
subcellular localization, the C–terminally HA–, YFP–tagged M3TC were transfected into
HEK-293 cells and the protein expression checked with immunocytochemical staining and
confocal microscopy. Whereas the full length mM31719 immunoreactivity is primarily ob-
served in intracellular compartments (Figure: 3.8A-B), the immunoreactivity of M3TC was
entirely found at the plasma membrane (Figure: 3.8C-D), indicating a binding of M3TC to
the plasma membrane.
A number of TRP channels have been shown to bear PH domains or similar phospholipid
binding motifs (e.g., TRPM4 [145]). Therefore, we manipulated the membrane lipid content
to document the possible changes in the mM31719 C–terminus subcellular localization. Since
the protein–lipid interaction through PH domain can be broken by activated PLCβ which
catalyzes the hydrolysis of PIP2 to form DAG and IP3, some agonists such as histamine,
carbachol (CCh) [50], PGE2 [136], thrombin [189], and UTP [4, 213] which can activate
PLCβ via a protein–coupled receptor were used to investigate the putative role of PH
domain in M3TC plasma membrane attachment. Figure 3.8E-H was obtained by using an
Olympus IX70 inverted microscope, and shows HEK-293 cells co-expressing a YFP–tagged
M3TC and the histamine H1 receptor (M3TC–H1) and the HEK-293 cells co-expressing
a YFP–tagged PH domain (from PLCγ) and the histamine H1 receptor (PH–H1). The
PH–H1 was used as a positive control (molar ratio, 1:1). After treatment with histamine
for 10 min, the PH domain was released from the plasma membrane (Figure: 3.8E-F), but
the M3TC was still bound to the plasma membrane (Figure 3.8G-H). The experiments were
repeated using carbachol (100 µM), PGE2 (1 µM), thrombin (4 units/ml) and UTP (100
µM), however, no disassociation of M3TC from the plasma membrane was detected (data
not shown). Thus, the binding of the mM31719 C–terminus to the plasma membrane is not
mediated by a PH domain or other PIP2 binding motifs.
M3TC could also be anchored to the cytosolic face of the membrane either through
N -myristoylation on a NH2-terminal glycine residue via an amide bond [216] or through
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Figure 3.8: Protein expression of the mM31719 C–terminus in HEK-293 cells and the
putative role of PH–domain in the plasma membrane attachment of the mM31719
C–terminus
Schematic of the C–terminal region of mM31719 that begins at residue 1169. HA– or YFP–tagged
M3TC were transfected into HEK-293 cells and visualized by immunocytochemical staining
and confocal microscopy. A-B: YFP– and HA–tagged mM31719 were localized in intracellular
compartments (arrow). C-D: plasma membrane localization of YFP– and HA–tagged M3TC
was observed (arrow). E-F: HEK-293 cells were cotransfected with the YFP–tagged M3TC and
the histamine H1 receptor (M3TC-H1). The histamine H1 receptor was activated with 100 µM
histamine, and the images were obtained by illumination with 475 nm light using an Olympus
IX70 inverted microscope with a 40× oil objective. As a positive control, YFP–tagged PH
domain co-expressed with H1 receptor (PH-H1) in HEK-293 cells showed a plasma membrane
localization (E). After 10 min histamine stimulation, the PH domain was disassociated from
the plasma membrane (broken square, F). G-H: YFP–tagged M3TC was still observed in the
plasma membrane (broken square, H) after the co-expressed H1 receptor was activated for
10 min with histamine. Abbreviations: H1, histamine H1 receptor; M3TC, C–terminus of
mM31719; PH domain, pleckstrin homology domain.
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Figure 3.9: Effects of cysteine residues on the plasma membrane attachment of
M3TC
M3TC and mutants of the C–termini were fused with YFP tags. Photos were taken using
a confocal microscope. A: Cysteine residues in M3TC are indicated, M3TC is bound to the
plasma membrane (arrow). B: The C–terminus of mM31337 was generated by PCR (residues
1166–1337). This short C–terminus is also attached to the plasma membrane (arrow). C-
D: Cys1301 and Cys1210 were mutated to Ser1301 and Ser1210 in the C–terminus of mM31337.
However both mutants showed high levels of membrane localization (arrows). E-F: Cytosolic
localizations of the C–termini of either M31337 or M31719 were observed when their amino acid
residues Cys1174–Cys1175 were both substituted by serine.
farnesylation and S -acylation (palmitoylation) via an ester linkage to the thiol group of
a cysteine residue [203]. Because N -myristoylation is a stable co-translational lipid mod-
ification process and its typical recognition motif (Met-Gly-X-X-X-Ser/Thr) [176, 253] is
missing in the M3TC, we focused on the analysis of the cysteine residues in M3TC with
site–directed mutagenesis and confocal microscopy methods. To more precisely map the
protein–lipid binding sites, a series of mutations in which the cysteine residues were step-
wise mutated to the corresponding serine (S) were performed, because the side chains of
serine and cysteine are most similar. All of the mutants were fused with YFP–tags as
described above. Mutations of Cys1301 or Cys1210 alone (C1301S, C1210S ) did not have
an impact on M3TC binding to the plasma membrane (Figure: 3.9C-D), while the muta-
tions of Cys1174–Cys1175 (CC1174SS ) in the M3TC protein of either mM31719 or mM31337
caused protein release from the plasma membrane into the cytosol (Figure:3.9E-F). These
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Figure 3.10: Effects of palmitoylation on the function and subcellular localization
of mM31719
The role of palmitoylation in mM31719 was analyzed by using immunocytochemical staining
and an aequorin–based functional assay with and without 2-bromopalmitate (2-BP) treatment.
A: The HA–tagged mM31719-SS mutant was still found in the intracellular compartment. The
subcellular localization of the mM31719 was unchanged by palmitoylation. The images were ob-
tained by confocal microscope. B-D: Compared to mM31719, the Ca2+ influx through mM31719-
SS upon the extracellular application of 10 mM Ca2+ and 50 µM PS was reduced. E-F: The
decreased Ca2+ entry through mM31719-SS mutant without 2-BP treatment was nearly equal
to the decreased Ca2+ entry through mM31719 wild–type with 2-BP treatment (100 µM). The
data indicate mean±SEM, n≥3. For statistics, unpaired Student’s t-test was used. The total
number of performed experiments was shown as numbers above the bars. ?? = P<0.01, ??? =
P<0.001. Abbreviations: 2-BP, 2-bromopalmitate; PS, pregnenolone sulfate.
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data demonstrate that the Cys1174–Cys1175 residues, but not other cysteine residues in the
C–terminus of mM31719, disrupted the plasma membrane localization of M3TC.
The M3TC attachment to the plasma membrane is most likely mediated by palmitoy-
lation via cysteine residues (Section: 4.2.1). In order to investigate the effects of this lipid
modification, we introduced two point mutations in the full–length mM31719 (mM31719-SS
mutant, Cys1174–Cys1175→Ser1174–Ser1175). 2-bromopalmitate (2-BP) which blocks palmi-
toyl acyltransferases and functions as a palmitoylation inhibitor [107, 255] was applied to
learn whether Cys1174–Cys1175 residues are involved in the mM31719 palmitoylation and
channel function. The Ca2+ entry of mM31719 wild–type and mM31719-SS mutant were
assessed with an aequorin–based functional assay in the presence and absence of 2-BP. For
immunocytochemical staining, HA–tags were fused to both mM31719 and mM31719-SS as
described above. HEK-293 cells expressing mM31719 and mM31719-SS were pre-incubated
with HBS/Ca2+ solution supplemented with or without 100 µM 2-BP for 30 min before the
application with extracellular 10 mM Ca2+ and 50 µM PS. We found that the subcellular
expression pattern of mM31719 was not changed by the Cys1174–Cys1175 mutations, because
HA–tagged mM31719-SS was still observed in the intracellular compartment of HEK-293
cells (Figure: 3.10A). Moreover, these Cys1174–Cys1175 mutations probably have effects on
mM31719 channel function, because upon the application of extracellular Ca2+ or PS, the[
Ca2+
]
i increase in HEK-293 cells expressing mM31719-SS mutant was less than it was in the
cells expressing mM31719 wild–type (Figure: 3.10B-D). We also found that 2-BP reduced
the Ca2+ entry through mM31719 wild–type. This decreased Ca2+ entry was not statisti-
cally significant between the mM31719 wild–type with 2-BP treatment and the mM31719-SS
mutant without 2-BP treatment (Figure: 3.10E-F). This means that a 2-BP–inhibitable
palmitoylation may be responsible for the reduced Ca2+ entry through mM31719.
Taken together, palmitoylation attaches the soluble C–terminus of mM31719 to the
plasma membrane. In the absence of palmitoylation in the C–terminus, mM31719 Ca2+
entry is reduced, despite the unchanged subcellular localization pattern. Thus, palmitoyla-
tion of the Cys1174–Cys1175 mediates this part of the channel function of mM31719.
3.2.2 Analysis of mM31719 homomer formation
TRP channels require a tetrameric assembly of pore–forming subunits to fulfill their phys-
iological functions [132, 187]. Some members of TRPM subfamily have been reported to
be expressed as oligomeric complexes such as TRPM4 [137] and TRPM6 [109], but the
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direct experimental evidence of TRPM3 multimerization has not been described. To study
homomultimerization of mM31719 and its subunit association in living cells, fluorescence
resonance energy transfer (FRET), co-immunoprecipitation (Co-IP) and yeast two hybrid
(Y2H) techniques were applied.
As an indication of subunit assembly, the proximity of C–terminally CFP– and YFP–
tagged mM31719 was measured by the FRET technique [8, 73]. The expression levels were
adjusted so that most cells had a molar ratio of YFP–tagged mM31719 (acceptor) and
CFP–tagged mM31719 (donor) to a 1.5–3-fold molar ratio to ensure comparable relative
CFP and YFP fluorescence intensities [6, 8]. Co-transfection experiments with mM31719–
CFP/TRPML1–YFP and with TRPML1–CFP/TRPML1–YFP (ML1) [225] were performed
as negative and positive controls, respectively. FRET signals were obtained by measur-
ing the donor (CFP) fluorescence recovery during selective photobleaching of the acceptor
(YFP). The acceptor was selectively photobleached at 515 nm (5 second illumination per
frame) [6], and the donor fluorescence recovery monitored at 440 nm. The FRET efficiency
was obtained by the extrapolated intersection of the linear regression line with the y axis at
FY FP /FY FP,0=0 [78]. Figure 3.11(D-E) shows that mM31719 displayed a significant FRET
(12.14±0.08 increase in CFP fluorescence) compared with negative control (1.15±0.22 in-
crease in CFP fluorescence). But the FRET efficiency of mM31719 was lower than it observed
in the ML1 group (39.56±0.23 increase in CFP fluorescence). Our FRET results indicate
that the mM31719 subunits interact with each other in living cells.
Co-immunoprecipitation (Co-IP) was used as an independent approach to test whether
mM31719 multimerizes. Co-IP was also used to determine whether the C-terminus and
the residues Cys1174–Cys1175 play a role in the homomultimerization of mM31719. Vari-
ous TRPM3 cDNA constructs (mM31719, mM31337, mM31719-SS, mM31337-SS) and mouse
TRPC4 cDNA (mC4) were tagged with HA or YFP at their C-termini, and co-transfected
into HEK-293 cells in different combinations. The combinations, mC4/mC4 [188], mC4/
mM31719 and mC4/mM31337 were used as positive and negative controls, respectively. Af-
ter a 36-hr incubation, the cells were solubilized and immunoprecipitated with a rabbit
anti–GFP antibody. Both cell lysates (upper panels) and immunoprecipitates (lower pan-
els) were subjected to SDS-PAGE and immunoblotted with an anti–HA antibody. Anti–
HA immunoreactivities were detected in the anti–GFP immunoprecipitates for mC4/mC4,
mM31719/mM31719, mM31719/mM31719-SS, mM31337/mM31337 and mM31337/mM31337-SS
cDNA combinations (Figure: 3.12A and B, lower right panel). Co-IP experiments not only
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Figure 3.11: Analysis of mM31719 homomultimerization using the FRET technique
A-C: Representative traces for FRET between control (negative), mM31719 and ML1 (positive)
groups are shown. Gray and black lines represent the single cell traces and means, respectively.
Changes in the relative fluorescence intensities of CFP (∆FCFP (%)) and YFP (FY FP (%)) emis-
sions are plotted against frames (5 second illumination per frame). D: Linear regression analysis
of relative donor fluorescence recovery (∆FCFP (%)) against fractional acceptor photobleach-
ing (FY FP (%)) is shown. E: FRET efficiency for homomeric analysis is statistically different
between negative control and mM31719 (1.15±0.22 and 12.14±0.08, respectively). The data
were obtained from 20–50 single cells from four independent transfections (n=4) and indicate
mean±SEM of 12-15 photobleaching experiments. Unpaired Student’s t-test was used for sta-
tistical analysis. Numbers above the bars indicate the total number of recorded cells. ??? =
P<0.001. Abbreviation: ML1, TRPML1.
confirm the protein interaction between mM31719 subunits, but also indicate that the amino
acid sequences from residues 1338 to 1719 and the residues Cys1174–Cys1175 do not play a
role in the homomultimerization of mM31719.
To further study the binding sites which determine the mM31719 subunit interaction, the
yeast two hybrid system (Y2H) was used as an in vitro approach. The N–terminal (N–Term,
residues 1–876) and C–terminal (C–Term, residues 1133–1719, and C–Term(S), residues
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Figure 3.12: Analysis of mM31719 homomultimerization using co-immunopre-
cipitation
Different combinations of mTRPM3 cDNAs tagged with HA or YFP were co-expressed in the
HEK-293 cells. HA–, and YFP–tagged mouse TRPC4 (mC4) were used as a control. Co-IPs
were performed with an anti–GFP antibody and Western blots were probed with an anti–HA
antibody. A: The detected HA immunoreactivities of mM31719 and mM31719-SS immunoprecip-
itated by an anti–GFP antibody revealed the protein interactions between mM31719/mM31719
and between mM31719/mM31719-SS (lower right panel). B: Protein interactions were also found
between mM31337/mM31337 and mM31337/mM31337-SS. The bands for mM31337 and mM31337-
SS were detected by an anti–HA antibody in the anti–GFP immunoprecipitates (lower right
panel). Abbreviations: mC4, mouse TRPC4; mM31337, short variant of mM31719; mM31719-
SS, mM31719 with CC1174SS mutation; mM31337-SS, mM31337 with CC1174SS mutation.
1133–1337) fragments were PCR–amplified from mM31719 and mM31337 by using primers
containing the desired enzyme restriction sites (Table: 2.10). The amplified PCR products
were subcloned into the pGBKT7/BD and pGAD424/AD vectors, respectively. Various
pGBKT7/BD and pGAD424/AD combinations with Y2H constructs were co-transformed
into the yeast strain AH109, and subsequently plated on synthetic dropout (SD) plates
using the medium–stringency screening method1 (Section: 2.2.4.1). Blue colored colonies
on SD/-Ade/-His/-Leu/-Trp/X-α-gal plates were used as indicators of protein interaction.
Figure 3.13 shows that the protein–protein interactions occur between C–terminal frag-
ments of mM31719 and mM31337 including C–Term/C–Term, C–Term/C–Term(S), C–Term
1All experiments were first performed using the high–stringency screening method, but no blue colonies
were obtained (data not shown).
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Figure 3.13: Analysis of the mM31719 and mM31337 subunit interactions using the
yeast two hybrid system
The N–terminus and C–terminus of mM31719 and the C–terminus of mM31337 were constructed
into the pGBKT7/BD vector expressing the GAL4 DNA binding domain and the pGAD424/AD
vector expressing the GAL4 transactivation domain. For control experiments, empty pG-
BKT7/BD and pGAD424/AD vectors were used. Various combinations of Y2H constructs
were co-transformed into AH109 yeast cells. The co-transformed cell cultures were first plated
on SD/-His/-Leu/-Trp plates to select for transformants, then the transformants were repli-
cated to SD/-Ade/-His/-Leu/-Trp plates containing 20 mg/L of X-α-gal. Colony growth and
blue color indicate a protein interaction within the following two-hybrid proteins: C–Term and
C–Term, C–Term and C–Term(S), C–Term(S) and C–Term(S). Interactions between N–Term
and N–Term, N–Term and C–Term, N–Term and C–Term(S) were not found. Abbreviations:
C–Term, C–terminus of mM31719 (residues 1133–1719); C–Term(S), C–terminus of mM31337
(residues 1133–1337); N–Term, N–terminus of mM31719 (residues 1–876).
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(S)/C–Term(S). No protein interactions of N–term with N–term, C–Term or C–Term(S)
were observed. These results strongly suggest that the mM31719 subunits involved in chan-
nel homomultimerization are determined by their C–terminal protein sequences. The bind-
ing sites for the protein–protein interaction may be located in the amino acid sequence from
residues 1133 to 1337.
Thus, we could show with three independent methods that TRPM3, like other TRPs, is
built from subunits. Furthermore, we can localize the multimerization sequence with Y2H
to the C–terminus (probably C-C domain, Section: 4.2.2). It is unlikely that palmitoylation
is involved in mM31719 homomultimerization.
3.2.3 Identification of putative interaction partners of mM31719
3.2.3.1 Identification of putative interaction partners of mM31719 using the
yeast two hybrid system
Evidence presented above shows that mTRPM3 displays constitutive activity and can be
activated by PS at high concentration (50 µM). This indicates that mTRPM3 may be
implicated in Ca2+ signaling or other signal transduction pathways. However, little is
known about the molecules that interact with mTRPM3 and mediate the physiological
functions of mTRPM3 in cellular signaling.
Because the mTRPM3 N–termini are common and highly conserved among different
TRPM channels, and we wanted to identify melastatin–specific determinants of function,
we chose the C–terminal 587 aa of mM31719 (M3CT, residues 1133–1719) as a “bait” to
screen a human kidney cDNA library with the aid of the yeast two hybrid (Y2H) system.
The “Bait” fusion plasmid (pGBKT7/BD-M3CT) was constructed and Y2H was performed
with a high-stringency scale procedure as described in Section 2.2.4.1. Before starting Y2H
screening, no auto–activation or toxicity of pGBKT7/BD-M3CT was detected (data not
shown), the library titer and mating efficiency were calculated to 6×106 (cfu/ml) and 1.67%,
respectively. The interactions between “bait” and “prey” candidates were verified in the
AH109 yeast strain under high or medium stringency conditions (Figure: 2.3).
Since the C–terminus of mM31719 is cytoplasmic, valid binding partners should be: 1)
co-localized in same cellular compartment in vivo, nuclear and extracellular proteins were
therefore not considered; 2) expressed in the same cells or tissues; 3) typical frequently
existed hits were not considered (e.g., ribosomal proteins). To meet these criteria, the amino
acid sequences of “prey” candidates were “filtered” by using various online database tools
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such as Entrez Gene, Human Protein Reference Database, LOCATE Subcelluar Localization
Database. The putative binding partners for M3CT identified by high or medium stringency
selection were listed in Table 3.1 and Table 3.2, respectively.
3.2.3.2 Analysis of protein kinase inhibitor–gamma as an interaction partner
for mM31719
According to the interaction partner lists above, mM31719 may take part in a variety of cell
biological activities, e.g., protein translation, cellular homeostasis and ion binding. Protein
kinase inhibitor–gamma (PKIG) was chosen as a candidate for studying the putative role of
mM31719 in cellular signal transduction, because PKIG is a competitive inhibitor of cAMP–
dependent protein kinase (PKA) and plays a crucial role in the PKA–dependent signal
transduction pathway [36]. Additionally, mTRPM3 activity could be regulated by protein
signal transduction pathways. The interaction between PKIG and mM31719 (or mM31337)
was analyzed by using Y2H (in vitro).
Figure 3.14: Subunit interaction analysis between mTRPM3 and PKIG
A: PKIG expression in AH109 cells was detected by Western blot with an anti–HA antibody. B:
The protein interaction between the C–terminus of mM31719 and PKIG was confirmed by Y2H
method with a high–stringency scale procedure (II). No interaction between the C–terminus of
mM31337 and PKIG was observed. Abbreviations: M3CT, C–terminus of mM31719 (residues
1133–1719); M3CT(S), C–terminus of mM31337 (residues 1133–1337); PKIG, protein kinase
inhibitor–gamma.
In Y2H experiments, vectors containing “bait” (M3CT or M3CT(S)2) and “prey” (PKIG)
were co-transformed into the AH109 yeast strain and induced to grow on high stringency
(QDO) plates. Protein–protein interactions were observed between the protein pairs pG-
BKT7/53 and pGADT/T (positive control), and pGBKT7/M3CT and pACT2/PKIG, but
2M3CT(S) is the C-terminus of mM31337 (residues 1133–1337)
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not in the protein pairs of pGBKT7/M3CT(S) and pACT2/PKIG (Figure 3.14B). Fig-
ure 3.14A shows that PKIG constructed in the pACT2/AD vector was expressed in the
AH109 yeast strain3.
Figure 3.15: Effects of db-cAMP on Ca2+ entry through mM31719 and mM31337
Aequorin–based intracellular Ca2+ measurements were performed to study the biological
role of PKIG in mTRPM3 channels. HEK-293 cells were transfected with different cDNA
combinations (molar ratio 1:1). Treatment with db-cAMP increased Ca2+ influx through
mM31719, but not through mM31337. No differences in the
[
Ca2+
]
i increase were ob-
served between the cells pre-treated with and without db-cAMP in the cells co-expressing
PKIG and mM31719. Db-cAMP treatment did not have any effects on the cells express-
ing pcDNA3.1/pcDNA3.1, pcDNA3.1/PKIG, pcDNA3.1/mM31337 and PKIG/mM31337. Bar
graphs represent mean±SEM, n=5 transfection experiments. Numbers above the bars indicate
the total number of experiments performed. Unpaired Student’s t-test was used for statistics,
?? = 0.001<P<0.05, n.s.= not significant. Abbreviation: PKIG, protein kinase inhibitor–
gamma.
To better understand a possible role of PKIG in mTRPM3 regulation, Ca2+ influx
3Predicted band size is 24 kDa: 0.11 × a fusion of the GAL4-AD (amino acids 768–881), an HA epitope
tag (9 aa), and amino acid residues of PKIG (76 aa). Th observed band size is about 34 kDa. This may be
due to post–translational modification, post–translation cleavage, or multimerization.
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through mM31719 and mM31337 were studied with or without co-expression of PKIG us-
ing a membrane–permeable cAMP–dependent protein kinase (PKA) activator, db-cAMP
[199]. Various cDNA combinations (2 µg) of mTRPM3 and PKIG were transiently trans-
fected into HEK-293 cells at a molar ratio of 1:1 as follows: 1) pcDNA3.1/pcDNA3.1; 2)
pcDNA3.1/ PKIG; 3) pcDNA3.1/mM31719; 4) PKIG/mM31719; 5) pcDNA3.1/mM31337; 6)
PKIG/mM31337. The cells expressing these cDNA combinations were pre-treated for 2 hr
in HBS/Ca2+ buffer either without or supplemented with db-cAMP (1 mM). The Ca2+
entry was induced by Ca2+ steps, and the increased
[
Ca2+
]
i was measured with aequorin.
Figure 3.15 shows that 1) db-cAMP did not induce any Ca2+ influx in the control groups
in which the cells only express pcDNA3.1/pcDNA3.1 or pcDNA3.1/PKIG; 2) PKIG did
not have any effects on the channel activities of mM31719 and mM31337; 3) in the cells
expressing pcDNA3.1/mM31719, the Ca2+ influx in the cells with db-cAMP treatment was
larger than it was in the cells without db-cAMP treatment; 4) db-cAMP treatment did
not influence Ca2+ influx in the cells expressing PKIG/mM31719, pcDNA3.1/mM31337 and
PKIG/mM31337. These data indicate that db-cAMP activates PKA which probably in turn
increases Ca2+ influx through mM31719. However, the role of PKIG in mTRPM3 regulation
needs further investigation.
In summary, we found a protein (PKIG) that interacts with the C–terminus of mM31719
at residues 1338–1719. PKIG might play a role in the TRPM3 function, but so far, with
the test performed to assen mM31719 activity, we cannot definitely delineate a biological
role of it in this process.
3.3 Tissue distribution of mouse TRPM3
Mouse TRPM3 expression was studied at the RNA (Northern blot) and protein (Western
blot with specific antibodies) levels, and by a lacZ assay of the TRPM3 mice with the
knockout allele.
3.3.1 Northern blot analysis of mouse TRPM3 tissue distribution
The Northern blot technique was first applied to identify mTRPM3 gene expression patterns
at the RNA level. About 1 µg of Poly(A)+ RNA of various tissues were analyzed. The
blot was hybridized with a 32P–labeled mM31719 cDNA, and reprobed with β–actin cDNA
as a control. As shown in Figure 3.16, mM31719 expression with transcripts of >9.0 kb was
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observed in both the brain and eye.
Figure 3.16: Northern blot analysis of mTRPM3 expression
Ca. 1 µg of Poly(A)+ RNA of various tissues were used for Northern blot analysis. Blots were
hybridized with cDNA probes for mM31719 to analyze mTRPM3 expression and for β–actin as
a control. TRPM3 transcripts were detected in the mouse brain and eye.
3.3.2 Western blot analysis of mouse TRPM3 expression
3.3.2.1 Characterization of mouse TRPM3 antibodies
Two antibodies (anti-M3-7: CLSRTSAFHSFESKH ; anti-M3-8: CNEKNESRLSRNDIQS)
against specific peptide sequences in the C–terminus of mM31719 were raised and affinity–
purified (Section: 2.2.6.5). The specificity and affinity of the antibodies to the mM31719
sequences were characterized by using immunocytochemical staining (Section: 2.2.6.3). 2
µg of C–terminally HA–tagged mM31719 were transiently transfected into HEK-293 cells,
which were then immuno–stained with anti–HA (positive control), anti-M3-7 and anti-M3-8
antibodies. C–terminally HA–tagged mTRPM1 served as a negative control and Alexa-488
as the secondary antibody. For either antiserum, we observed strong immunofluorescence
signals with a pattern indistinguishable from the anti–HA staining. No cross–reactions were
observed in the mTRPM1 (mM1) control groups (lanes II, IV). The results indicate that
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Figure 3.17: Immunofluorescence with mouse TRPM3 antibodies
The cells were imaged with a laser scanning confocal microscope. Lanes I-V: 2 µg of HA–
tagged mM31719 or mM1 were transfected into HEK-293 cells. Anti–HA, anti-M3-7 and anti-
M3-8 antibodies were tested for their ability to detect mM31719 or mM1 expression. Compared
to the anti–HA antibody (lane I), anti-M3-7 and anti-M3-8 antibodies displayed specificity
and affinity to the mM31719 (lanes III and V) and did not cross–react with mM1 (lanes II,
IV). Lanes VI-VII: The anti-M3-8 antibody was used to detect mouse TRPM3 expression in
melanocytes. The melanocytes were directly isolated from TRPM3+/+ mice, and stained with
and without anti-M3-8 antibody (lane VI, VII). Alexa-488 was used as the secondary antibody.
Bars represent 20 µm.
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both antibodies have enough specificity and affinity for mM31719 (lanes III and V) compared
to the positive control (lane I) (Figure 3.17).
3.3.2.2 Analysis of the TRPM3 protein expression in the adult mouse eye
Figure 3.18: Analysis of TRPM3 protein
expression in the adult mouse eye
In HEK-293 cells, TRPM3 protein expression
was detected using anti–HA (lane 2) and anti–
M3-8 antibodies (lane 4). Membrane proteins
extracted from TRPM3+/+ and TRPM3−/−
mouse eyes were blotted with the anti–M3-8 an-
tibody. No TRPM3 protein expression was ob-
served in TRPM3−/− mouse eyes (lane 5), but
TRPM3 protein expression was detected in the
TRPM3+/+ mouse eye (lane 6).
We purchased TRPM3 knockout mice which
were generated by Lexicon genetics Corp. us-
ing a GeneTrap strategy, in which a β-geo fu-
sion construct was inserted into the intron be-
tween exon 1 and exon 2 of the mTRPM3
gene by homologous recombination. In or-
der to make sure that the TRPM3−/− mouse
to be used for experiments as described be-
low is a complete TRPM3 null allele mouse,
we performed Western blots to test whether
a mTRPM3 protein is still present in the
TRPM3−/− mouse. According to the re-
sults from the Northern blot (Section: 3.3.1),
mouse eyes were chosen for the Western
blot. Total membrane protein extracted from
TRPM3+/+ and TRPM3−/− mouse eyes was
electrophoresed, blotted, and probed with
an anti-M3-8 polyclonal antibody to detect
TRPM3 protein expression. As a positive con-
trol, 2 µg of HA–tagged mM31719 (mM31719–HA) were transiently transfected into HEK-293
cells. The over–expressed mM31719–HA in HEK-293 cells was detected with an anti–HA
antibody (Figure: 3.18, lane 2) and an anti–M3-8 antibody (Figure: 3.18, lane 4). In HEK-
293 cells, 2 µg of empty pcDNA3.1 vector was used as a negative control (Figure: 3.18,
lanes 1 and 3). TRPM3 protein expression was observed in the eyes of TRPM3+/+ mice
(Figure: 3.18, lane 6), but not in TRPM3−/− mice (Figure: 3.18, lane 5). These data indi-
cate that TRPM3 is expressed in the TRPM3+/+ mouse eye as a protein of the expected
size of the long TRPM3 splice variants, e.g., mM31719. TRPM3 protein expression was not
detectable in the TRPM3−/− mice.
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We also performed immunofluorescence experiments on eye cryosections with anti–
TRPM3 antibodies. However, specific mTRPM3–immunoreactive signals were undetectable
against the background (data not shown).
In summary, the Western blot analysis confirms that mTRPM3 is expressed in the mouse
eye and no mTRPM3 protein expression is present in the TRPM3−/− mouse. However, the
anti–TRPM3 antibodies are not sensitive enough for cryosection staining. Thus we carried
out lacZ staining using a lacZ transgenic mouse model (s. below).
3.3.3 Histochemical and immunohistochemical analysis of TRPM3 ex-
pression using a lacZ transgenic mouse model
Because of the low Northern signals and the high background immunofluorescence in tissue
cryosections stained with anti–TRPM3 antibodies (s. above), we resorted to a genetically
based method taking advantage of a lacZ transgenic mouse model (Figure: 2.8). We utilized
the lacZ gene expression driven by the TRPM3 promoter(s) to detect TRPM3 tissue local-
ization via lacZ histochemical staining (Section: 2.2.8.1). LacZ staining is an enzyme–based
assay and provides a good signal-to-noise ratio with a high sensitivity.
Whole embryos (embryonic day (E) 9, 9.5, 11.5, 13, 14) and the frozen sections of tissues
harvested from developing (E13) and mature TRPM3−/− mice were histochemically stained
with X-Gal. As a negative control, the lacZ staining was always performed for the whole
embryos and frozen sections obtained from TRPM3+/+ mice (data not shown).
3.3.3.1 LacZ gene expression in lacZ transgenic TRPM3−/− adult mice
Although the gross expression of mTRPM3 has been described in some tissues and organs
[106, 157], the expression profile of mTRPM3 has not yet been established at the cellular
level. Hence, a large number of tissues and organs (e.g., CNS (brain and retina), digestive
system (stomach, small intestine, pancreas and liver), reproductive system (testis, uterine
tubes), spleen, kidney, skin and lung) of lacZ transgenic TRPM3−/− adult mice were used
to study lacZ gene expression under the control of the TRPM3 promoter(s).
The samples subjected to lacZ staining were obtained from adult (6-month) TRPM3+/+
and TRPM3−/− mice. Tissues were dissected, embedded on cryostat chucks, and sectioned
as described in Section 2.2.6. X-Gal staining was performed overnight4 at 37℃, and the
4Initially, lacZ staining of frozen sections was performed 1 hr, 3 hr, etc.. However, no obvious blue
precipitates or sparse blue precipitates were seen. According to the low expression pattern of lacZ gene
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Figure 3.19: LacZ gene expression of mTRPM3 in the CNS
Frozen brain sections of adult lacZ transgenic mice were stained with X–Gal for β-galactosidase
activity. A: Intense staining was visible in the layers I, IV, V and VI of the cerebral cortex. B:
DAPI counterstaining was used to show different layers of cerebral cortex. C-D: The choroid
plexus is covered by an X-Gal–stained epithelium projecting into the brain ventricle. X-Gal
staining was also present in the ependyma, dentate gyrus and hippocampus. E-H: Intense
lacZ signals were primarily present in the granular layer of the dentate gyrus and pyramidal
cell layer of the hippocampus proper. I: X-Gal stained choroid plexus was observed in the
brain ventricle. J-L: The cerebellum displays a strong lacZ staining in the Purkinje cell layer
and granule cell layer. Brains from TRPM3+/+ mice didn’t show any β-galactosidase activity
(data not shown). Abbreviations: CA, Cornu Ammonis; Chp, choroid plexus; DG, dentate
gyrus; EP, ependyma; GL, granule cell layer; GrDG, granule cell layer of the dentate gyrus; HP,
hippocampus; Lp, lamina propria; ML, molecular layer; MoDG, molecular layer of the dentate
gyrus; PL, Purkinje cell layer; PoDG: polymorph layer of the detate gyrus; PyL: pyramidal cell
layer; PyC: Purkinje cells; WM, white matter.
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images were taken using an Axiovert 200M inverted microscope (Section: 2.2.6.2).
In brain cryosections, strong β-galactosidase activity was seen in the cerebral cortex
(layers I, IV, V and VI, Figure: 3.19A-B), dentate gyrus (granule cell layer, Figure: 3.19C,
E-F), hippocampus proper CA1-CA3 (pyramidal cell layer, Figure: 3.19C-H), choroid plexus
epithelium (Figure: 3.19C, D, I, J), ependyma (Figure: 3.19C, D) and cerebellum (Purkinje
and granule cell layers, Figure: 3.19K, L).
The adult mouse retina exhibited strong lacZ signals in the ganglion cell layer and inner
nuclear layer. Weak β-galactosidase activity was also present in the outer plexiform layer
(Figure: 3.20).
Figure 3.20: LacZ gene expression of mTRPM3 in the retina
Histochemical analysis of the retina of adult lacZ transgenic mice with X–Gal. A: LacZ staining
was located in the ganglion cell, inner nuclear and outer plexiform layers (arrowhead). B: The
arrangement of retinal layers was shown using DAPI counterstaining. Retina from WT mice
did not show any β-galactosidase activity (data not shown). Abbreviations: Ch, choroid; GC,
ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer, LCR, layers of rods and
cones; ONL, outer nuclear layer; OPL, outer plexiform layer; RPE, retinal pigment epithelium.
Cryosections of the stomach, duodenum, jejunum, ileum and colon were investigated to
assess the lacZ gene expression in the gastrointestinal tract. Histochemical analysis revealed
that lacZ staining is restricted to the structure which lies between the circular and longi-
tudinal layers of the muscularis externa (Figure: 3.21). In order to confirm whether it is
neurogenic, a neuronal marker anti–MAP2 antibody [198] was applied. In double–labeling
experiments, X-Gal positive cells and MAP2 stained cells colocalized (Figure: 3.21K, L).
Therefore, it is likely that TRPM3 is expressed in the myenteric plexus in the gastrointesti-
nal tract. Using the β-galactosidase assay, the lacZ gene expression was also detected in the
observed in HEK-293 cells (data not shown) and the low amounts of TRPM3 expression detected in Northern
and Western blots, these sparse blue precipitates imply a low TRPM3 expression. Therefore, sections were
routinely incubated with X-Gal for 24 hr.
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Figure 3.21: LacZ gene expression of mTRPM3 in the gastrointestinal tract
Cryosections of the stomach (A-B), duodenum (C-D:), jejunum (E-F), ileum (G-H) and colon
(I-J) from adult TRPM3−/− and TRPM3+/+ mice (data not shown) were histochemically
stained with X-Gal, and counterstained with DAPI. Auerbach’s plexus between the circular
and longitudinal components of the muscularis externa showed intense lacZ staining. K-L:
Cryosection of a part of intestinal tract was double–stained with X–Gal and anti–MAP2 anti-
body. Colocalization of X–Gal staining and MAP2 immuno–staining was observed (arrowhead).
Abbreviations: AP, Auerbach’s plexus; BV, blood vessels; IC, inner circular muscle; GB,
Brunner’s glands; M, mucosa; ME, muscularis externa; MM, muscularis mucosae; OL, outer
longitudinal muscle; PP, Peyer’s patch; Se, serosa; Sm, submucose.
islet of Langerhans, but not in the cells and tissues of liver of adult lacZ transgenic mice
(Figure: 3.22).
In the reproductive system, lacZ positive cells were observed in the testis (Figure: 3.23A-
D) and uterine tubes (Figure: 3.23M-P), but not in the uterus (Figure: 3.23I-L) and ovary
(Figure: 3.23E-H). In the testis, β-galactosidase activity was found in the cells of the seminif-
erous tubules, but not in the Leydig cells in the interstitial tissue. In addition, X-Gal–stained
cells were also not present in the tunica vaginalis (data not shown). In the uterine tubes,
lacZ stainings are present in the mucosal layer composed of ciliated cells and secretory (peg)
cells.
The lacZ staining analysis revealed lacZ gene expression in the skin, heart, kidney, lung
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Figure 3.22: LacZ gene expression of mTRPM3 in the liver and pancreas
Cryosections of pancreas and liver from adult TRPM3 knock–out and wild–type mice (data not
shown) were histochemically stained with X-Gal, and counterstained with DAPI. A-D: LacZ
positive cells in islets of Langerhans are shown (A, C). The islets of Langerhans are shown by
darkfield microscopy (B) and DAPI counterstaining (D). E-H: No β-galactosidase activity was
observed in the liver. Abbreviation: Hs, hepatic sinusoids.
and spleen. Single X-Gal–stained cells were detected in the epidermis. However, X-Gal
stained cells were not present in the sebaceous gland in the dermis (Figure: 3.24A-D). In
the heart, sparse lacZ signals were found in a specific structure localized between myocardial
tissues (Figure: 3.24E-H). In the kidney cortex, positive staining was observed in the renal
tubules and glomerulus (Figure: 3.24I-L, arrowhead). In the conducting airways, sparse pos-
itive lacZ signals were detected between the two bronchial cartilage plates (Figure: 3.24M-P,
arrowhead) or two tracheal cartilage plates (data not shown), but was not found in the other
cell types or tissues (such as bronchioles and alveoli, data not shown). An X-Gal–stained
cryosection through the spleen shows that the positive lacZ staining was mainly present in
the fibrous trabeculae, but not in the other splenic cells and tissues including trabecular
vessels which ramify in the trabeculae throughout the organ (Figure: 3.24Q-T, arrowhead).
In summary, in the adult mouse, TRPM3 is predominantly found in the nervous system
such as cortex, choroid plexus, cerebellum, hippocampal formation, myenteric (Auerbach’s)
plexus, and retina. In order to investigate the origin of the TRPM3 expression profiles, we
did similar staining with mouse embryos at different embryonic stages.
87
3.3. Tissue distribution of mouse TRPM3
Figure 3.23: LacZ gene expression of mTRPM3 in the reproductive system
Adult TRPM3 wild–type mice served as a negative control (data not shown). Darkfield mi-
croscopy (A, E, I) and DAPI counterstaining (D, H, L ,M , P) were applied to demonstrate
to the cytoarchitecture of the corresponding tissues. A-D: X-Gal positive cells were found in
the seminiferous tubules, but not in the interstitial tissue of testis. E-H: No positive X-Gal
stained cells were observed in the ovary. I-L: No positive X-Gal stained cells were observed in
the uterus. M-P: LacZ positive staining was observed in the tunica mucosa layer of the uterine
tubes. Abbreviations: CL, corpus luteum; Co, cortex; En, endometrium; Ep, epithelium;
F, follicle; Fc, follicle cells; GF, Graafian follicle; IT, interstitial tissue; L, lumen; LC, Leydig
cells; LP, lamina propria; Me, medulla; My, myometrium; ST, seminiferous tubules; TM, tunica
mucosa; TS, tails of spermatozoa.
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Figure 3.24: LacZ gene expression of mTRPM3 in the skin, heart, kidney, con-
ducting airways and spleen
The microanatomical structures of each tissue were shown by means of a darkfield microscopy
(Figs E, M) and DAPI counterstaining (Figs A, D, H, I, L, P, Q, T). LacZ staining was
observed in the epidermis (strata spinosum and basale) (Figs B, C), heart (Figs F, G), kidney
(Figs J, K), bronchi (Figs N, O), and spleen (Figs R, S). Abbreviations: BC, bronchial
cartilages, Bo, Bowman’s capsulae; BR, bronchus; Ca, capsule; De, dermis; Ep, epidermis;
My, myocardium; RC: renal corpuscle; SB, secondary bronchi; Sg, sebaceous gland; Stg, strata
spinosum and basale; TM, tunica mucosa; Tmp, tunica muscularis propria; Tr, trabeculae; Tu,
tubules; Tv, trabecular vessel.
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3.3.3.2 Tissue distribution of TRPM3 during mouse development
Mouse embryos were used to further study mTRPM3 tissue distribution. The embryo lacZ
staining identifies tissues in which the gene of TRPM3 is expressed.
Figure 3.25: LacZ staining of whole TRPM3−/− mouse embryos
LacZ staining in whole mouse TRPM3−/− embryos (E9, 9.5, 11.5, 13, 14). A: At E9, staining
was found in otic pit. B-C: Besides otic vesicle, lacZ expression was also present in the re-
gions of optic vesicle, diencephalic roof and rhombencephalon. D: The X–Gal-stained digits of
footplates are clearly seen. The pinnae were developed, and the intense staining was detected
in the eye, diencephalic roof, dorsocaudal telencephalon, rhombencephalon and indented ante-
rior footplate. E: Except for mesencephalon, strong staining was found throughout the brain.
Stained separated toes were clearly observed in this stage. F: In contrast to the wild–type
mouse embryo (bottom), the TRPM3−/− mouse embryo (E13) showed significant lacZ gene
expression. But no evident morphological changes were observed between TRPM3+/+ and
TRPM3−/− mice. Abbreviations: Aa, forelimb bud; Ba, branchial arch; D, diencephalon;
Ey, eye; F, choroid fissure; Hl, hindlimb bud; L, lens vesicle (just closed); M, mesencephalon;
Nc, neopallial cortex; O, pinna; Op, optic vesicle; Otp, otic pit; Otv, otic vesicle; Pc, pericardial
region; Rh, rhombencephalon; Spc, spinal cord; Tel, telencephalon; Ti, separated toes.
Whole embryo lacZ staining We started out doing whole embryo staining by dissecting
embryos at stage E9 (embryonic day 9) from pregnant TRPM3 mutant mouse mothers. The
embryos were fixed with glutareldahyde (0.2% (v/v)), stained with X-Gal (1 mg/ml), and
visualized using an Axiovert 200M inverted microscope (Carl Zeiss). The β-Galactosidase
activities in embryonic TRPM3−/− mice were observed in the otic pit region at E9 (Fig-
ure: 3.25A). Besides the otic pit/vesicle (Figure: 3.25A–C), intense lacZ staining was also
found in the region of the ear (Figure: 3.25D, E), eye (Figure: 3.25B–E), rhombencephalon
(Figure: 3.25B–E), diencephalic roof and dorsocaudal telencephalon (Figure: 3.25B–D), and
the limb buds (Figure: 3.25D, E). Weak staining was also seen in the region of the telen-
cephalon and spinal cord (Figure: 3.25C–D). At stage E14, lacZ staining was detected in
the brain with the exception of the mesencephalon (Figure: 3.25E). Compared to wild–type
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Figure 3.26: TRPM3–lacZ expression in frozen cranial sections at stage 13
The level of each cross–section is represented in the embryo (E13) at the top left. A: At the level
of the diencephalon and mesencephalon, lacZ expression was mostly present in the dorsocaudal
telencephalon and the roof of the diencephalon (A-b). B: LacZ staining was observed in the
choroid plexus which projects into the 4th ventricle forming finger–like evagination (B-c and
B-d), and originates from the medial wall of the lateral ventricle (B-b). C-D: X-Gal positive
cells were detected in the inner ear tissues such as the endolymphatic sac, posterior semicircular
canal (C-c), lateral semicircular canal (C-d), saccule (D-b). E-F: The pinna was formed (E-a),
and intense staining was found in the pigment (E-b) and neural layers of retina (F-b), and
corneal ectoderm (E-b, F-b). Abbreviations: 3.V, third ventricle; 4.V, fourth ventricle; Ce,
corneal ectoderm; Chi, choroid invagination; Cp, choroid plexus; Di, diencephalon; Ey, eye;
Ems, endolymphatic sac; Pi, pinna; Pl, pigment layer of retina; Rne, neural layer of retina;
Sa, saccule; Scl, lateral semicircular canal; Scp, posterior semicircular canal; Tc, telencephalic
vesicle.
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Figure 3.27: TRPM3–lacZ expression in frozen cranial and cervical sections at
stage 13
The level of each cross–section is represented in the embryo (E13) at the top left. G: At the
level of the eye, high level of β-galactosidase activity was observed in the lens and retina. The
lumen of the lens vesicle has disappeared owing to the elongation of the lens fibers (d). The lens
epithelial and fibril cells, the retina (pigment and neural layers) were intensively stained by X-
Gal (b-d). H: Using X-Gal staining, intense expression of TRPM3 was observed in the olfactory
epithelium in the lumen of the primitive nasal cavity, and the low expression of TRPM3 was
found in the dorsal root ganglion and spinal cord (arrow). Darkfield microscopy clearly showed
the dorsal root ganglions (c). I: Low expression of TRPM3 in the epithelium of the tongue
was revealed by X-Gal staining. Darkfield microscopy (c) and counterstaining with DAPI (e)
showed the tongue structure and the epithelium of the tongue, respectively. Abbreviations:
Ce, corneal ectoderm; Cp, choroid plexus in roof of fourth ventricle; Drg, dorsal root ganglion;
Ey, eye; En, external naris; Hc, hyaloid cavity; L, lens; Le, lens epithelium; Lf, lens fibers;
Lv, lateral ventricle; Na, lumen of primitive nasal cavity; Nc, neopallial cortex; Oe, olfactory
epithelium; On, unmyelinated nerve fibers within optic stalk; Rf, right forelimb; Rne, neural
layer of retina; Rpl, pigment layer of retina; Te, epithelium of tongue; To, tongue; Vh, vitreous
humour.
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embryos (Figure: 3.25F, bottom), TRPM3−/− embryos (E13) displayed a significant lacZ
expression pattern. However, there were no evident morphological changes between them.
This result indicates that TRPM3 gene expression in mouse embryos is restricted only to
some specific regions such as the brain, eye and ear.
Figure 3.28: TRPM3–LacZ expression in frozen thoracic sections at stage 13
The cross–section levels of the forelimb in the embryo (E13) are represented at the left. The
blue staining indicates β-galactosidase catalysis of the X-Gal substrate. Section J–L: Intense
X-Gal staining was present in the regions beneath the outer ectoderm (arrowhead, J-b and L-b)
and cartilage primordia of the ulna/radius and digital bones (K-b). No X-Gal-stained cells of
premuscle mass were detected (arrow, J-b). Abbreviations: Cur, cartilage primordium of the
right ulna/radius; Cpd, cartilage primordium of the digital bones; Ect, ectoderm; En, external
naris; Gup, primitive gut; Ll, left lobe of liver; Pmm, premuscle mass of proximal extensor
group of muscles; Rf, right forelimb.
Histological analysis of lacZ activity distribution in frozen mouse embryonic
sections (E13) Based on the lacZ expression observed in the whole mouse embryos (Sec-
tion: 3.3.3.2), frozen cryostat sections which include the regions showing intense lacZ signals
were made (10 µm thickness). According to the tissue distribution of mTRPM3 previously
reported [1, 92, 157], TRPM3−/− mouse embryos at stage E13 was studied because this
stage of mouse development is characterized by the appearance of the choroid plexus and
the disappearance of the lens lumen [93]. Sectioned embryo stained for X-Gal activity (blue)
revealed that TRPM3 was highly expressed in the choroid plexus (Figure: 3.26A-B), inner
ear (Figure: 3.26C-D), eye (retina and lens, Figure: 3.26E-F, 3.27G), olfactory epithelium
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Figure 3.29: TRPM3–LacZ expression in frozen Caudal sections at stage 13
The cross–section levels of the hindlimb in the embryo (E13) are represented at the top right.
Section M: TRPM3 expression was evident in the hindlimb (b). Weak lacZ signals were also
found in the dorsal root ganglia and spinal cord (c-f). Dapi was used for counterstaining (f).
Section N: Paired umbilical arteries and one umbilical vein embedded in Wharton’s jelly within
the umbilical cord are shown (a). β-galactosidase activity was present in the umbilical ligament
(arrowhead, b), but not in the endothelia of the midgut (c-d) and endothelia of umbilical vessels
(e-h). Dapi was used for counterstaining. Abbreviations: Drg, dorsal root ganglion; Fp, foot
plate; Lmg, lumen of midgut; Mgl, mitgut loop; Pc, precartilage condensation within hindlimb;
Rh, right hindlimb; Spc, spinal cord; T, tail; Ua, umbilical artery; Uc, umbilical ligament; Uv,
umbilical vein; Wj, Wharton’s jelly.
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(Figure: 3.27H) and cartilage primordium of developing limb buds (Figure: 3.28, 3.29M). A
low level TRPM3 expression was also observed in the dorsal root ganglia (Figure: 3.27H),
the epithelium of tongue (Figure: 3.27I), the spinal cord (Figure: 3.29M) and the umbilical
ligament (Figure: 3.29N).
Table 3.3: LacZ gene expression in the lacZ transgenic TRPM3−/− mouse
Channel Tissue distribution Embryonic origina
Nervous
Cerebral cortex: layers I, IV, V and VI Neural tube, P84
Cerebellum:Purkinje and granule cell layers Neural tube, P84
Neural
Hippocampal formation: granular layer of the
dentate gyrus, pyramidal layer of the hippo-
campus proper
Neural tube, P7
Ependyma Neural tube, E12
Choroid plexus epithelium Neural tube, E8.5
Spinal cord Neural tube
Dorsal root ganglia Neural crest
Myenteric (Auerbach’s) plexus Neural crest, E9.5-14.5
Epidermis: melanocytes or Merkel cells Neural crest, E13
others
Heart: autonomic nervous tissues, connective
tissues, or constitutive/ectopic cardiac skeletal
elements
Neural crest, E8.5
Sensory
Eye (retina): neural layer (ganglion cell and
inner nuclear layers), pigment layer
Neural tube, E9.5
Eye (lens): epithelium and fibers Surface epithelium, E10
Eye: corneal epithelium Surface epithelium, E11.5
Epithelial
Inner ear: endolymphatic sac Surface epithelium, E10
Inner ear: semicircular canals Surface epithelium, E13
Olfactory epithelium Surface epithelium, E10.5
Uterine tubes: mucosa epithelium Coelomic wall epithelium
others
Islets of Langerhans Endoderm epithelium, P70
Limb buds: precartilage primordia Mesenchymal–epithelial
transformation, E12
Testis: spermatogenic cells or Sertoli cells Seminiferous epithelia, E14
Othersb kidney, lung, spleen, and umbilical ligament
ahttp://www.mouseatlas.org/data/mouse/devstages. E: embryonic day; P: postnatal day.
bThe cell types have not been determined
In summary, like the tissue expression observed in the adult mouse, TRPM3 was pri-
marily detected in the nervous and sensory systems of the mouse embryos such as choroid
plexus epithelium, neural and pigment layers of retina, inner ear, and olfactory epithelia.
Based on the expression pattern observed, the main role of mTRPM3 is likely to be in the
nervous and sensory systems. Therefor, after a general analysis of the phenotype, we briefly
looked in more detail at an aspect of sensory and nervous function of TRPM3.
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3.4 Phenotypic analysis of a TRPM3−/− mouse model
A major goal of this work was to investigate the phenotype of TRPM3 by preparing a
knockout allele. After characterizing TRPM3 knock–out mouse model, we focused on the
following questions: 1) is the TRPM3−/− mouse viable?; 2) what is its general appearance
such as coat color, posture and gait?; 3) does the TRPM3−/− mouse have physiological
defects, especially neuronal and/or sensory defects?
3.4.1 Genotyping and genetic background correction
Before preforming a phenotypic analysis, the TRPM3 mutant mice were to be genotyped
and tested for the presence of the mTRPM3 gene, mRNA and protein. Due to the mTRPM3
knockout procedure, the original lines carried a number of genetic backgrounds. For ex-
ample, they have 129S5EvBrd (A/A) and B6(Cg)-Tyrc−2J/J (a/a; c/c) genetic background
(Section: 2.2.8.1). It is known that the Agouti gene is involved in controlling melanocytic dif-
ferentiation in the skin in a paracrine manner [201] and mediating α-melanocyte–stimulating
hormone signaling pathway [122, 241], and the tyrosinase gene plays a critical role in the
melanin production [18]. In TRPM3 lacZ transgenic mice, the tyrosinase gene is mutated
(G291→T291). Therefore, to study the roles of mTRPM3 in the visual system (e.g., eye
pigment cells) and the melanocytes, it was necessary to remove these mutations.
In order to obtain mice heterozygous for the TRPM3 null allele, we mated two heterozy-
gotes (TRPM3+/−) with each other to produce an F1 generation. Theoretically, the F1
population will follow the principles of Mendelian segregation, resulting in 1/4 homozygous
mutants (TRPM3−/−), 2/4 heterozygotes (TRPM3+/−), and 1/4 homozygous wild–type
(TRPM3+/+). For genotyping and genetic background isogenization, touchdown PCR was
applied (Sections: 2.2.8.2 and 2.2.8.2). The homozygous TRPM3 knock-out mice (m/m)
were identified by using primer pairs against the gene trap insertion (PNeo), and primer
pairs against wild–type allele (PWt)5 (Figure: 3.31A, lane IV). Furthermore, Western blots
confirmed that the knockout mice lack TRPM3 protein expression (Section: 3.3.2.2). Ho-
mozygous Agouti mice (A/A) were selected from the homozygous TRPM3 knockout mice
using primer pairs against the non-Agouti (a) sequence (Figure: 3.31B, lane III). Among
the homozygous Agouti TRPM3 knockout mice (A/A; m/m), the homozygous non-albino
5Four primer pairs (not shown) against different positions in wild–type allele were used to ensure a
homologous genotype of TRPM3 knockout mouse.
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Figure 3.30: Generation of homozygous Agouti and non-albino TRPM3−/− mouse
The TRPM3 mutant allele (M/m) introduced by gene trapping is retrovirally infected into
the strain 129S5EvBrd-derived ES cells (A/A; M/M). After the ES cells have been injected
into the early embryos, the embryos are intermediately transferred to the recipient female mice
(strain B6(Cg)-Tyrc−2J/J (a/a; c/c; M/M)). The progeny mice which are heterozygous for the
TRPM3 mutation were mated with each other to produce homozygous Agouti and non-albino
TRPM3−/− mice
mice (C/C) was identified through DNA amplification and sequencing, by which the non-
mutated tyrosinase sequence shows only one distinct peak at position 540 (Figure: 3.31C,
bottom). Once the homozygous Agouti and non-albino TRPM3−/− mice (A/A; C/C; m/m)
were generated, they were used for some phenotypic analyses, e.g., the visual test.
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Figure 3.31: Generation of homozygous Agouti and non-albino TRPM3−/− mice
using genotyping and DNA sequencing
A: Primer pairs against the wild–type allele (PWt) and the gene trap insertion (PNeo) were used
to identify homozygous TRPM3 knock-out mice (m/m). Compared to wild–type (lane III) and
heterozygous (lane II) mice, homozygous TRPM3 knock-out mice were identified using PNeo
primer pairs, but not by using PWt primer pairs (lane IV). B: Homozygous Agouti mice (A/A)
were selected from homozygous TRPM3 knockout mice by using primer pairs against non-Agouti
(a) sequence. Thus, no signals of homozygous Agouti mice were observed in the DNA gel (lane
III). H2O (lane IV) and DNA sequence of an albino mouse (lane I) were used as negative and
positive controls, respectively. C: The non-mutated tyrosinase sequence of homozygous non-
albino mouse (C/C) was found through DNA amplification and sequencing. The sequence has
only one peak at position 540 (bottom) in comparison with it in the heterozygous non-albino
mouse (C/c, top). Abbreviations: PWt, primers against wild–type allele; PNeo, primers
against gene trap insertion; Ho, homozygous; He, heterozygous; Wt, wild–type.
3.4.2 The viability of TRPM3−/− mice
To assess the role of TRPM3 in normal development, TRPM3+/− mice were bred with
each other. From a total of 204 animals, we observed that homozygous TRPM3−/− mice
are viable and fertile. TRPM3+/− mice have a normal Mendelian ratio of genotypes in the
offspring (51:104:49 for TRPM3 wild–type:heterozygous:homozygous mutant mice), with no
gender bias (99:105 for male:female). Thus, although TRPM3 is highly conserved among
the members of TRPM subfamily, its loss does not affect its survival.
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3.4.3 Morphological observations on TRPM3−/− mice
To assess their general health, we monitored the physical appearance of the mice. Both
TRPM3 knock–out male and female mice are indistinguishable from their wild–type and
heterozygous littermates by gross observations. The TRPM3 wild–type, heterozygous and
knock–out mice routinely engage in grooming behavior. No differences in coat color (white–
bellied agouti) and whisker thickness of mice were observed. The ear pinnae and footpads
are pink colored – a sign of good health. The body size and weight of adult mutant
mice and their littermate controls were recorded weekly, but no difference was found (data
not shown). No abnormalities in posture and gait of TRPM3−/− were detected during a
5-minute session in an open field (Figure: 3.32A). No distinct morphological differences
between TRPM3 wild–type and knockout mice were observed at E9, 9.5, 11.5, 13, 14
(Section: 3.3.3.2). In summary, no gross morphological changes were detectable between
TRPM3+/+, TRPM3+/−, TRPM3−/− mice. The TRPM3−/− mouse is apparently healthy.
3.4.4 Behavioral analyses of the visual ability of TRPM3−/− mice
As described above, TRPM3 is mainly found in nervous and sensory tissues (Section: 3.20).
Because behavioral analyses of visual ability can be used to test the neuronal and sensory
functions of mice, some basic tests of mouse visual ability such as the visual placing test
and visual cliff test were performed.
The visual placing test showed that TRPM3−/− mice (n=8) extended their forepaws
for landing when they were slowly lowered towards the table surface (Section: 2.2.8.3).
This result indicates that the TRPM3−/− mouse is not blind. In the visual cliff test, 11
TRPM3−/− mice (mTRPM3-KO) and 12 TRPM3+/+ mice (mTRPM3-WT) were evaluated
for their gross visual ability in a visual cliff apparatus (Figure: 2.9). Each mouse was tested
for 10 consecutive trials. Figure 3.32B demonstrates that the mean percent correct was
78.2% (SE ± 4%) for the mTRPM3-KO mice and 85.8% (SE ± 2.3%) for the mTRPM3-
WT mice (P = 0.11). These data imply that the TRPM3−/− mice show normal visual
behavior and have gross visual ability.
In summary, although TRPM3 is highly conserved, the phenotype of its mutation in
the TRPM3 is minor. The TRPM3−/− mouse is viable, fertile and healthy. So far, we
can conclude that the TRPM3−/− mouse has normal visual ability, motor behavior (e.g.,
posture and gait) and general appearance (e.g., grooming behavior, coat color, body size
and weight).
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Figure 3.32: Phenotype of TRPM3−/− mice and visual testing
A: No distinct differences in general appearance (e.g., coat color) or activity were observed
between TRPM3 knock–out and wild–type mouse (male, 16 weeks). B: TRPM3−/− mice
showed intact gross visual ability as compared to TRPM3+/+ mice. The percentage of time
the mice spent moving on the horizontal plane (“safe” side) was recorded. Values indicate the
group means ± SEM. Unpaired Student’s t-test was used for statistics. The total number of
tested mice was shown as numbers above the bars.
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TRPM3 is a prototypical melastatin channel in the chordate. Several publications con-
cerning its mRNA sequences, splicing variants, function, and expression pattern have been
published before and during this work. In many regards, the findings show disagreements,
even between mouse and human species. Therefore, there is still considerable need for ad-
ditional studies to address TRPM3’s biological role at the cellular and whole animal level.
We cloned two new TRPM3 splice variants from mouse kidney: mouse TRPM31719
(mM31719) and mouse TRPM31337 (mM31337). Both variants were functionally expressed
in heterologous expression systems. Heterologously expressed mM31719 and mM31337 form
Ca2+–permeable channels that are constitutively active. The molecular structure and chan-
nel properties of mM31719 were analyzed by using different molecular biological approaches.
The tissue expression profile of mTRPM3 was established down to the cellular level by
means of a lacZ TRPM3−/− mouse. Despite TRPM3’s high level of conservation and its
broad expression, the TRPM3−/− mouse is viable and has similar general appearance to
the wild–type mouse.
4.1 Molecular cloning and functional analysis of mM31719 and
mM31337
4.1.1 Cloning and characterization of mM31719 and mM31337
Using 5’-RACE and PCR, mM31719 and mM31337 were cloned from mouse kidney. The
sequences were analyzed by DNA sequencing and the ClustalW2 software. The general
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structural features of the mM31719 and mM31337 sequences include: 1) the first coding exon
corresponds to the exons known for human TRPM31325 and a human full–length TRPM3
splice variant (unpublished data of our group); 2) N–termini contain a large homology
region; 3) both variants have conserved pore helices, selectivity loops, and pore structures.
The pore lacks a short amino acid stretch (additional 13 amino acid residues) found in
previously published splice variants [157] ; 4) mM31337 is 382 amino acid residues shorter
than mM31719 in the C–terminus (Figure: 4.1).
Figure 4.1: TRPM3 protein isoforms
The TRPM3 protein isoforms are basically distinguished by their different N–, and/or C–
terminus architectures resulting from alternative splicing. The different amino acid residue
sequences are labeled with different colors. The TRPM3 isoforms with channel activity are
highlighted with blue bars. Modified from Oberwinkler et al. [2005].
To further investigate the functional properties, both variants were subcloned into the
pcDNA-3.1 expression vector, and their protein expression tested after heterologous expres-
sion in HEK-293 cells. Western blots showed that mM31719 and mM31337 had strong protein
expression levels in HEK-293 cells. The subcellular localization of mM31719 and mM31337
were mainly detected in the intracellular compartments by immuno–staining, although they
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were also occasionally found at the plasma membrane. Because this intracellular localization
pattern may not reflect the physiological pattern for mTRPM3 expressed in vivo [155, 156],
and TRPM3 has also been suggested to be involved in the functions of epithelial cells
[68, 70], we used MDCK cells as a cell model to study the mM31719 expression pattern
in a differentiated epithelium. Because the differentiated MDCK cells are largely untrans-
fectable and because mM31719 expression in undifferentiated MDCK cells was also observed
to be in the intracellular compartment, we generated a stable MDCK cell line which in-
ducibly expressed HA–tagged mM31719 (M3pGene cells) to study the subcellular localization
of mTRPM3 in the epithelia. When M3pGene cells were grown on a semi–permeable filter
to form differentiated cells, protein expression of mM31719 was exclusively detected in the
basolateral plasma membrane.
Many regulatory pathways or agents have been considered to be involved in the regu-
lation of the TRPM3 channel activities. We used aequorin– and/or fura-2–based methods
to measure
[
Ca2+
]
i changes in HEK-293 cells expressing mM31719 and mM31337, upon the
extracellular applications of thapsigargin (1 µM), hypo–osmolality, D–erythro–sphingosine
(20 µM), Ca2+ (10 mM) or PS (50 µM). In agreement with the studies reported by Grimm
et al. [2003] and Oberwinkler et al. [2005], mM31719 and mM31337 are constitutively active
and Ca2+–permeable. Ca2+ steps resulted in the increase in
[
Ca2+
]
i. Although mM31719
and mM31337 can be activated by PS, which was also observed by Wagner et al. [2008] us-
ing another TRPM3 isoform, the PS concentration needed for activation (in the micromolar
range) is unlikely to be physiologically important for TRPM3. The possibility that similar
substances work at lower concentration is further investigation needed. In contrast to the
studies published by Grimm et al. [2005], Harteneck et al. [2007] and Lee et al. [2003],
D–erythro–sphingosine, hypo-osmolality and thapsigargin did not result in the increased[
Ca2+
]
i in mM31719 and mM31337 expressing cells compared to controls. These differences
may be due to different TRPM3 spice variants used in the experiments. Our results in-
dicate that mM31719 and mM31337 are not SOC, osmolality–regulated and lipid–activated
channels, but are constitutively active Ca2+–permeable channels.
We found that TRPM3 is a constitutively active Ca2+–permeable channel. Therefore, we
wanted to find ions which block Ca2+ influx through TRPM3. Based on a close phylogenetic
relationship to TRPM7 in which the trace divalent ions play an important role, we tested
Cd2+, Co2+, Cu2+, Mg2+, Mn2+, Ni2+, Sr2+ and Zn2+ to investigate whether they have
effects on Ca2+ permeation through mM31719. With the exception of Mg2+, other ions
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noted above (1 mM) reduced Ca2+ influx through mM31719 (Figure: 3.5). Furthermore,
we tested a series of Ni2+ and estimated the IC50 value for Ni2+ inhibition of Ca2+ entry
through mM31719 (Figure: 3.4). However, at high concentrations divalent metal ions (≥1
mM) may be toxic to cells in the cell culture [86]. Thus, we conclude that divalent ions
probably affect the Ca2+ permeation through mM31719, and Mg2+ does not inhibit mM31719
Ca2+ entry at the physiological concentration.
4.1.2 Mutagenesis analysis of the pore
Our experimental results show that mM31719 is permeable to Ca2+. Therefore, we tested
whether the pore plays a role in cation permeation through mM31719. The function of the
pore was analyzed using site–directed mutagenesis method.
According to published work on TRP channels and sequence homology to the bacte-
rial K+ channel (KcsA channel), the proposed structural basis of the TRPM3 pore region
contains a hydrophobic pore helix and a hydrophilic selectivity loop [149, 161, 215, 244].
In TRPM3, the putative pore helix and selectivity loop are proposed to be formed by
amino acid residues Pro1060 to Tyr1065 and Ala1070 to Arg1075, respectively [149, 244]. For
a visual presentation, a model for mM31719 pore structure was generated using ClustalW2
and Swiss Model Workspace software (Section: 1.3.1.2). In this model, the TM5 domain
faces the lipid membrane, whereas the TM6 domain lines the pore region. Four TM5–
pore–TM6 subunits are thought to form a putative cation–permeable channel (Figure: 4.2)
[9, 42, 61, 191, 228, 249].
Based on various studies with TRPM4, TRPM6 and TRPM7, Pro1060, Gly1066, and
Asp1074 were replaced by Arg1060, Val1066, and Ala1074, respectively (Section: 3.2.1.1). The
functional data for these mutants were obtained from an aequorin–based intracellular Ca2+
assay. The experimental findings show that Pro1060 within the pore helix and Gly1066 within
the linker between the pore helix and selectivity loop are essential for the mM31719 chan-
nel activity: 1) Pro1060 and Gly1066 are highly conserved among the members of TRPM
subfamily; 2) P1060R and G1066V mutations resulted in a loss of channel function (Sec-
tion: 3.6); 3) because the Pro1060–induced helix kink may expose of carbonyl oxygens which
are in turn capable of binding cations [186], the mutation of Pro1060 may influence the
cation binding in mM31719; 4) because glycine confers a high conformational flexibility on
the protein chain and probably plays a role in the loop formation [100, 229], a change in
the conformation of the loop of mM31719 could be induced by the Gly1066 mutation.
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Figure 4.2: Pore model of mM31719 using KcsA channel as template
A pore model for mM31719 was generated by using ClustalW2 software and Swiss Model
Workspace [9, 42, 61, 191, 228, 249]. The side (A) and top (B) views of the mM31719 pore
structure are shown. A: The TM5 domain faces the lipid membrane, while the TM6 domain
lines the pore region. The amino acid residues in TM5 and TM6 are colored in red. The
pore helix, selectivity loop, and amino acids to be mutated (P1060R, G1066V, D1074A) in the
pore region are indicated in red, blue, and green, respectively. B: A putative cation–permeable
channel is formed by 4× the TM5–pore–TM6 domains from four subunits.
The ion selectivity of the channel depends on the structure of the selectivity filter. In
the bacterial K+ channel, carbonyl oxygens line the walls of the selectivity filter and form
transient binding sites for dehydrated K+ ions [42]. The selectivity loop of mM31719 has
two acidic residues (Asp1071 and Asp1074) which could provide carbonyl oxygen atoms [42]
or amino acid side chains [228] to line the pore structure. Nilius and colleagues found that
mutation of Asp984 within the TRPM4 selectivity loop1 yielded a non–functional channel
with a dominant negative phenotype [149]. However, this result was not observed in the
experiment with mM31719, in which the Asp1074 was substituted by an alanine. In spite
of this, Ca2+ influx through mM31719 was decreased as a result of the neutralization of
Asp1074 (Section: 3.2.1.1). This observation indicates that Asp1074 may be involved in the
formation of the selectivity filter, but is not the ion interaction site per se. Thus, Asp1074
seems not to be an important determinant for mM31719 Ca2+ permeation. The possible
structural elements (e.g., critical amino acid residues and pore diameter) that determine
the selectivity filter function of mM31719 need further investigation.
In addition, all mM3-RYW, mM3-VEV, and mM3-AP mutants were co-expressed with
1Asp984 in TRPM4 is correspondent to Asp1074 in mM31719.
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wild–type mM31719. No dominant negative effects of them were observed by means of an
aequorin–based intracellular Ca2+ assay (Figures: 3.6 and 3.7). We interpret these findings
as an indication, that all or at least the majority of these residues have to be mutant within
a multimeric pore in order to disrupt Ca2+ entry.
In summary, the two murine cDNAs we identified are strictly homologous to the one we
have identified in human brain. In contrast to the latter, they are expressable in heterologous
cell models and encode constitutively active Ca2+–permeable ion channels.
4.2 Molecular structure and functional relevance of the C–
terminus
Because the N–terminus is highly conserved throughout the TRPM subfamily and the struc-
ture and function of the C–terminus are unknown, we focused on analyzing the functional
components of the C–terminus of mM31719. Apart from TRP and Coiled–Coil (C–C) do-
mains, no other functional elements have been reported in the C–terminus of mTRPM3.
To elucidate its molecular structure and functional relevance, the C–terminus of mM31719
was studied using different methods including molecular cloning, immuno–staining, FRET,
confocal microscopy, site–directed mutagenesis, and the yeast two hybrid system (Y2H)
(Section: 3.2.1.2).
4.2.1 C–terminus of mM31719 and palmitoylation
The cDNA sequence of the mM31719 C–terminus (M3TC, amino acid residues 1166–1719)
was amplified by PCR and cloned into the pcDNA3.1/V5-His-TOPO® vector. A YFP tag
was added to its isolated C–terminus by means of in–frame fusion. The immunofluores-
cence signal of the YFP–tagged M3TC was found to be exclusively localized at the plasma
membrane of the HEK 293 cells.
Attachment of soluble protein to the cytosolic plasma membrane could be due to: 1)
a covalently attached lipid anchor such as isoprenoid, palmitoyl or myristoyl groups (Sec-
tion: 3.2.1.2); 2) non-covalent interactions (e.g., electrostatic interactions and hydrophobic
bonds) with other membrane proteins; 3) lipid–binding motifs (e.g., pleckstrin homology
(PH) domain). Using different ligands activating signaling pathways ultimately result-
ing in PLC stimulation, phospholipid binding domains (e.g., PH domain) were found to
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be unlikely. Subsequently, N -myristoylation (Section: 3.2.1.2) was ruled out, because N -
myristoylation is a stable co-translational lipid modification process and the typical recogni-
tion motif (Met-Gly-X-X-X-Ser/Thr) is not present in the C–terminus of mM31719. Farne-
sylation (Section: 3.2.1.2) and palmitoylation of cysteine residues provide the other covalent
modification mechanism. Hence, to study whether farnesylation and/or palmitoylation are
involved in the mM31719 C–terminus membrane attachment, all of the cysteine residues in
the C–terminus were mutated. The cysteine residues of the mM31719 C–terminus were step-
wise replaced by serine residue (Section:3.2.1.2). The results indicate that the amino acid
residues Cys1174–Cys1175 are involved in the protein–membrane attachment. Furthermore,
this finding also implies that palmitoylation is probably responsible for the C–terminus
membrane attachment, because 1) the cysteine residue for farnesylation is located four
residues from the protein’s C-terminus, but the Cys1174–Cys1175 residues are found to be
much more N–terminal, and 2) palmitoylation is most common protein–lipid modifica-
tion among the integral and peripheral membrane proteins [224]. In order to study the
functional implication of palmitoylation in mM31719 membrane attachment, we applied 2-
bromopalmitate (2-BP) (a palmitoylation inhibitor), and generated a mM31719-SS mutant
of the whole channel cDNA (Cys1174–Cys1175 to Ser1174–Ser1175 mutations). The results
imply that: 1) palmitoylation probably mediates Cys1174–Cys1175 membrane attachment;
2) palmitoylation of the C–terminus exerts influence on the mM31719 channel function, al-
though it does not change the mM31719 expression pattern in HEK-293 cells; 3) besides the
C–terminus, palmitoylation could also occur in the N–terminus or transmembrane domains
of mM31719, because Ca2+ influx through mM31719-SS mutant with 2-BP treatment is much
less than Ca2+ influx through mM31719-SS mutant without 2-BP treatment (Figure: 3.10E-
F).
Although the mechanisms by which the membrane–bound Cys1174–Cys1175 influence
mM31719 channel activity are not understood, it can be assumed that 1) palmitoylation
targets mM31719 to some specialized lipid microdomains on the cytosolic face of the plasma
membrane where mM31719 function as a cation channel [45]; 2) palmitoylation may affect
the interaction of mM31719 with other ion channels or signal molecules; 3) palmitoylation
may be a basolateral localization signal for mM31719; 4) attachment of Cys1174–Cys1175 to
the membrane possibly stabilizes the functional homomer structure of mM31719.
According to the sequence alignments, both Cys1174 and Cys1175 are highly conserved
among the TRPM3 isoforms, but are not present in the other members of TRPM subfamily
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Table 4.1: Domain composition of mM31719
Domain Putative biological role Ref.
TRP domain — —
palmitoylation site subcellular trafficking —
Coiled–Coil domain multimer assembly [218]
PKIG binding site PKA signaling —
(data not shown). However, other cysteine residues might fulfill their function in other
TRP channels. For example, palmitoylation of a stathmin-2 domain in the N–terminus of
TRPC5 is involved in the loading of TRPC5 in transport packets directed into growth cones
[57]. Thus, the modification of Cys1174 and Cys1175 of mM31719 by palmitoylation may be
unique for TRPM3 in the TRPM subfamily.
4.2.2 C–terminus of mM31719 and homomultimerization
Because all TRP channels are thought to form tetramers as functional units [95, 187], it is
likely that mM31719 is expressed as a multimer to form a functional pore structure. Sup-
porting the possibility of homomultimerization, the interactions between mM31719 subunits
were confirmed by using Co-IP and FRET techniques (Figures: 3.12 and 3.11). Additionally,
the results from Co-IP and Y2H show that the interaction site for mM31719 homomultimer-
ization may lie in the C-terminus in a region from the amino acid residues 1133 to 1337
(Section: 3.2.2). This finding is consistent with previously reported studies in which the
Coiled–Coil (C–C) domain was suggested to be responsible for the self–tetramerization of
TRPM3 [218]. The contribution of the C–terminus in the self–association of channels is
also found in other TRP channels. For example, the interaction sites of TRPV1 subunits
[54] and TRPM8 subunits [48] are located in the TRP domain and Coiled–Coil (C–C) do-
main, respectively. In the case of TRPM3, we found that the protein sequence required
for channel multimerization resides in the C–terminus sequence of both new splice variants,
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and, therefore, might also be the TRP domain or C–C domain.
4.2.3 C–terminus of mM31719 and its putative interaction partners
Many membrane proteins such as ion channels regulate cell function by forming molecular
complexes with binding partners [7]. Therefore, to understand the physiological role of
mM31719, it is important to identify other proteins with which it interacts. To minimize
the identification of false positive protein interactions (Section: 2.2.4.1), a GAL4–based
yeast two hybrid (Y2H) screening was conducted because the AH109 yeast strain of this
Y2H system contains four reporter genes which are under the control of three completely
heterologous Gal4–responsive UAS and promoter elements–GAL1, GAL2, and MEL1 [87].
Because no functional elements in the C–terminus of mM31719 have been described, the
M31719 C–terminus (M3CT, residues 1133–1719) was chosen as a “bait” to screen a human
kidney cDNA library to identify potential binding partners for M31719 (Section: 3.2.3).
A list of confirmed hits was obtained by using either high or medium stringency se-
lection procedures (Tables: 3.1 and 3.2). The majority of these would not be necessarily
involved in channel function and will require a more detailed analysis. We investigated one
example, cAMP–dependent protein kinase inhibitor gamma (PKIG), in more detail, be-
cause Ca2+ influx through mM31719 was increased when the cells expressing mM31719 were
pre–incubated with db-cAMP. The evidence for a protein–protein interaction between the
C–terminus of mM31719 and PIKG were verified by Y2H. The binding site for PKIG may be
located between or involve the amino acid residues 1338–1719 of the mM31719 C–terminus,
because no interaction between the C–terminus of mM31337 and PKIG was observed by
Y2H (Figure: 3.14). However, no effects of PIKG on the mM31719 channel activity was
found in the experiment using aequorin. Therefore, whether PKA signaling plays a role in
the mTRPM3 function needs to be investigated further.
Crystallin–alpha B (CRYAB) and eukaryotic translation elongation factor 1 alpha 1
(EEF1A1) are also proteins of interest. Crystallin-alpha (alpha A and alpha B) are basic
structural proteins of the vertebrate lens. Compared to crystallin-alpha A which is mainly
found in the lens, CRYAB is widely expressed in different tissues such as lens, brain and
kidney. Accumulation of CRYAB in the brain is associated with some neurodegenerative
diseases such as multiple sclerosis (MS) and Alzheimer disease [205, 222]. Mutation of
CRYAB might lead to cataract formation because crystallin has a major contribution to
the refractive power and translucency of the lens [17]. Combined with the findings noted
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in Section 4.3.1, the hypothesis could be proposed that the interaction of mM31719 with
CRYAB in the lens epithelium might be involved in the lens ion–homeostasis underlying
the regulation of mM31719. EEF1A1 transfers each aminoacyl-tRNA molecule onto the ri-
bosome. Because EEF1A1 is bound to GTP, it raises the possibility that the C-terminus of
mM31719 may contain a specific GTP interacting site (e.g., GTP kinase domain). Hence,
mM31719 might be involved in G-protein regulated signal cascade. However, all such as-
sumptions need to be confirmed by different biological and biochemical approaches.
4.3 Expression pattern of mouse TRPM3
4.3.1 Expression analysis of TRPM3 in mouse tissues using Northern
blot, antibodies and lacZ staining
It was hitherto believed that TRPM3 gene expression was restricted to a limited number
of tissues. For example, human TRPM3 (hTRPM3) is highly expressed in the kidney,
while mouse TRPM3 (mTRPM3) is primarily detected in the brain, but not in the kidney
[58, 106, 155, 157].
To investigate mTRPM3 expression, we initially carried out Northern blot analysis.
Except for brain and eyes, no mRNA transcripts were detected in other tissues including
the kidney (Figure: 3.3.1). These data are in line with the results reported by other re-
search groups [58, 106, 157]. For the detection of TRPM3 protein, commercially available
and own antibodies were used and characterized by Western blot and immunostainings.
However, the commercially available antibodies were distinctly unspecific for mTRPM3 in
both immunofluorescence staining and in Western blots (data not shown). Our peptide
antibodies displayed strong background staining in cryosection, although they worked well
in the immunocytochemical staining in overexpression models. Our peptide antibody was
also used to detect TRPM3 protein expression in native mouse tissue (eyes). In agreement
with the Northern blot, TRPM3 protein expression was found in the eyes of TRPM3 wild–
type mouse (but not in the TRPM3 knockout mouse). The molecular mass (>170 kDa)
was consistent with the calculated molecular mass of mM31719 (ca. 190 kDa) and with the
molecular mass seen in HEK-293 cells expressing mM31719. These results indicate that the
long isoforms, like mM31719, are the major cDNAs expressed in the mouse eye.
The Northern blot has a high specificity so that the false positive results are unlikely.
However, it has a low sensitivity, and thus signals resulting from weak gene expression may
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be missed [206]. Application of specific antibodies is another conventional experimental
method to study gene expression. Nevertheless, the antibodies against TRPM3 applied in
the immunohistochemical staining (cryosection) had a strong background signal. Therefore,
to investigate the expression pattern of TRPM3 more precisely, we purchased a TRPM3
knockout mouse whose TRPM3 gene was disrupted by Gene Trapping using a lacZ reporter
gene construct (Figure: 2.8). The β-galactosidase encoded by lacZ gene was detected by
X-Gal staining. Compared to immunostaining, lacZ staining is highly sensitive at the single
cell level [46] and has very low background [28].
Whereas no lacZ signals were observed in vascular tissues, smooth muscles of the gut,
and most of the viscera, we could detect isolated signals in testis, kidney glomerulus, and
pancreatic islet. The latter is in line with a recent report by Wagner et al. [231], which
reports that TRPM3 is detectable in pancreatic islets. Whereas the lacZ signals were rather
rare in those organs of mesodermal origin that were studied by Northern blot, TRPM3 sig-
nals were most abundant in neuronal/ectodermal tissues. According to the lacZ staining,
mTRPM3 expression is primarily found in the cerebral cortex (layers I, IV, V and VI),
cerebellum (Purkinje and granule cell layers), dentate gyrus (granule cell layer), hippocam-
pus proper CA1-CA3 (pyramidal cell layer), neural layers of retina (ganglionic and inner
nuclear layers) and myenteric (Auerbach’s) plexus. All of these tissues are of neuroecto-
dermal origin. Other noteworthy expression signals were seen in the embryonic ear bubble,
olfactory epithelia and dorsal root ganglion.
In summary, our expression studies showed a predominant expression of mTRPM3 in
sensory and neuronal cells of ectodermal origin.
4.3.2 Mouse TRPM3 and subcellular localization
Epithelial cells and neurons, two types of polarized cells, exhibit functional as well mor-
phological polarity, i.e. different functions are associated with two distinct morphologic
surface domains: apical/axonal and basolateral/somatodendritic domains [3, 179, 204]. For
example, the somatodendritic domain receives and processes signal information, while the
axonal domain is responsible for the rapid transmission of electrical impulses [20, 134]. To
generate this cell–surface polarity and be able to perform their physiological function, cells
need to target newly synthesized proteins (e.g., ion channels) and lipids to the appropriate
domains of cell membranes [138, 252].
As far as we know, regulation of
[
Ca2+
]
i by TRP channels is often restricted to some
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specific microdomains in polarized cells [19, 135, 170]. For example, the TRPV4 channel
is localized basolaterally in the epithelial cells of kidney where it responds to osmolality
changes and triggers Ca2+ influx [68, 112, 212]. The TRPV4 channel is also observed in the
apical membrane of the ciliated epithelia where it functions as a mechano- and thermosensor
in the regulation of ciliary beat and cell volume [68, 102, 111]. Mouse TRPM3 was localized
basolaterally in the M3pGene MDCK cell line (Section: 3.1.2). This result indicates that
mTRPM3 is localized in the basolateral domain of epithelial cells and thus, probably resides
in the somatodendritic compartment, rather than the axon, in neurons.
4.3.3 Mouse TRPM3 expression and its biological roles
Since mTRPM3 is primarily expressed in nervous and sensory tissues, the discussions of
suggestive biological roles of mTRPM3 are focused on the hippocampal formation, choroid
plexus epithelium and eye (retina and lens) where the most lacZ staining was observed.
The mammalian choroid plexus (CP) is a highly ramified vascular structure composed
of a layer of cuboid epithelial cells derived from ependymal cells which surround a core of
capillaries and loose connective tissue. The CP produces cerebrospinal fluid (CSF) which
nourishes the brain and protects the developing and mature brain from trauma. CSF
secretion involves ion movement across the epithelium from the blood to the ventricles and
is achieved by the asymmetrical distribution of ion transporters and channels in the apical
or basolateral domain of the CP epithelial cells. The ion movement gives rise to an osmotic
gradient which drives H2O secretion isosmotically [23]. In the TRP superfamily, TRPV4 is
expressed in modified ependymal cells of CP and may act as a mechano- and thermosensitive
sensor for epithelial homoeostasis [68, 129]. Because mTRPM3 is strongly expressed in the
modified ependymal cells lining the CP and because mTRPM3 is localized in the basolateral
domain of the epithelium, it could be hypothesized that mTRPM3 may be involved in the
generation of an electrical gradient for ion transport (e.g., Ca2+) via unknown pathways.
TRPM3 has also been reported to be responsive to extracellular hypo-osmolality [68, 70].
However, we could not reproduce the functional data published by Harteneck et al. [68, 70].
Thus, TRPM3 should not be considered as an osmo–sensor in the CP.
The most important function of the hippocampal formation is in learning and mem-
ory. Ca2+ plays a pivotal role in the molecular mechanisms underlying the formation of
memories, especially long–term synaptic potentiation (LTP) and depression (LTD). Depo-
larization of the post-synaptic neuron (e.g., somata or dendritic spines) leads to Ca2+ entry
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which in turn triggers LTP [143]. TRPC5 [57], TRPC6 [160], TRPV1 [55], TRPM2 [69, 116]
and TRPM7 [245] have been reported to be expressed and play an important role in the
mouse hippocampal formation (e.g., TRPC5 may be involved in the regulation of hippocam-
pal neuron development [57]). Because mTRPM3 is highly expressed in the hippocampal
formation (especially the granule cell layer of dentate gyrus and the pyramidal cell layer
of hippocampus proper (CA1-CA3)), it may play a role in learning and memory formation
and its underlying mechanisms. To evaluate learning and memory abilities in TRPM3−/−
mice, behavioral experiments should be applied in future studies to clarify these questions.
We found mTRPM3 in several sensory organs, but focused on the eye. The observation
that considerable mTRPM3 expression is detected in the retina (pigment epithelium, gan-
glion cell and inner nuclear layers) and lens (epithelium and fibres) raises the possibility
that mTRPM3 plays a role in visual function. Therefore, visual ability tests such as visual
placing and cliff tests were performed with TRPM3−/− mice. However, the TRPM3−/−
mice were found to be not blind and their overall visual ability (e.g., depth perception)
remained intact (Section: 3.4.4). Though mTRPM3 might, for instance, multimerize with
other ion channels in retinal cells, the main conclusion now is that mTRPM3 does not
play a major role in the primary sensory processes. However, mTRPM3 might still con-
tribute to more subtle aspects of visual processing at the level of retina. Some studies also
suggested that mTRPM3 could be a candidate gene for “early-onset pulverent cataract”
(CAAR) [106, 147]. CAAR is an autosomal recessive form of hereditary cataract caused by
mutations in the alpha-A crystallin gene [74]. The alpha-A and alpha-B crystallins are two
subunits of alpha crystallins which together with beta and gamma crystallins constitute ca.
90% of the soluble protein of the vertebrate eye lens. The alpha-B crystallin is considered
to be involved in the formation of dominant congenital posterior polar cataract in human
[17]. Y2H assay showed that mTRPM3 interacts with alpha-B crystallin (Table: 3.2). Thus,
mTRPM3 may play a role in the regulation of protein solubility and cataract formation in
the lens via alpha-B crystallin.
4.4 Phenotype of the TRPM3 knockout mice
We obtained TRPM3 knockout mice offered by Lexion genetics. Before the phenotypic
analysis, the mouse was genotyped and its genetic backgrounds were isogenized for skin col-
oration markers (Agouti (A), tyrosinase (C)). The absence of mTRPM3 protein expression
in the TRPM3−/− mouse was confirmed by Western blot. Two heterozygotes (TRPM3+/−)
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were mated with each other to produce an F1 generation. The results from the phenotyping
of the F1 generation showed that the TRPM3−/− mouse is viable with a normal Mendelian
offspring ratio. Compared to the TRPM3 wild–type mouse, no differences of general ap-
pearance such as grooming behaviors and coat color were observed. Body size and weight
are normal compared to the TRPM3+/+ mouse. Its motor behavior such as posture and
gait are normal, and no evidence for ataxia was found. Based on the high expression
of mTRPM3 in retina, we performed initial studies on vision. However, the TRPM3−/−
mouse’s overall visual ability is intact. Although TRPM3 is highly conserved in the TRPM
family, the mutation in the TRPM3 gene did not appear to exert a major influence on its
phenotype.
In summary, we found that mTRPM3 is highly Ca2+ permeable and, to a considerable
extent, constitutively active, like a number of TRP channels (e.g., TRPM6 and TRPM7).
Besides TRP and C-C domains, palmitoylated Cys1174–Cys1175 residues and a putative
binding position for channel homomultimerization were detected in the TRPM3 C–terminus.
While TRPM1 expression is restricted to a few tissues (e.g., pigmented cells), TRPM3 is
wildly expressed in variety of cells and tissues, and is especially strong in the nervous and
sensory systems. Unlike the TRPM6−/− mouse [232], the TRPM3−/− mouse is viable and
not embryonically lethal. The phenotypic analysis showed that the TRPM3−/− mouse lacks
morphological and behavioural defects, and its overall visual ability is intact.
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TRPM3 is a highly conserved melastatin–like transient receptor potential (TRP) gene with
direct orthologs in all chordates and close homologs in all bilateral animals. So far, little is
known about its biological role, activation mechanism, expression pattern and the functional
role of its domains. The aim of this work was to clone a cDNA of mouse TRPM3, to express
it in in vitro overexpression models and evaluate its function, to raise antisera against
TRPM3 in order to determine its cellular expression profile in the mouse and, finally, to
obtain a knock–out allele in the mouse in order to assess its biological role.
1. In this work, we cloned two cDNAs of mTRPM3, both starting with the unique start-
ing exon we had identified in a 5'–RACE study. One variant is 1337 amino acids
long and has a shorter C–terminal domain than the other, which has 1719 amino
acid residues. Both splice variants are readily expressable in HEK-293 cells. Plasma
membrane localization was greatly augmented by stable inducible expression in dif-
ferentiated, polarized MDCK cells, where mTRPM31719 resided in the basolateral
compartment. When overexpressed in HEK-293 cells, TRPM3 was unresponsive to
hypo- or hyperosmolar stimuli, D–erythro–sphingosine and protocols used to elicit
store–operated calcium entry. Instead, we observed a robust constitutive calcium
entry through TRPM3, which was seen with both splice variants and abolished by
point mutations in the pore domain.
2. We confirmed by means of fluorescence resonance energy transfer (FRET) and co-
immunoprecipitation that TRPM3, like other TRP channels, forms multimeric chan-
nel complexes. The C–terminus of TRPM3 was found to attach to the plasma
membrane through a palmitoylation of a dual–cysteine motif, a modification that
quantitatively affected calcium entry through TRPM3. In a systematic yeast two
hybrid screen of a kidney library against the C–terminus of TRPM3, we identified
a number of candidate interaction partners of TRPM3, including alpha-B crystallin
and protein kinase inhibitor gamma (PKIG).
3. We investigated the TRPM3 expression pattern by a combination of Northern blots,
Western blots and lacZ stainings in a mouse model based on the GeneTrap approach.
We found TRPM3 to be mainly enriched in eye and brain tissues, but, unlike human
TRPM3, very low levels in kidney. Using lacZ staining of cryostat sections, TRPM3
was detected mainly in sensory tissues like the bipolar and gangion cell layers of the
eye, the embryonic ear bubble and dorsal root ganglia. In the brain, a considerable
enrichment of TRPM3 gene activity was seen, among others, in various neuron popu-
lations of the hippocampus formation (dentate gyrus, CA1, CA3), the Purkinje cells
layer, and the neocortex. Thus, TRPM3 is mainly expressed in cells of ectodermal
origin.
4. We characterized a mouse model in which TRPM3 had been targeted by a gene
trap insertion. We confirmed the gene trap insertion by means of PCR, we con-
firmed the absence of the protein in eye tissues by means of a Western blot using a
newly made peptide rabbit antiserum, and we isogenized the genetical background
for skin coloration markers using Mendelian crosses. A basic study of TRPM3’s
phenotype showed the absence of morphological and overall behavioural defects and
complete viability of the mutant. Further assays addressing the visual abilities of
the TRPM3−/− mouse showed no signs of blindness.
In summary, we cloned cDNAs of TRPM3, expressed them in vitro and found that TRPM3
is calcium–permeable and constitutively active. TRPM3 is palmitoylated on its C–terminus
and interacts with a variety of proteins we identified by a yeast two hybrid approach, many
of them novel in this regard. TRPM3 is highly enriched in sensory and central nervous
tissues. The TRPM3−/− mouse is viable without any major neurological or sensory defect
as far as tested. Further investigation on tissues which will have to address the specific
function of TRPM3 where it is enriched.
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